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General 
 
h   Study 
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f   Number of arms 
k   Number of therapists 
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m   Arithmetic mean cluster size 
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n   Number of patients, or sample size 
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ρ   Intraclass correlation coefficient 
deff   Design effect 
 
y   Observed outcome 
y   Mean observed outcome 
µ   Mean outcome 
2
hs   Observed usual or naïve variance for study h  
2
hσ   Usual or naïve variance for study h  
2
bσ   Between-cluster variance 
2
wσ   Within-cluster variance 
2
tσ   Total variance 
 
SSE   Residual or error sums of squares 
SSB   Sums of squares between clusters 
SSW   Sums of squares within clusters 
SST   Total sums of squares 
MSB   Mean squares between clusters 
MSW   Mean squares within clusters 
MST   Total mean squares 
df   Degrees of freedom 
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ϕ   Non-centrality parameter for a t  distribution 
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le   Random error for the 
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thl patient in the control arm, also as ( )10le  
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thl patient in the intervention arm, also as ( )11le  
( )
( )2
ltherapistu  Random intercept for the 
thl patient at the therapist level 
( )
( )2
ltherapistv  Random coefficient for the 
thl patient at the therapist level 
( )
( )2
0 ltherapistu  Random intercept for the 
thl patient in the control arm 
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( )2
1 ltherapistu  Random intercept for the 
thl patient in the intervention arm 
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( )2
ltreatq   Random intercept for the 
thl patient at the treatment level 
( )
( )3
ltherapistp  Random intercept for the 
thl patient at the therapist level 
( )
( )3
lstudyτ   Random coefficient for the 
thl patient at the study level, also as ( )
( )2
lstudyτ  
 
2
eσ   Sampling variance of the random error for the 
thl patient 
2
ξσ   Sampling variance of the random error for the 
thl intervention patient 
2
0eσ   Sampling variance relating to le0  
2
1eσ   Sampling variance relating to le1  
2
uσ   Between-therapist variance relating to the random-intercept ( )
( )2
ltherapistu  
2
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ltherapistv  
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0uσ   Between-therapist variance relating to the random-intercept ( )
( )2
0 ltherapistu  
2
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*
,
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hε
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he
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2
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{ }2ˆ
,hAz
σ   Within-study variance relating to the transformed estimate hAz ,ˆ  
{ }2ˆ
,hKGz
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,hMDθ
σ   Sampling variance of the mean difference 
hSMD ,θ   Population standardised mean difference relating to study h  
hdsCohen ,'
ˆθ  Cohen’s d estimate of hSMD ,θ  
hgHedges ,'
ˆθ  Hedges’ g estimate of hSMD ,θ  
{ }2ˆ
,' hgHedgesθ
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Abstract 
 
Randomised trials of complex interventions are typically designed, conducted, 
and analysed as if they are drug trials. Although there are many parallels there 
are also a number of important distinctions, which are seldom considered when 
designing individual trials. One of these concerns the involvement of therapists 
in delivering psychotherapy. Systematic reviews and meta-analyses provide an 
opportunity for exploring the full range and complexity of issues encountered in 
realistically complex situations. The first objective of the thesis was therefore to 
develop a conceptual framework for understanding the role of the therapist in 
trial designs. It was addressed by a review of the psychotherapy and statistical 
literatures structured according to the broad concepts of precision, internal and 
external validity and refined on the basis of a systematic methodological review 
of Cochrane reviews meta-analysing trials involving psychotherapy. The second 
objective was then to review, adapt, illustrate and compare methods for meta-
analysing psychotherapy trials with nested designs. Methods for meta-analysing 
ICC estimates, absolute and standardised mean differences were adapted to 
allow for heteroscedasticity between treatments at the therapist- and patient- 
levels. These were illustrated using the example of counselling in primary care, 
with comparisons being made between aggregate and one-step approaches to 
the meta-analysis of individual-patient-data. 
 
It was argued that the therapist has two roles in randomised trials. Firstly, they 
are one component of a multi-component intervention, and are thus a potential 
treatment variable. Second, the nesting of patients within therapists creates an 
additional level in the design, so the therapist is also an experimental unit. The 
inability to conceal or randomise allocations leads to observational components 
within the trial design and to heteroscedasticity which deserves more attention. 
Characterising complex interventions, like psychotherapy, with more than one 
treatment variable could facilitate greater understanding of their components, 
how they interact, which are important, to what extent, and for whom. It also 
brings what is currently referred to as process research into the remit of trials, 
enabling a more complete evaluation of the causal effects. The broad concept 
of multiple experimental units makes cluster-randomised, longitudinal, multi-
centre, crossover, therapist- and group-based intervention trials special cases 
of a more general class of multilevel trial. All involve clustering effects; their 
nature and the appropriate statistical model varying according to the design. 
Methods were proposed for the meta-analysis of continuous outcome data for 
two-level nested designs. A general approach was adopted, where possible, to 
incorporate methods covering cluster-randomised trials and the Behrens-Fisher 
problem. It was clear that this is a relatively untouched methodological area in 
need of further exploration. For the same reasons as it became necessary to 
summarise clinical research, it is recommended that systematic methodological 
reviews be carried out on a larger scale in future. 
 
Therapist Variation within Meta-Analyses of Psychotherapy Trials   17/12/2010 
University of Manchester; Doctor of Philosophy; Rebecca Elizabeth Ann Walwyn 
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1 INTRODUCTION 
 
The randomised controlled trial (RCT) is usually considered the gold standard research 
design for evaluating the causal effects of therapeutic interventions. The methodology 
used has largely been developed in the context of simple interventions, such as drug 
treatments. Randomised trials of complex interventions are, thus, typically designed, 
conducted and analysed as if they were drug trials. Although there are many parallels 
there are also a number of distinctions. These have been explored in the recently 
updated guidance on the development and evaluation of complex interventions1, 2, in 
which complex interventions are defined as containing several interacting components. 
One of the distinctions identified concerned the involvement of care providers in the 
intervention delivery. In psychotherapy research, therapist involvement is particularly 
central to the design. The nature and implications of this are the topic of this thesis. 
 
1.1 Motivating Example: The PACE Trial 
 
Much of the motivation for this thesis originated from discussions, formal and informal, 
regarding care providers in the PACE trial3. The PACE trial (Pacing, graded Activity, 
and Cognitive behaviour therapy: a randomised Evaluation) is near completion having 
randomised 641 patients with a clinical diagnosis of Chronic Fatigue Syndrome/Myalgic 
Encephalomyelitis or Encephalopathy (CFS/ME) to one of four interventions: 
 
(i) Adaptive Pacing Therapy plus Standardised Specialist Medical Care (APT); 
(ii) Cognitive Behavioural Therapy plus Standardised Specialist Medical Care (CBT); 
(iii) Graded Exercise Therapy plus Standardised Specialist Medical Care (GET); or 
(iv) Standardised Specialist Medical Care (SSMC) 
 
Patients were recruited from six secondary care services within the UK between March 
2005 and November 2008. All consecutive patients with a clinical diagnosis of CFS/ME 
referred to the services during this period were screened for eligibility. Referrals were 
made by clinicians outside the services, including general practitioners in primary care. 
Screening was carried out by clinicians within the services, and “centres” were defined 
by the clinical service. Either clinician could have been a “centre”, instead or as well. 
Figure 1.1 gives a schematic illustration of the relationship between treatments and 
care providers in the PACE trial. 
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Figure 1.1 Schematic Diagram of the PACE Trial Design 
 
Note: T1 to T21 are therapists, D1 to D35 are doctors 
 
Allocation of interventions to patients was by minimisation with a random component4, 
stratified by centre, and whether patients met CDC criteria for CFS, London criteria for 
ME, or had a current depressive disorder, respectively. Medical care (SSMC) across all 
four intervention arms was provided by centre-specific doctors, including psychiatrists, 
psychiatric registrars and physicians: none were research doctors employed specifically 
for the trial. Therapy (APT, CBT and GET) was delivered by centre-specific therapists. 
There was a debate at the planning stage about whether therapists should provide all 
or only one of the therapies. It was thought that contamination between the therapies 
should be minimised and that this would be more easily achieved if different therapists 
provided each therapy. Besides this, it was believed that each therapy might naturally 
be championed by a different professional group: APT by occupational therapists, CBT 
by psychotherapists, and GET by physiotherapists. Hence, by design, one therapist per 
centre was specifically employed to provide each therapy, so allocation of therapists to 
patients was determined by the centre and allocated intervention. SSMC doctors were 
allocated to patients using the usual practice within each service. 
 
The therapies (APT, CBT and GET) were intended to be structurally equivalent, in that 
the number of initial training days for the therapists and the number and length of the 
therapy sessions were to be roughly constant. Therapy provision was standardised to 
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minimise variability between therapists within therapies. As equipoise was promoted to 
all four interventions throughout the trial, medical care was also standardised. Since 
the service was a stratification factor at randomisation, it was to be included as a fixed 
effect in the primary analysis. Clearly, this trial shares many features with drug trials. 
 
1.2 Focus on Psychotherapy 
 
The involvement of people in the provision of complex interventions is not restricted to 
psychotherapy or even to medicine. The issue generalises to education, physiotherapy, 
surgery, occupational therapy, complementary therapies and beyond. However, there 
are potentially important differences in the research questions and practices that could 
affect the way in which this issue is addressed. Each discipline has also developed its 
own methodological literature, published largely in subject-specific journals, separated 
from the statistical and mainstream trial methodology literature. A trade-off was made, 
as a consequence, between breadth and depth when defining the scope of this thesis. 
To enable the approach to be broad and inclusive, and to use experience of the field, 
the application area was limited to psychotherapy. By 1997, over 450 distinct forms of 
psychotherapy5 and 100 distinct forms of group psychotherapy6 had been identified. 
The thesis did not focus on any specific modality. 
 
Defining what is meant by the term psychotherapy is far from straightforward, in large 
part because there is no universally accepted definition to draw on. Broadly speaking, 
psychotherapy is a complex therapeutic intervention based on psychological principles. 
Wampold7 adds to this, that psychotherapy involves primarily face-to-face interactions 
between a trained therapist and a client and is typically individualised to the client and 
their disorder, problem or complaint, but this is perhaps too restrictive. Psychological 
interventions delivered over the phone or via a computer were thus included, as well 
as those delivered by paraprofessionals, such as General Practitioners (GPs) or nurses. 
Self-help interventions delivered with the guidance of a therapist were also included, 
although purely self-help interventions, such as bibliotherapy, were not. Interventions 
involving the clients in groups, or multiple therapists per client, were included, as were 
standardised or structured therapies. Psychotherapy is commonly grouped according 
to its format and theoretical model. Individual psychotherapies are often distinguished 
from group psychotherapies as different formats. Categories based on the theoretical 
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orientation include psychotherapies using psychodynamic, cognitive and behavioural, 
systemic, humanistic, supportive, integrative or eclectic principles. 
 
1.3 Conceptualising the Role of Therapists in Trial Designs 
 
Perhaps the main reason why therapists are overlooked to a large extent in the design 
and analysis of psychotherapy trials is the widespread use of the drug metaphor within 
the clinical trial literature. The procedures used by the therapist are equated with the 
drug whilst the therapist is equated with the prescribing doctor. The reasoning behind 
some of the features of drug trials is implicit, so the consequences of substituting or 
omitting these features can be unclear. They are also seldom questioned during the 
design phase of individual psychotherapy trials. Legitimate concerns about this have 
led some to question how appropriate randomised controlled trials are for evaluating 
psychotherapy. It is possibly more accurate to infer that such questions apply to the 
trial design rather than to randomisation per se. The first objective of this thesis was, 
therefore, to develop a conceptual framework for understanding the role of therapists 
in psychotherapy trial designs. 
 
1.3.1 Stratification versus Treatment Factors 
 
One source of confusion relates to the distinction between stratification and treatment 
factors. Any therapist variability remaining after standardisation might be regarded, for 
instance, as subsumed within centre variability, so attention is focused on the centres, 
making reference to the literature on centre effects8-19. Indeed there may be a one-to-
one relationship between centres and therapists. Relationships between the patients, 
treatments and centres may differ from those between the patients, treatments and 
therapists however. Moreover, centres are allocated to patients prior to randomisation, 
while the therapists are assigned to the patients before treatment but generally after 
randomisation. On this basis, centres can be regarded a potential stratification factor 
and the therapists a potential treatment factor. 
 
In the PACE trial, the referring and the recruiting clinicians were potential stratification 
factors. The SSMC doctors and the therapists were potential treatment factors. Where 
the recruiting clinician was also the SSMC doctor, the line between these two types of 
factor might, at first, seem blurred. It is not, however, because the SSMC doctors only 
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provided medical care, and did so for all four arms of the trial, so medical care is a co-
intervention given by a separate sample of care providers. This division makes the role 
of the SSMC doctors akin to that of the care providers in a drug trial. If the recruiting 
clinicians had provided both the therapy and medical care, they would have remained 
a potential stratification factor because they were non-randomly assigned to patients 
before treatment allocation. If the SSMC doctors had provided both the medical care 
and the therapy, they would have remained a potential treatment factor as they were 
assigned to the patients alongside the interventions. Since their assignment might be 
random or non-random depending on the choice of design, they are regarded here as 
“potential” treatment factors. The focus of the thesis is on care providers as potential 
treatment factors. Issues relating to care providers as potential stratification factors 
are similar to those for multi-centre trials. 
 
1.3.2 Performance Bias, Common Factors and Non-Specific Effects 
 
In drug trials, the research question usually relates to the drug rather than to the drug 
as a function of the context in which it was provided. This is because such trials aim to 
make generalisations beyond their context. The medical care given by the doctor, their 
characteristics, and the nature of the doctor-patient relationship are not of interest for 
this research, neither are the clinical service or the geographical location. The physical 
separation between the drug and its context permits its identity to be blinded to every- 
one involved in the trial including patients, care providers and outcome assessors. This 
is achieved via a placebo, if the comparison is no drug, or by making the appearance 
of the drugs identical otherwise. The consequence is that it is then reasonable to make 
the assumption that there is no interaction between the treatment effect and the care 
providers when analysing patient outcomes. This in turn simplifies the statistical model 
but it has implications for sample size and interpretation. The presence of systematic 
differences in the provision of the intervention or any co-interventions, or performance 
bias, questions the validity of this assumption and signifies a more complex underlying 
model incorporating this interaction. The success of blinding is, therefore, a function of 
the size of this interaction. Since a drug trial is not powered to detect it, knowledge of 
how the trial was conducted is usually used to judge its size, and the credibility of the 
trial results. 
 
It is not possible to blind a therapist to the procedures they use in psychotherapy. This 
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makes the role of the therapist in a psychotherapy trial fundamentally different to that 
of a prescribing doctor in a drug trial, in that it is more accurate to equate a therapist 
plus the procedures with a drug, as therapists are part of the treatment rather than its 
context. It also questions the relevance of the concept of performance bias in this 
setting because the assumption that there is no interaction between the procedures 
and the care provider is simply untenable, even at the design stage. However, instead 
of just accepting this, the field has responded by creating placebo psychotherapies to 
control for the placebo effect20, 21. As is to be expected, this has caused considerable 
debate. Since the reason for a placebo no longer applies, one aspect of this debate 
concerns the definition of a placebo in this setting (see Horvath22). A variety of terms 
has been used, reflecting the lack of consensus, including “non-specific” control and 
“common factors” control. A recent issue of Clinical Psychology-Science & Practice was 
devoted to discussing the rationale behind them23-27. It is clear from this that the issue 
the field is attempting to address is not how to define a psychotherapy placebo, but 
how to evaluate the individual causal effects of a multi-component or multivariate 
treatment. As drugs are single-component treatments, included as a single variable in 
a statistical model, the drug metaphor falls down. That is, unless, perhaps, you extend 
the analogy to include combinations of drugs in an open-label trial, where each drug is 
entered as a separate variable in the model, along with relevant interaction effects. 
 
A second aspect of this debate regards the relative importance of the so-called specific 
and common factors to the total effect of psychotherapy. This has become an emotive 
issue because specific factors tend to be equated with drugs which are independent of 
the therapist, and common factors with their context, including the therapist. Luborsky 
et al28 first asserted that the total effects of most, if not all, psychotherapies do not 
differ, referring to the Dodo bird’s verdict in Alice in Wonderland that “Everyone has 
won, and all must have prizes”. This has been used as a vehicle to raise the profile of 
common factors, one of which is thought to be the therapist7, 29-36. This is valuable, but 
it can be unhelpful, when done at the expense of the procedures that generally come 
under the specific factors. Kazdin26, instead, posed the following challenge to the field: 
  
“Let us do experimental manipulations to explore what can be done to improve therapy 
in relation to both specific and common factors. In the process, we shall learn much 
about the mechanisms of change and how to better help patients.” (p.186) 
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1.3.3 Multilevel Trial Designs 
 
Blinding of the prescribing doctors in a drug trial generally means they provide all the 
drugs in the trial so that the treatment effect is estimated within each doctor, although 
the estimation procedure does not generally take account of this (see Figure 1.2). If 
there is no interaction between a drug and the doctor, the population treatment effect 
will be identical for all doctors. Any variability that is observed in the treatment effects 
across doctors will arise due to chance alone. If the doctors are included in the model, 
either as a fixed or a random stratification effect, this will increase the precision of the 
treatment effect estimate where the outcome varies between the doctors enough to 
warrant the loss of residual degrees of freedom. 
 
Figure 1.2 Simplified Schematic Diagram of a Drug Trial 
 
 
The nesting of patient outcomes within geographical regions, services, recruiters, care 
providers, outcome assessors, informants, and patients creates additional levels within 
the designs of all trials, not just those that employ cluster-randomisation. Interactions 
are possible between the treatment effect and each cluster type, leading to treatment-
related clustering effects. A blinded drug trial, that has concealed randomisation, uses 
blinding of the assignment, treatment, and outcome assessment to rule out possible 
sources of treatment-related clustering, and any higher-order interactions, leaving the 
clusters stratifying the treatment effect. As with fixed stratification factors, a decision 
could be made to account for the clusters in the design and subsequent analysis based 
on the extent to which doing so is expected to increase the precision of the treatment 
effect estimate. 
 
If blinding cannot be used to remove important sources of treatment-related clustering 
then additional concealed randomisations could be considered instead. When they are 
not, the treatment effect is conditional on the populations from which the clusters are 
sampled. Generalisations are hence restricted to the treatment context, but they need 
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not be further restricted to the trial context. This means that the process of ensuring 
the trial design adequately addresses the research question is more complicated, but it 
does not mean that trials of complex interventions are either inherently more biased or 
less robust or credible than drug trials. As the therapist is arguably the most important 
source of treatment-related clustering in psychotherapy trials, therapists were focused 
upon in this thesis. 
 
1.4 Incorporating Therapist Variation into Meta-Analyses 
 
Once it is accepted that treatment-related clustering associated with the care providers 
is neither entirely avoidable or should necessarily be avoided, the next challenge is the 
shared lack of experience within the medical statistics and psychotherapy fields of fully 
taking the therapist into consideration when designing trials. One of the first steps that 
should be taken when planning trials is to systematically review the existing evidence-
base. This may include an assessment of the quality of previous trials, pooling of data 
across trials, or both activities. This presents an opportunity, as one way of raising the 
general level of experience and of establishing the range and complexity of issues that 
may be encountered, is for methodologists to liaise more closely with those conducting 
systematic reviews. Meta-analyses also provide a useful parallel for analyses of multi-
centre trials, as studies in a meta-analysis corresponds to the centres in a multi-centre 
trial. Early-phase psychotherapy trials, of necessity, are small, involve few therapists, 
and can completely confound therapists with centres. Due to their size, meta-analyses 
provide a means of gaining experience of fitting realistically complex statistical models, 
applicable to trials such as PACE, with real datasets. The second objective of the thesis 
was consequently to review, adapt, illustrate and compare methods for meta-analysing 
trials involving psychotherapy to take account of the therapist. 
 
1.5 Thesis Overview 
 
In this chapter the PACE trial has been used to motivate a discussion of the limitations 
of the drug metaphor for randomised trials of complex interventions, focusing interest 
on the therapist. The scope of the thesis was outlined, limiting the application area to 
psychotherapy, with two objectives being defined. The first was to provide a complete 
conceptualisation of the role of therapist in psychotherapy trial designs. A distinction 
was made here between stratification and treatment factors, with the therapist defined 
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as potential treatment factor. Performance bias was defined as an interaction between 
the therapist and the intervention effect, implying the presence of multiple interacting 
treatment factors in trials of complex interventions. Nesting of patient outcomes within 
therapists was argued to create multiple experimental units in psychotherapy trials and 
lead to treatment-related clustering. The second objective was to explore methods for 
meta-analysing psychotherapy trials incorporating therapists as a factor. 
 
Chapter 2 expands the conceptual framework using the familiar concepts of precision, 
internal and external validity, reviewing the psychotherapy and statistical literatures. 
Research questions that relate to therapeutic approaches, therapist characteristics and 
packages of the two are unified. Three basic trial designs are introduced which map to 
the relationship between interventions and therapists. Implications for the precision of 
treatment effects are given for statistical analyses and sample size. More complex trial 
designs are then described for trials with multiple therapists per patient. Implications 
for internal and external validity are outlined and conclusions are drawn. 
 
The framework is used in Chapter 3 to structure a systematic methodological review of 
Cochrane reviews of comparative studies involving psychotherapy. The frequency with 
which specific trial designs appear is explored, together with the range and complexity 
of issues that would be encountered by meta-analysts in a psychotherapy setting. The 
search strategy and eligibility criteria for selecting the systematic reviews are provided. 
The systematic reviews meeting the criteria and the studies within those reviews are 
described. Data is extracted and summarised in support of reviewers’ recognition of 
the concept of therapist variation, and also their recognition of the precision, internal 
and external validity implications of therapist variation. 
 
Chapter 4 uses the methodological review as a sampling frame to select counselling in 
primary care as an example to illustrate the methods described in the remainder of the 
thesis. The Cochrane review37 is introduced along with the example meta-analysis, the 
trials included, and the individual-patient-data (IPD). This consists of a background to 
the field of counselling in primary care, a summary of the review methodology, its 
original analysis and published results. The trial methodology is outlined on a trial-by-
trial basis, providing the published summary data and analyses. The practicalities of 
obtaining the individual-patient-data relating to these trials are then described. 
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Chapters 5, 6 and 7 address the second objective of reviewing, adapting, illustrating 
and comparing methods of meta-analysis. Chapter 5 considers methods for obtaining 
and pooling intraclass correlation coefficients (ICC), adapting a random-effects meta-
analytic approach proposed by Blitstein et al38 for cluster-randomised trials. The lack of 
relevant estimates is highlighted and the small-sample issues introduced. Adhoc versus 
systematic strategies for obtaining ICC estimates are then contrasted. Blitstein et al’s38 
method is described and adapted to take account of biases arising from the method of 
estimation, the skewed sampling distribution and bounding negative estimates, and of 
variability in cluster sizes within studies. Relevant external estimates are obtained and 
compared to the internal study estimates. The steps required to pool these estimates 
are then described, comparing existing approaches to those proposed in the chapter. 
The chapter ends with a discussion of the availability of study estimates, the need for 
further work, the role of sampling variation and the implications for study reporting. 
 
Chapter 6 compares aggregate-data and one-step multilevel approaches to the meta-
analysis of absolute mean differences, adapting the methods suggested by Kwong and 
Higgins39 and Sidik and Jonkman40. The rationale is given for allowing for treatment-
related clustering effects, and for taking account of any between-study heterogeneity. 
Standard fixed and random effects meta-analysis models are presented and extended, 
relaxing independence and homoscedasticity assumptions and allowing for imprecision 
in the estimated weights and the use of finite samples. Equivalent one-step models are 
given, including those exploring predictors of between-study heterogeneity in the fixed 
or random effects. These are illustrated and compared with a subset of the counselling 
in primary care trials. The programming code is given for the one-step models in an 
appendix. 
 
Chapter 7 compares aggregate-data and one-step multilevel approaches to the meta-
analysis of standardised mean differences, adapting those proposed by Huynh41, White 
and Thomas42, Hedges43 and Goldstein et al44. Issues concerning the choice of metric 
are introduced for different model assumptions and the need for a general approach is 
discussed. Standard fixed and random effects meta-analysis models are first presented 
and a general approach is developed that allows for clustering and heteroscedasticity. 
Equivalent one-step models are then provided and the preparation of the data needed 
for these models described. These are illustrated and compared using all the trials of 
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counselling in primary care. Programming code is again given for the one-step models 
in an appendix. 
 
A discussion of the thesis is found in Chapter 8. This is structured according to the two 
objectives, placing the thesis in the context of the existing literature. Areas for further 
research are identified. 
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2 THERAPIST VARIATION WITHIN RANDOMISED 
TRIALS OF PSYCHOTHERAPY: IMPLICATIONS FOR 
PRECISION, INTERNAL AND EXTERNAL VALIDITY 
 
2.1 Introduction 
 
Psychotherapy is defined as a non-pharmacological intervention delivered by therapists 
based on psychological principles. The intervention of interest in a psychotherapy trial 
broadly lies “somewhere in the therapist and his behavior”45 (p.128). While it is 
generally reasonable to assume a drug is manufactured uniformly, this assumption is 
less plausible for psychotherapy both generally and in the context of randomised trials. 
Variation is expected in psychotherapy content and format across patients45-47, across 
time within patients45 and across time within therapists48, 49. Akin to doctors prescribing 
drugs, therapists are able to influence patient adherence to psychotherapy and the 
provision of co-interventions. Therapists, however, are additionally able to influence 
the content of psychotherapy via their skill, expertise, competence or fidelity to the 
therapy model and its format via their personal characteristics. 
 
The notion that patient outcomes vary between therapists has been recognised by 
psychotherapy researchers and clinicians since the origin of the field7, although not 
universally as Kiesler45 highlighted. Methods for studying the contribution of therapists 
to patient outcomes have changed over time50. Up to 1960, research was mainly 
qualitative involving the elicitation of expert opinions on therapist characteristics 
deemed to be important (e.g. Luborsky51). Since then associations between therapist 
characteristics and patient outcomes have been studied (see reviews by Parloff et al52 
and Beutler et al53) and comparisons made of patient outcomes between individual 
therapists (see Ricks54, Howard et al55, Orlinsky & Howard56, Brooker & Wiggins57, 
Luborsky et al58, 59, McLellan et al60 and Shapiro et al61 for early examples; Okiishi et 
al62, 63, Wampold & Brown64, McKay et al65, Lutz et al66, Baldwin et al67 and Dinger et 
al68 for more recent examples; and see the March 2006 edition of Psychotherapy 
Research69-74 and re-joiners75-77 for a discussion of the use of multilevel models in this 
context). 
 
Despite awareness of therapist variability, the statistical and wider conceptual 
implications of therapist variation for psychotherapy trials have not been widely 
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recognised. Research on the relationship between individual therapists and patient 
outcomes has also been separated from randomised trials78. While psychotherapy 
researchers readily recognise that average patient outcomes may vary between 
therapists, they infrequently appreciate that this is equivalent to patient outcomes 
being clustered within individual therapists leading to intra-therapist correlation. This 
violates the assumption of statistical independence in much the same way as nesting 
of individuals within clusters does in cluster randomised trials. Ignoring clustering of 
patients within therapists tends to lead to over-precise estimates of the intervention 
effect and an increase in the type I error. 
 
The clustering implications of therapist variability were outlined firstly within the 
psychotherapy literature by Martindale79 and then by Crits-Christoph and Mintz80. 
Subsequently Roberts81, Lee and Thompson82, 83 and Roberts and Roberts84 have 
brought the issue to the attention of the mainstream medical statistics community. 
This widening awareness has culminated in the inclusion of items specifically relating 
to therapist or care provider variation in the extended CONSORT guidelines for the 
reporting of non-pharmacological trials85. The publication of these guidelines should 
motivate increased interest in this topic both in psychotherapy trials and more 
generally. 
 
The potential impact of therapist variation on the design, analysis and reporting of 
randomised trials is threefold. While attention has focused primarily on the implications 
for the precision of treatment effect estimates, therapist variation also has implications 
for internal and external validity. This chapter uses all three aspects as a broad 
framework for understanding the implications of therapist variability, drawing together 
and building upon the associated psychotherapy and statistical literatures. In so doing, 
parallels with other trial designs and associated methods of analysis are made. 
 
2.1.1 Research Questions 
 
Therapists and their behaviours may be viewed as potentially interacting components 
of a “complex intervention”86. Based on the drug metaphor of treatment, trialists often 
emphasise particular therapist behaviours or therapeutic approaches, such that the 
therapist is considered part of the therapeutic context7. At other times, emphasis is 
placed on packages of particular therapeutic approaches and “the therapists who both 
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choose to and are chosen to administer them”48 (p.308). In which case, the therapist 
can be viewed as an integral part of the intervention itself81. 
 
Figure 2.1 illustrates three types of comparison between interventions: 
 
1. Where the therapeutic approach is of interest, a comparison might be made 
between A and B or between C and D. So for example, counselling could be 
compared to advice, both provided by counsellors. 
2. Where a package is of interest, a comparison might be made between A and D 
or between B and C. As an example, counselling provided by counsellors could 
be compared to advice provided by general practitioners. 
3. Where particular therapist characteristics are of interest, a comparison might 
be made between A and C or between B and D. For example, counselling 
provided by counsellors and general practitioners could be compared. 
 
The research question will determine the comparisons made, and these should in turn 
determine the trial design. In all three cases, variation may be anticipated in the 
provision of psychotherapy between individual therapists and therefore also potentially 
in patient outcomes across therapists. Whilst lack of clarity is a precursor for poor 
design, these comparisons may be of interest separately or in combination. 
 
Figure 2.1 Example Comparisons 
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2.2 Trial Designs 
 
The comparison of two interventions, where each patient receives psychotherapy from 
just one therapist, is considered first. In the nested design (Figure 2.2a) each therapist 
provides the intervention within just one intervention arm, a design described as 
hierarchical by Martindale79. As an example, Schnurr et al87 compared Prolonged 
Exposure to Present-Centred Therapy for women with Posttraumatic Stress Disorder 
where each therapeutic approach was provided by a different sample of therapists. In 
the special case where there is no therapist involvement in one of the arms81, 83, 84 the 
design can be described as partially nested (Figure 2.2b). This may arise where the 
control intervention is no treatment, a waiting list or self-help. For example, Kubany et 
al88 compared Cognitive Trauma Therapy with a waitlist control for women with 
Posttraumatic Stress Disorder. Alternatively, in the crossed design79 each therapist 
provides psychotherapy in both arms (Figure 2.2c). An example of this is the 
comparison of Cognitive Behavioural Therapy with Nondirective Supportive Therapy for 
sexually abused children provided by therapists experienced in treating this patient 
group89. 
 
Figure 2.2 Nested, Partially Nested and Crossed Designs 
 
(a) 
 
 
(b) 
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(c) 
 
 
Note: T1 to TK are therapists 
 
The crossed design is restricted to situations where therapists are able to deliver both 
interventions. It is really only applicable where different therapeutic approaches are 
compared, or where psychotherapy may be viewed as a co-intervention therefore. The 
latter arises where the combination of psychotherapy and a drug is compared to 
psychotherapy plus a placebo, for example, or where two formats of the same 
psychotherapy (e.g. telephone vs. face-to-face) are compared, as was the case in 
Lovell et al90. One advantage of separating the role of doctors and therapists in a trial 
assessing the efficacy of a psychotherapy-drug combination is that it may then be 
possible to blind therapists to the drug/placebo component of the intervention and 
therefore also to treatment status. 
 
Parallels can be drawn between parallel-group/crossover designs and nested/crossed 
designs at the level of the therapist. Interventions are allocated to patients within the 
former but to therapists within the latter. In a parallel-group trial patients are nested 
within interventions, while it is the therapists who are nested within interventions in a 
nested design. In a crossover trial intervention sequences are allocated to patients. 
Similarly one may consider a sequence of intervention assignments as being allocated 
to therapists in a crossed design, so that patients within therapists correspond to 
periods within patients in a crossover trial. The point in the intervention sequence at 
which a patient is assigned to the therapist is therefore equivalent to the period in a 
crossover trial. If each therapist were to see just two patients, intervention sequences 
might be allocated to therapists much as they are to patients in an AB/BA crossover 
design. Possible carryover effects within therapists from the first patient to the second 
would need to be considered and differential carryover from one intervention to the 
other would invalidate the use of both designs. However, as therapists typically treat 
more than two patients, intervention sequences would generally be longer in a crossed 
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design so that these designs are more likely to be comparable to replicate crossover 
trials91. In the special case where intervention sequences are formed of replicates of 
shorter sequences it may be possible to separate order effects from those over time 
within therapists. 
 
Parallels can be drawn between completely randomised, matched-pair and stratified 
cluster randomised trials and different nested designs as well by equating the therapist 
in a nested design to the cluster within a cluster-randomised design. The allocation of 
interventions to clusters is blocked or stratified (e.g. by centre) in matched-pairs and 
stratified cluster randomised designs, with matched-pairs designs being a special case 
of the stratified design, where the number of clusters and interventions within strata is 
equal. Limitations of matched-pairs designs92 therefore also apply to nested designs 
where the number of therapists equals the number of interventions within a centre. 
Likewise a cluster randomised crossover design93, 94 corresponds to a crossed design. A 
crossed design is also related to matched-pairs cluster randomised designs, but now 
the therapist corresponds to a pair of clusters rather than the cluster, which is perhaps 
a more tenuous analogy. Other analogies for a crossed design are multicentre trials 
with the therapist corresponding to the centre, and meta-analyses with therapists 
corresponding to studies. 
 
2.3 Implications for Precision 
 
2.3.1 Statistical Analyses  
 
Suppose ly  is a continuous outcome for the 
thl patient within a typical drug trial. An 
analysis of covariance model can be written as: 
 
llll exty +++= βθα  (2.1) 
 
where lt is an intervention indicator variable, θ is the intervention effect, le  is ( )2,0 eN σ  
the patient level error term, and lx  and β  are matrices representing fixed patient or 
therapist level baseline covariates and their coefficients. For simplicity of presentation 
let lα  equal lxβα + . Consider now a nested design where jm patients are treated by 
the thj  therapist. Using Goldstein’s95 notation, between-therapist variation can be 
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represented by a random effect )2( )(ltherapistu  with distribution ( )2,0 uN σ . The outcome for 
the thl patient treated by the thj  therapist is then given by a random intercept model 
 
)1()2(
)( lltherapistlll euty +++= θα  (2.2) 
 
In this notation the bracketed superscript refers to the level of the random effect and 
( )ltherapist  in the subscript is the mapping of patients to therapists. Between-
therapist variation 2uσ  inflates the standard error of the intervention effect estimate θˆ  
in the same way that between-cluster variation does in cluster randomised trials. 
Intra-therapist variability is measured by the intraclass correlation coefficient (ICC) uρ  
defined by ( )222 / euuu σσσρ += . This model, suggested by a number of authors49, 79-81, 96, 
97, assumes the clustering effect is the same for both interventions. 
 
Where therapist variation is considered a nuisance, a two-stage analysis has been 
proposed79, 80, 97, using a test of non-zero therapist effect to determine whether to 
include a random effect for therapist. Model (2.2) is then only used if the null 
hypothesis is rejected. Elkin78 indicated that such analyses may be carried out but not 
reported because they are seen as a “necessary, but preliminary, step for any 
outcome analyses” (p.13). Even with the suggested use of significance levels of 20% 
to 30% for the preliminary analysis98, 99 this strategy has not been recommended by 
Lee and Thompson82 or by Roberts and Roberts84. The preliminary test will have low 
power to detect intra-therapist correlation coefficients with potentially considerable 
design effects, a point also made by Donner and Klar100 in the context of cluster 
randomised trials. What is more, in common with other pre-testing procedures, for 
example tests for carry-over effect in crossover trials, this analysis strategy misuses 
hypothesis testing, as failure to reject the null hypothesis of no effect does not justify 
its acceptance84. 
 
Suppose now that between-therapist variability differs across intervention arms. This 
could occur because one intervention is more suited to standardisation than the other, 
resulting in average patient outcomes being more homogeneous for one arm than the 
other. Lee and Thompson83 suggest a random coefficient model 
 
)1()2(
)(
)2(
)( llltherapistltherapistlll etvuty ++++= θα   (2.3) 
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where )2( )(ltherapistv  is a ( )2,0 vN σ  for individually randomised trials with clustering effects. 
Random effects at the same level may be correlated, so )2( )(ltherapistu  and 
)2(
)(ltherapistv  may 
have a covariance term, say uvσ . In a nested design lt  does not vary within therapists 
so only one of the random effect parameters 2vσ  or uvσ  is identified
83. In this situation, 
estimation procedures add constraints such as setting either 2vσ  or uvσ to zero or setting 
uvσ  equal to
2
uσ− . Separate intraclass correlation coefficients for each intervention 
arm are then 
 ( )2220 euu σσσρ +=  and ( ) ( )222221 22 evuvuvuvu σσσσσσσρ +++++=  
 
Where 0=uvσ , 
22
vu σσ +  is forced to be greater than or equal to 
2
uσ , so it is more 
appropriate to set 02 =vσ  here as a covariance may be negative, while a variance 
cannot be. 
 
An alternative parameterisation81, 83 of model (2.3) is 
 
( ) )1()2( )(1)2( )(0 1 llltherapistlltherapistlll etututy ++−++= θα   (2.4) 
 
where )2( )(0 ltherapistu and 
)2(
)(1 ltherapistu , distributed ( )20,0 uN σ  and ( )21,0 uN σ  respectively, are 
now random intercepts for each intervention arm. Whilst this model is slightly more 
cumbersome to fit, it is easier to interpret where the intervention is a package or 
therapist characteristic. It also gives the between-therapist variance estimates directly 
for each intervention arm, which avoids constraints on their relative size and may be 
convenient for reporting. Since )2( )(0 ltherapistu  and 
)2(
)(1 ltherapistu relate to independent samples 
their covariance is zero, consistent with model (2.3). The intra-therapist correlation 
coefficients for each intervention arm are now simply ( )220200 euu σσσρ +=  
and ( )221211 euu σσσρ += . In a nested design the relationship between the parameters 
of models (2.3) and (2.4) is 220 uu σσ =  and uvuu σσσ 2
22
1 += . 
 
Models (2.1) to (2.4) assume a common patient level variance 2eσ  across intervention 
arms. Heteroscedasticity at the patient level may bias estimates of the between-
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therapist variance84. For this reason Roberts and Roberts84 suggest the two-level 
heteroscedastic model 
 
llllltherapistltherapistlll tetvuty
)1()1()2(
)(
)2(
)( ξθα +++++=   (2.5) 
 
Where )1(lξ is ( )2,0 ξσN . A recommended parameterisation of a two-level heteroscedastic 
model for a nested design is, however, 
 
( ) ( ) lllllltherapistlltherapistlll tetetututy )1(1)1(0)2( )(1)2( )(0 11 +−++−++= θα    (2.6) 
 
Separate intra-therapist correlation coefficients for the arms are then 
 ( )2020200 euu σσσρ +=  and ( )2121211 euu σσσρ += . 
 
Roberts and Roberts84 show that where the distribution of cluster sizes differs across 
arms in a nested design, allowing for heteroscadasticity between arms at the therapist 
level by fitting model (2.3) or (2.4), or more fully with model (2.5), may give different 
standard errors of the intervention effect when compared to the simpler model (2.2). 
In their reanalysis of a trial comparing general practitioner (GP) and nurse practitioner 
(NP) care in primary care101, models (2.2) and (2.5) gave noticeably different standard 
errors. This is explained by large numbers of GPs with smaller clusters sizes coupled 
with a larger ICC for GPs and a smaller standard error in the GP as opposed to the NP 
arm. In psychotherapy trials, cluster size is typically determined by the organisation of 
care and may differ systematically between arms. This may justify the use of models 
(2.3) to (2.5). This is in contrast with cluster randomised trials, where randomisation 
will ensure the average cluster size in each trial arm is similar, at least in expectation, 
so that models (2.2) to (2.5) give similar standard errors for the intervention effect. 
 
If a trial has a partially nested design, each patient in the non-therapist arm could be 
assumed to be a cluster of size one in model (2.2). Alternatively, one might constrain 
the random intercept to the therapist arm using a random coefficient model83 
 
)1()2(
)( llltherapistlll etvty +++= θα   (2.7) 
 
While model (2.2) forces the total variance to be equal across arms, model (2.7) 
forces the total variance in the therapist arm to be greater than that in the control arm 
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if 2vσ  is positive. Roberts & Roberts
84 showed that misspecification of the patient level 
variance within model (2.7) can bias estimation of the between-therapist variance and 
hence the standard error of the intervention effect and its test size. They suggest 
fitting the following two-level heteroscedastic model allowing the patient level variance 
to be estimated separately in each arm 
 
llllltherapistlll tetvty
)1()1()2(
)( ξθα ++++=   (2.8) 
 
This may be better re-parameterised as 
 
( ) lllllltherapistlll tetetuty )1(1)1(0)2( )(1 1 +−+++= θα    (2.9) 
 
Models (2.2) to (2.4) can also be applied for a crossed design. If model (2.2) is used 
(e.g. McKay et al65), the effect of the intervention is assumed to be constant across 
therapists and the random intercept )2( )(ltherapistu  can be thought of as a stratifying effect. 
As such, in the special case where model (2.2) is appropriate, the crossed design may 
be considered a stratified design. 
 
In other applications of the crossed design, between-therapist variation in the effect of 
the intervention is plausible because therapists may exhibit differential skill, expertise, 
competence or fidelity to the therapy model across arms. This suggests use of model 
(2.3)79, 83 where 2uσ ,
2
vσ  and uvσ  are now all estimable
83 and uvσ  represents between-
therapist variability in the treatment effect. Between-therapist variation in outcome 2uσ  
is easier to interpret marginally where there is a single sample of therapists, so that 
model (2.3) may be preferred over model (2.4)83 in this context. If )2( )(ltherapistu is treated 
as a set of fixed parameters, model (2.3) is equivalent to the random-effects meta-
analysis model described by Whitehead102 (p.131) for individual-patient-data, where 
therapists equate to studies. 
 
Although less intuitive, an alternative analysis for the crossed design might be a three-
level model, with patients nested within therapists, and interventions both nested 
within and crossed with therapists 
 
)1()2(
)(
)3(
)( lltreatltherapistlll eqpty ++++= θα   (2.10) 
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The random effects )3( )(ltherapistp  and 
)2(
)(ltreatq  have distributions ( )2,0 pN σ  and ( )2,0 qN σ  
respectively and )(ltreat  refers to the intervention within therapist received by the 
thl patient. Here the crossed design is viewed as a specific type of nested design (see 
Dunn and Clark103 (p.178) for a discussion of the relationship between crossed and 
nested factors). Model (2.10) is equivalent to that suggested for analyses of matched-
pairs cluster randomised designs104 where therapists correspond to strata and to that 
proposed for cluster-randomised crossover trials94 with the therapists equated to 
clusters. In contrast to models (2.3) and (2.4), model (2.10) assumes that between-
therapist variation 2uσ  is equal to 
22
qp σσ +  for both interventions. Where 
2
vσ  equals 
22 qσ , constraining the covariance uvσ  equal to 2
2
vσ−  in model (2.3) makes the latter 
equivalent to model (2.10). Conversely, constraining 20uσ  equal to 
2
1uσ  in model (2.4) 
makes the covariance u01σ  equal to 
2
pσ  in model (2.10). A final analysis option would 
be to treat )3( )(ltherapistp  as a set of fixed effects, which is another model suggested for 
individual-patient-data meta-analysis102. 
 
The variances of )2( )(ltherapistu  in model (2.3) and 
)3(
)(ltherapistp  in model (2.10) do not directly 
contribute to the variance of the treatment effect θ  in the crossed design, but the 
variances of )2( )(ltherapistv and 
)2(
)(ltreatq do. Whilst model (2.3) follows more naturally from a 
crossed design, model (2.10) is convenient for sample size estimation, as it partitions 
therapist variation into the between-therapist or marginal variance 2pσ  and the within-
therapist but between-interventions variance 2qσ . 
 
Models (2.2) to (2.10) assume that the order in which a therapist treats their patients is 
unimportant. This may not be the case where therapist learning or fatigue changes a 
therapist’s performance over time so that patient outcomes are no longer exchangeable 
within therapists. There may be carryover from one patient to the next, and in a crossed 
design from one intervention to the next, depending on the sequence of allocations. If 
change over time within therapists is plausible, the model adopted should ideally reflect 
this, perhaps through use of a more complex covariance structure. Cook et al105 provide 
an example of a model including learning curve effects. 
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Models (2.2) to (2.10) can be fitted in standard multilevel software using maximum 
likelihood (ML), restricted maximum likelihood (REML), or alternatively within a Bayesian 
framework using MCMC106. However, small numbers of clusters (i.e. therapists) and 
heterogeneity of cluster sizes within arms may lead to convergence problems. It may also 
be difficult to fit a two-level heteroscedastic model in a Bayesian framework. 
 
2.3.2 Power and Sample Size  
 
Sample size estimation methods for psychotherapy trials are similar to those for cluster 
randomised trials. Methods for completely-randomised cluster randomised trials are 
directly applicable to the nested design where model (2.2) is appropriate. Donner and 
Klar107 (p.57) give an asymptotic formula derived from a z-test for the number of 
clusters in each arm that can be applied in this context to choose the number of 
therapists k2  
( ) ( )( )
m
mzzk uρσ
θ
βα 1122
2
2
2
2/ −+×
+
=   (2.11) 
 
where m  is the number of patients treated by each therapist, and uρ  is the ICC from 
model (2.2). 
 
Where there is differential clustering (i.e. models (2.3) to (2.9)) the variance at the 
summary level will differ and the analysis corresponds to that of an unequal variance 
t-test108 rather than the standard t-test, a point noted by Hoover109. This is the case 
particularly for partially nested designs84. Hoover109 suggests using an approximation 
developed by DiSantostefano and Muller110 to calculate sample size. This underestimates 
power where the variance is greater in the larger arm110, which is the likely situation at a 
summary level in a partially nested design84. This also seems unnecessary given the exact 
method for the unequal variance t-test is implemented in sample size software such as 
nQuery Advisor111 based on the methods described by Moser et al112. The number of 
therapists can therefore be estimated by taking the summary level variance to be 
 
( ) ( )( ) iiiii mmsum /1122 ρσσ −+=   (2.12) 
 
in the thi intervention arm. A Stata routine113 is available that uses the Moser et al112 
method in this context. 
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If the sample size formulae for completely-randomised cluster randomised trials are 
expressed in terms of normal deviates, as in (2.11), they will underestimate sample 
size and overestimate power where the number of clusters is small. Specifically, where 
the intraclass correlation coefficient is taken to be zero, this will give the same sample 
size and power as a trial with no clustering. In contrast, estimates based on the Moser 
et al112 method take account of uncertainty in the cluster level variance estimates via 
the degrees of freedom related to the number of therapists. Using the latter method, 
there is a penalty even where one believes the ICC to be negligible or zero. So it is 
recommended that the number of therapists and patients be based on this method, 
rather than (2.11), to encourage designs with larger numbers of therapists, and thus 
greater protection of power when larger than expected values of the ICC are found. 
 
Table 2.1 illustrates the Moser et al112 method for a standardised effect size of 0.5, 
under model (2.2). If therapist variation is completely ignored, the total trial sample 
size is 128 for 80% power. If intraclass correlation is assumed to be zero, and there 
are only 5 therapists in each arm, power is reduced to 68%. Power would still be 80% 
if (2.11) had instead been used. The reduction in power is substantial with an 
intraclass correlation coefficient of 0.05. If the number of therapists is kept constant 
the increase in the required patient sample size to achieve 80% power is sizeable, with 
diminishing returns once the number of patients exceeds 1/ρ, a point made by Donner 
and Klar92 in the context of cluster randomised trials. 
 
Table 2.1 Sample Size and Power for a Nested Design using Moser et al112 Methods 
( )222 / euuu σσσρ +=  
Therapists  
in each 
intervention arm 
Patients  
per 
therapist 
Total trial 
patient 
sample 
size Power 
 No clustering 128 80% 
0 5 13 130 68% 
0.025 5 13 130 56% 
0.05 5 13 130 48% 
 Increasing numbers of patients per therapist  
0 5 18 180 81% 
0.025 5 30 300 80% 
0.05 5 130 1300 80% 
 Increasing numbers of therapists  
0 7 13 182 86% 
0.025 8 13 208 83% 
0.05 9 13 234 80% 
Note: α=0.05 (two-sided); standardised effect size is 0.5 
 
Equal allocation is the norm for randomised controlled trials, as this maximizes power 
 Page 42 of 238 
for a given sample size. However, this is based on the variance of treatment means 
being equal for both interventions, which may not be the case in a psychotherapy trial. 
Where there is heteroscedasticity in the clustering effect, the power for a given sample 
size can be maximised by changing the allocation ratio between the intervention arms. 
Assuming the total variance in each arm is given by 20tσ  and 
2
1tσ , the standard error of 
the intervention effect is 
 
( )( )( ) ( )( )( )
N
Rm
NR
Rm tt +−+++−+ 111111 11
2
100
2
0 ρσρσ   (2.13) 
 
where patients are allocated in the ratio R:1 for intervention 0 and 1, 0ρ  and 1ρ  are the 
treatment-specific intraclass correlation coefficients, and N is the total sample size. This 
corrects typographical errors in Roberts84, 113. Assuming an asymptotic approximation, 
the power is maximized for a given sample size with an allocation ratio 
 
( )( )
( )( )0020
11
2
1
11
11
ρσ
ρσ
−+
−+
=
m
mR
t
t   (2.14)
 
 
For a partially nested design this ratio simplifies to  
 
( )( )112
0
2
1 11 ρ
σ
σ
−+ m
t
t    (2.15) 
 
which is the formula given by Moerbeek and Wong114. 
 
Estimates of sample size and power for a crossed design under model (2.10) basically 
are the same as those for a matched-pairs cluster-randomised trial analysed using a 
matched-pairs t-test107, where each therapist corresponds to a stratum. Assuming the 
number of patients treated by each therapist is m in each of two interventions (i.e. the 
total caseload is m2 ), Donner and Klar’s107 formula can be modified to take account of 
uncertainty in the variance estimates to give the number of therapists, k2 , by 
 
( )( )






+×
+
=
−− 2
2
2
,12/,122 qe
n
kk
m
tt
k σσ
θ
ϕβα
   (2.16)  
 
where t  and nt  are the central and non-central t -statistics, 2qσ  is the within-therapist 
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variance in the intervention effect, and ϕ  is the non-centrality parameter equal to 






+ 2
2
2 qe
m
σ
σθ . The number of therapists k , being on both sides of equation (2.16), 
has to be found iteratively. 
 
Implications of within-therapist variation in the intervention effect are illustrated in 
Table 2.2 for a standardised effect size of 0.5. Again there is a penalty for trials with 
small numbers of therapists, even where one believes qρ  to be negligible. For a nested 
design (see Table 2.1) 208 patients and 16 (2x8) therapists would be needed where 
the intraclass correlation uρ  is 0.025 under model (2.2). This reduces to 160 patients 
and 16 therapists where qρ  is equal to 0.025 under model (2.10). Given the stratifying 
effect of pρ  is ignored so qρ  is likely to be smaller than uρ  and under equal allocation 
model (2.2) is likely to be more powerful than models (2.3) to (2.9), the gain may be 
even greater. If model (2.3) is preferred over model (2.10) for the crossed design, 2qσ  
can simply be replaced by 2/2vσ  in equation (2.16). 
 
Table 2.2 Sample Size to Achieve 80% Power in a Crossed Design with Model (2.10) 
( ) ( )222 eqqq σσσρ +=  Number of Therapists 
Minimum number of patients 
per therapist to achieve 
80% power 
Total trial 
patient 
sample 
size Power 
No therapist effect - 128 80% 
     
0 8 22 176 81% 
0.025 8 30 240 81% 
0.05 8 44 352 80% 
     
0 12 14 168 84% 
0.025 12 16 192 83% 
0.05 12 18 216 81% 
     
0 16 10 160 84% 
0.025 16 10 160 80% 
0.05 16 12 192 83% 
Note: α=0.05 (two-sided); standardised effect size is 0.5 
 
Current experience of reanalysing psychotherapy trials suggests that cluster sizes may 
be highly variable, with small numbers of therapists treating large numbers of patients 
and the remainder treating just a handful. The sample size formulae given above and 
illustrated in Tables 2.1 and 2.2 assume equal cluster size within arms. Power is lost as 
variability of cluster sizes in each arm increases, but the effect is not great provided 
the variance in cluster sizes within arms is relatively small115, 116. Unfortunately in this 
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setting, as dedicated research therapists may often be employed to provide the bulk 
but not all treatment, the variation in cluster size within arms may be large. Grossly 
unequal cluster sizes within the arms should be avoided to prevent substantial loss of 
power. Experience suggests that they may also cause boundary value problems when 
model fitting. 
 
2.4 More Complex Trial Designs 
 
2.4.1 Three or More Arms 
 
Where psychotherapy trials compare more than two interventions, the three basic trial 
designs (see Figure 2.2) may be found in combination. Take for example the NIMH 
Treatment for Depression Collaborative Research Program (TDCRP) trial48, 117-119 that is 
depicted in Figure 2.3. This well-known trial individually-randomised 250 patients with 
a diagnosis of Depression to one of four interventions: Cognitive-Behavioural Therapy 
(CBT); Interpersonal Psychotherapy (IPT); Imipramine Hydrochloride plus Clinical 
Management (IMI-CM); or Placebo plus Clinical Management (PLA-CM). Different 
therapists provided CBT and IPT, such that for these interventions a nested design 
was used. The same therapists (psychiatrists in this case) provided the clinical 
management within IMI-CM and PLA-CM. As such, a crossed design was used for 
these interventions. Allowing for heteroscedasticity at the therapist and patient levels, 
model (2.5) could be extended to analyse this trial by additionally constraining the 
covariance uvσ  to the IMI-CM and PLA-CM arms. 
 
Figure 2.3 Combined Nested & Crossed Example: TDCRP trial119  
 
Note: T1 to T17 are therapists; D1 to D9 are doctors. 
 
Partial clustering could also arise in the context of a crossed design where there is no 
therapist involvement in one (or more) arms. For example, Blanchard et al120 
randomised 98 patients with Posttraumatic Stress Disorder to one of three therapists 
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and then to one of three interventions: Cognitive Behavioural Therapy (CBT); 
Supportive Psychotherapy (SUPPORT) or Waitlist (see Figure 2.4) using a factorial 
design. The same three therapists provided CBT and SUPPORT but there was no 
therapist involvement in the waitlist condition. 
 
Figure 2.4 Partially Crossed Example: Blanchard et al120 
Supportive 
Psychotherapy
Cognitive 
Behavioural Therapy
Waitlist
T1 T3T2
Partially Crossed Design
 
Note: T1 to T3 are therapists 
 
Model (2.5) could be extended here to constrain both the between-therapist variance 
2
uσ  and the covariance uvσ  to the crossed arms. However, in practice it is unlikely that 
this model would fit due to the small number of therapists and patients in the trial. As 
such, )2( )(ltherapistu  might be treated as a set of fixed parameters in a meta-analysis type 
model. 
 
2.4.2 Multiple Therapists-per-Patient 
 
Up to now it has been assumed that patients receive psychotherapy from just one 
therapist in a simple nested design. Alternatively patients may receive psychotherapy 
from more than one therapist, which might occur in several ways. An intervention may 
be a combination of different therapeutic approaches with each approach delivered by 
a different type of health professional. Goldstein95 describes this as creating a cross-
classified relationship between patients and health professionals. Alternatively a course 
of psychotherapy might be made up of several sessions, which could be delivered by 
different therapists of the same type. This is an example of a multiple membership 
relationship95, where sessions are not included as a specific level within the analysis. 
The intervention might also involve a uni- or multidisciplinary team of therapists within 
each session, a situation common in group-based interventions. Goldstein95 suggested 
diagrams to represent simple hierarchical, cross-classified and multiple membership 
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relationships, which can be used to illustrate the relationship between patients and 
therapists in a psychotherapy trial (see Figure 2.5). 
 
Figure 2.5 Single versus Multiple Therapist-Per-Patient Designs 
 
 
 
 
 
  (i) Hierarchical                  (ii) Cross-classified            (iii) Multiple membership 
 
A simple hierarchical relationship is represented by a single arrow between the patient 
and therapist. Where a cross-classified relationship is present, a single arrow between 
the patient and psychotherapist and between the patient and doctor reflects a one-to-
many relationship between patients and health professionals. This is analogous to 
pupils being nested both in schools and localities in educational research95. Where a 
multiple membership relationship is present, a double arrow between the patient and 
therapists instead reflects a one-to-many relationship between patients and therapists 
of the same type. In theory cross-classified and multiple membership models121, 122 can 
be fitted in software such as MLwiN123 using maximum likelihood or restricted maximum 
likelihood. Even if the trial generates data of sufficient quality to set up these analyses, 
model fitting is likely to be problematic unless sample sizes are much larger than is 
typically seen in psychotherapy trials. Additional levels are used to construct a hierarchy, 
and then constraints are added. This may be simplified in more complex situations by 
adopting a Bayesian framework using MCMC106, 121. 
 
The PACE trial3 provides an example both of cross-classified and multiple membership 
relationships between patients and health professionals (see Figure 2.6). Six hundred 
patients with chronic fatigue syndrome/ME are being individually randomised to one of 
four interventions: Adaptive Pacing Therapy plus Standardised Specialist Medical Care 
(APT); Cognitive Behavioural Therapy plus Standardised Specialist Medical Care (CBT); 
Graded Exercise Therapy plus Standardised Specialist Medical Care (GET); or simply 
Standardised Specialist Medical Care (SSMC). The first three interventions are multi-
component in nature with each component being provided by a different set of health 
professionals. This creates cross-classified relationships for APT/SSMC, CBT/SSMC and 
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GET/SSMC and a hierarchical relationship for SSMC. The fourth intervention includes 
only one of these components, so there is also partial nesting. For a relatively small 
proportion of patients, more than one therapist is involved in their care, as might be 
expected in clinical practice, due to staff turnover. This creates multiple membership 
relationships between patients and health professionals. 
 
Figure 2.6 Multiple Therapist Per Patient Example: The PACE Trial3 
  
 
Note: T1 to T24 are therapists; D1 to D35 are doctors. Therapists are nested; doctors are crossed; there is no therapist 
involvement in SSMC. 
 
Where interventions are administered in groups, an additional source of clustering is 
present. The relationship between patients and groups can also be described in terms 
of Goldstein’s95 classification. If group membership remains fixed across the course of 
a trial, and patients belong only to one group, the structure is simply hierarchical with 
patients nested within groups, in turn nested within therapists. Many group-based 
intervention trials include insufficient numbers of therapists to enable all three levels to 
be fully taken into consideration. In these circumstances it may be more important or 
feasible to take account of group variation than it is to take account of therapist 
variation. Each group may be administered by more than one therapist, either of the 
same type, creating a multiple membership structure, or of a different type, creating a 
cross-classified structure. If the patient is involved in more than one type of group 
intervention as part of their treatment package (e.g. initial and maintenance groups) 
and membership of these groups is defined separately, the design is cross-classified. 
Alternatively if group membership is fluid, with patients joining or leaving each group 
across the course of a trial, as may be the case in rolling groups, such as Alcoholics 
Anonymous, one could consider this to be a multiple membership design with each 
group session equating to a group. 
 
Therapists Doctors
Patient
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2.5 Implications for Internal Validity 
 
When considering the degree to which the effects of interventions result from a causal 
association between the intervention and patient outcome, it has been suggested that 
effort should focus on the avoidance of four potential biases124. Selection biases are 
systematic differences in baseline characteristics between arms. Performance, attrition 
and detection biases arise if there is a differential effect of additional/co-interventions, 
loss to follow-up or outcome assessment between arms, respectively. While all four 
biases may be present at both the patient and therapist levels, due to the multilevel 
nature of the design, the focus here will be on two potential selection biases. The first 
relates to the method of allocating interventions to therapists and affects the causal 
interpretation of intervention effects. The second relates to the method of allocating 
therapists to patients and affects the causal interpretation of therapist variation. It is 
important to consider concealing allocations in both cases. 
 
The implications of non-random, or purposive, allocation of interventions to therapists 
will depend to some extent on the research question (Figure 2.1). Any confounding of 
therapeutic approaches and therapist characteristics is problematic where interest is 
isolated to particular therapeutic approaches, or to particular therapist characteristics. 
Confounding of therapeutic approaches and therapist characteristics may cause little 
or no concern, however, where the intervention is intentionally a package, or indeed 
where a factorial design is used to investigate the additive and interacting effects of 
particular therapeutic approaches and particular therapist characteristics. 
 
The focus in the PACE trial (Figure 2.6) has been on packages where each intervention 
component is provided by a different professional group. Broadly, APT is provided by 
occupational therapists, CBT by psychotherapists, GET by physiotherapists and medical 
care (SSMC) by doctors. Interpretation of the results will therefore be restricted to the 
therapeutic approaches as provided by particular professional groups within the trial. If 
the aim had been to make inferences regarding the therapeutic approaches in isolation 
the random allocation of therapeutic approaches to health professionals would have 
ensured average baseline comparability of therapist characteristics across therapeutic 
approaches. 
 
It is not uncommon for psychotherapy researchers to note that the assignment of 
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therapeutic approaches to therapists ideally should be random7, 79, 125, 126. Yet this is 
still very much an exception in practice (but see UKATT Research Team127 and Schnurr 
et al128, 129 for examples). Staines126 (p.169) echoes the prevalent view, stating that 
“random assignment of therapists to conditions is likely to be even more difficult 
organizationally than random assignment of clients”. It is therefore of note that 
Schnurr et al129 (p.633) report that “there were no problems with therapists wanting to 
switch their assignments, or in adhering to their assigned therapy if it was not their 
preferred therapy”. Considering the professionals perspective, Wampold and Serlin96 
suggest that non-random allocation mirrors clinical practice where therapists’ have the 
freedom to provide their preferred therapeutic approach. However, in this case the 
research question relates to packages and interpretation of the results should reflect 
this. 
 
Where therapist variation is of interest in its own right, random allocation of therapists 
to patients is important if confounding of therapist variation by patient characteristics 
is to be avoided. Lambert130 (p.482) suggested that “since most research does not 
consider each therapist to be an independent variable this procedure is rarely used”, 
but see Brooker & Wiggins57, Blowers et al131, Borkovec et al132, Durham & Turvey133, 
Butler et al134, Barlow et al135 and Durham et al136 for examples. Lambert130 (p.482) 
goes on to say that random allocation “is an added burden to the research and clinical 
staff, but one that could be well worth the effort” as it facilitates causal interpretation 
of individual differences in therapist outcome. Practical difficulties relating to therapist 
availability at the point of randomisation may be avoided by building sufficient capacity 
into the design129, something that is also needed to address the implications of small 
numbers of therapists for precision. 
 
Removing confounding of therapist variation by patient characteristics could also affect 
the standard error of intervention effect estimates within a nested design, either by 
increasing or decreasing the size of the clustering effect. Lutz66 suggests that where 
therapists specialise in specific patient groups the distribution of patient characteristics 
across therapists may be influenced by random assignment of therapists to patients, 
such that therapist variation is decreased. Conversely, where therapists are assigned 
suitable patients according to their level of expertise in clinical practice, Lutz66 thought 
that random assignment may increase therapist variation, as differences in therapist 
performance may be greater when the complete spectrum of patients are included. 
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In some circumstances it may be either desirable or practical to maintain pre-existing 
therapist-patient allocations. For example, patients will often already have their own 
GP. In other circumstances, the geographical location will place restrictions on which 
therapists can be assigned to patients. For example, by embedding counsellors within 
general practices, counsellors are effectively allocated to general practices rather than 
to patients. As such, allocation of counsellors to patients is pre-determined based on 
the general practice patients attend. There may also be only one therapist available 
within a clinical service, such that therapist variation is aliased with centre effects. 
 
A number of randomisation methods are possible both for nested and crossed designs. 
Three possibilities for nested designs are given in Figure 2.7. Individual randomisation 
refers to random allocation of treatments to patients. In Figure 2.7, the therapeutic 
approach, therapist characteristic or package constitute the treatment. Allocation of 
treatments to therapists and of therapists to patients remains non-random, such that 
these aspects of the design are observational. Treatment effects are hence vulnerable 
to confounding by therapist characteristics and their interaction with characteristics of 
patients. The former may not be an issue if the treatment is a therapist characteristic 
or package, however. Therapist variation is also susceptible to confounding by patient 
characteristics. This would be problematic if causal interpretation of therapist variation 
was desired. An alternative option might be to regard the individual therapist as the 
treatment, and to individually randomise treatments by allocating individual therapists 
to patients, thereby avoiding confounding both the therapeutic approach and therapist 
variation by patient characteristics. This could be attractive where the intervention is a 
therapist characteristic or package. 
 
Figure 2.7 Some Possible Allocation Schemes for Nested Designs 
 
 
Then again, a cluster randomised design could be employed, in which the therapeutic 
approach is randomly assigned to therapists. The allocation of interventions to patients 
might then be determined by the pre-existing assignments of therapists to patients. 
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Therapist variation will be vulnerable to confounding by patient characteristics in this 
design because the allocation of therapists to patients is observational. If unconcealed 
random allocation of interventions to therapists precedes the non-random allocation of 
therapists to patients, a recruitment bias is possible, similar to that suggested more 
generally for cluster randomised trials137, due to confounding of intervention effects by 
patient characteristics. As such, while the clustering effect may be unaffected by the 
use of cluster randomisation in this context, internal validity considerations may rule 
against use of this design where alternatives are feasible. 
 
Another possibility would be firstly to randomly allocate interventions to therapists and 
then therapists to patients using a multi-tiered experimental design138. The individual 
therapists are the experimental units in the first randomisation, and treatments in the 
second. If the order in which these two randomisations is performed is unimportant, 
the design is referred to as composed by Brien and Bailey138, and has no aspect that is 
observational. This precludes use of dynamic allocation methods such as minimisation, 
where each allocation is conditional on the unit characteristics of previous allocations, 
which are unknown at the outset, however. Where interventions can only be randomly 
allocated to therapists prior to randomly allocating therapists to patients, the design is 
referred to as randomised inclusive138. Thus, while confounding of intervention effects 
by patient characteristics may be avoided if the second randomisation is concealed the 
effect of intermediate events (therapist training) on baseline therapist characteristics 
may also be an important consideration. Both multi-tiered designs may be theoretically 
attractive options, if therapeutic approaches are to be compared, but likewise may be 
difficult to implement. 
 
Where therapeutic approaches are of specific interest it will be important to investigate 
baseline comparability of therapist characteristics across intervention arms78, 139, and of 
patient characteristics between therapists78, particularly if allocation of psychotherapies 
to therapists is non-random. Baseline comparability of patient characteristics across 
therapists would also be important where therapist characteristics or packages are of 
interest. These comparisons could be seen a check on the adequacy of randomisation, 
where this is appropriate, or as part of a more general assessment of the impact of 
confounding if aspects of the design are observational. As such, it may be important to 
draw upon the methods of analysis commonly used within epidemiology. Imbalance in 
observed therapist characteristics between arms could, in theory, be dealt with using 
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covariate adjustment, stratification, or weighting. However, this may be difficult in 
practice due to limited degrees of freedom resulting from small numbers of therapists. 
 
It may also be impossible to distinguish therapist variation from the variation in patient 
adherence or effect of co-interventions between-therapists and thus from performance 
bias when unblinded therapists provide both the intervention and any co-interventions. 
Similarly, therapist variation is indistinguishable from variation between interviewers in 
outcome assessment, and therefore detection bias, if unblinded therapists are involved 
in treatment and outcome assessment. One method of limiting the role of detection 
bias in therapist variation is to separate treatment from outcome assessment using 
blinded independent raters. The role of performance bias in therapist variation might 
be reduced by choosing a nested over a crossed design. 
 
Wilkins140 (p.4) differentiated between two types of therapist characteristic. Therapist 
traits, such as therapist age, gender and profession, were defined as “relatively stable 
and enduring across therapy and extratherapy situations”. In contrast, therapist states 
are “situation-dependent” including therapist expertise, skill or commitment. Wilkins140 
argued that therapist traits can be controlled effectively using a crossed design, but 
that therapist states cannot. As such, crossed designs might be considered susceptible 
to performance bias. Elkin et al48 adopted a nested design for CBT and IPT within the 
TDCRP trial (Figure 2.3) because these treatments were considered too different for 
therapists to provide with equal expertise, skill and commitment. It seems likely that 
such a design was adopted, at least in part, in an attempt to limit the potential for 
performance bias in a trial where blinding was not feasible. This trial can be viewed as 
an example of an expertise-based trial141, in that much effort was put into ensuring 
adequate, consistent therapist expertise across interventions using a nested design. 
 
2.6 Implications for External Validity 
 
Martindale79 was first to outline the statistical basis for generalisation in this context, 
although it has also been discussed by others47, 96, 97, 125, 142. Martindale suggested that 
random selection of patients and therapists is necessary for intervention effects to be 
generalised to their respective populations. He went on to argue that therapists must 
be a random effect in analyses for generalisations to be made on a statistical basis. At 
the other extreme, Siemer and Joorman125, 142 have argued in favour of a fixed-effects 
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approach, suggesting that inferences based on random allocation alone are possible 
but are limited to the local population. Crits-Christoph et al97 adopted a compromise 
position, arguing that inferences can be made to a hypothetical population of similar 
therapists in the absence of random allocation. It may be concluded that the further 
away one moves from random selection and allocation, the less robust the basis for 
generalisation. 
 
A factor is considered random if the levels included are drawn from a larger population 
of possible levels, and there is interest in this larger population. In contrast, a factor is 
considered fixed if all of the levels of interest are specifically included in the model. 
Arguing against a fixed effects approach, Wampold and Serlin96 suggest that particular 
therapists are rarely of interest. For this reason Martindale79 and Crits-Christoph et al97 
also state that there is little, if no, scientific value in treating therapists as fixed. 
However, it is not always possible to include therapists as a random effect, particularly 
in early phase trials where the number of therapists is likely to be small. Paul and 
Licht47 suggest that the scientific value of a study comes primarily from its ability to 
provide causal inferences rather than the nature of the generalisations possible. With 
this in mind, it would seem reasonable to place less emphasis on generalisation during 
the earlier stages of development and evaluation125, using information gathered at this 
stage to inform the design of a large definitive trial81 where this is warranted. 
 
Another aspect of external validity relates to the selection of therapists into a trial. 
Elkin78 recommended reporting formal therapist eligibility criteria, suggesting that 
different criteria may be used to select therapists for different therapeutic approaches 
where packages are being compared. As such, therapists may originate from a single 
population or from multiple populations, depending on the particular interventions. 
Elkin78 also suggested that trialists should provide parallel information on the flow of 
therapists through a trial, similar to that given in a CONSORT diagram for patients. 
This would allow readers to assess the impact of the therapist recruitment process on 
generalisability of results, but also staff turnover and its implications for therapist 
variation. 
 
Therapists volunteering to work in a trial are likely to differ from therapists in clinical 
practice. They may be the therapy developers or unusually expert in early phase trials. 
Later on they may be younger, more enthusiastic or more committed than their 
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counterparts in practice. This will be an issue where external validity is considered 
important. While considering packages or providers, Roberts81 argued for each sample 
of health professionals being equally representative of its respective population within 
usual care. Elkin78 recommended reporting therapist baseline characteristics to allow 
readers to assess the representativeness of therapist samples included in a trial. This 
is relevant because provision of psychotherapy is assumed to vary inside and outside 
of the trial setting. Recruiting therapists directly from clinical practice using broad 
eligibility criteria might lead to them being more representative, but it could also 
increase the size of the clustering effect by increasing the range of therapist expertise. 
If the intervention is a package or particular therapist characteristic, an assessment of 
the generalisability of the treatments provided in the trial would also be important81. 
This might be done by providing therapist baseline characteristics separately for each 
therapist sample. 
 
2.7 Conclusions 
 
Randomised trials of psychotherapy are characterised not only by the complexity of 
their interventions but also by the complexity of their designs and associated data 
structures. Once it is acknowledged that therapists create an additional level with the 
design, psychotherapy trials become part of a wider class of “multilevel” randomised 
trials characterised by their complex data structures. Recognition of this has been 
obscured by a common perception that clustering is only an issue in trials where 
cluster randomisation is used. Greater consideration needs to be given from the outset 
to the broad principles of experimental design when considering relationships between 
treatments and therapists and between therapists and patients. Trialists should then 
justify what is appropriate and feasible to address their particular research question, 
appreciating the consequences of adopting a particular design and analysis strategy. 
Clearer and more precise reporting of research questions, trial designs and therapist 
variation is therefore needed, as is the prospective gathering of therapist data. Even 
where multiple randomisations are not feasible or appropriate, it can be argued that 
considering them aids understanding of potential biases associated with observational 
aspects of a design, mirroring the view that RCTs provide a model for epidemiological 
studies143. 
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3 A SYSTEMATIC METHODOLOGICAL REVIEW OF 
COCHRANE REVIEWS OF COMPARATIVE STUDIES 
INVOLVING PSYCHOTHERAPY 
 
3.1 Introduction 
 
Statistical pooling or meta-analysis of summary-data across studies can be viewed as a 
two-stage process in which summary statistics are first extracted from each study and 
then a weighted average is calculated of them144, 145. The summary statistic is often an 
odds ratio or relative risk, if outcomes are binary, or an absolute or standardised mean 
difference, if they are normally distributed. Weights are typically defined by the inverse 
of the variance of the summary statistic146, 147 and hence are a function of the standard 
errors calculated within the individual studies. Observations are frequently assumed to 
be statistically independent of one another, with a common variance across treatment 
arms within studies148. Consequently the presence of heteroscedasticity or clustering in 
the studies invalidates the use of these methods, unless standard errors are estimated 
from analyses that properly reflect these features of the data. 
 
The past decade has seen growing interest in the specific methodological challenges 
faced in the meta-analysis of randomised trials with multilevel designs. Methods have 
been proposed for use in pooling studies with repeated-measures149-152, crossover153-156 
and cluster-randomised42, 43, 157-160 designs and, recently, individually-randomised trials 
with inherent clustering39. What is common across this literature is a consideration of 
the impact of within-study clustering when combining data from trials with complex 
data structures, particularly where this has been ignored in published study analyses. 
While the general clustering issue is shared by all multilevel trial designs, the ensuing 
data structures vary in important respects. For example an assumption is usually made 
in relation to cluster-randomised trials that the between- and within-cluster outcome 
variances are equal across arms107. This leads to a common clustering effect across all 
treatment arms, indexed by an intraclass correlation coefficient. Nested therapist and 
group-based intervention studies are characterised by variance heterogeneity, both at 
the cluster (i.e. the therapist or group) and patient levels across arms, however84. An 
important corollary is that the size of any associated clustering effect is anticipated to 
fluctuate between treatments in such studies. It is thus necessary to consider not only 
the impact of clustering but also that of relaxing homoscedasticity assumptions. 
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Two empirical reviews have been published of the approaches taken by reviewers to 
the synthesis of cluster-randomised and crossover trials so far156, 161. Elbourne et al156 
found that, of the 1000 reviews published in Issue 1, 2001 of the Cochrane Database 
of Systematic Reviews, 184 included crossover trials. Of these, only Hubbert et al162 
adjusted for the associated clustering effects. The most frequently adopted approach 
was to treat crossover trials as if they had parallel-group designs. This was done by 
ignoring within-study clustering and including data from both treatment periods (56; 
30%) or from the first period only (95; 52%). The remaining reviews either excluded 
crossover trials (11; 6%) or reported their findings within the text (21; 11%). A clear 
approach was rarely stated in the Methods section, and those reported varied across 
Cochrane Review groups. 
 
Laopaiboon161 searched MEDLINE, EMBASE, Health Star, SCIsearch and the Cochrane 
Library for reviews published up to 2000 that included cluster-randomised trials. Of the 
25 reviews identified, 16 (64%) were found in the Cochrane Database of Systematic 
Reviews. Fifteen (60%) included more than one cluster-randomised trial, their design 
and unit of randomisation differing within meta-analyses for the most part. Only one 
review satisfactorily adjusted for associated clustering effects163. Fawzi et al164 inflated 
standard errors by 30%, but did so in spite of whether the estimation method allowed 
for clustering. Glasziou et al165 adapted the methods described by Rao and Scott166 but 
appeared to regard individually-randomised trials as having one cluster per arm161. The 
most common approach was to use the published standard errors (15; 60%). This was 
appropriate in two reviews167, 168, where all of the cluster-randomised trials had been 
analysed taking clustering into account161. Of the remaining reviews, 6 (24%) reported 
the results in the text and 1 (4%) did not clearly state what methods had been used. 
In no case was a rationale given, however clear, for the approach adopted161. 
 
The presence of additional levels in meta-analyses has potential implications for the 
precision, internal and external validity of the pooled treatment effect estimates. The 
emphasis given to precision, largely at the expense of validity, in the methodological 
literature is mirrored in guidance given to reviewers by the Cochrane Collaboration169. 
This was revised in May 2005 to include additional sections on crossover and cluster-
randomised trials, in part as a response to this literature. The possibility of selection, 
performance, attrition and detection biases at multiple levels was not mentioned, nor 
was generalisation of treatment effects to units at all levels. What advice was given 
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was also specific to these designs. The aim of this chapter was to explore the range, 
complexity and recognition of issues arising in meta-analyses of psychotherapy trials, 
with particular attention to the multilevel aspects. While such issues are expected to 
be widely applicable, psychotherapy provides a clear focus and its definition was kept 
deliberately broad. The absence of space constraints, along with their structured and 
electronic format, makes the reviews in the Cochrane Database of Systematic Reviews 
an ideal sampling frame. Extensive citation in medical journals, policy documents and 
practice guidelines170 further justifies their quality being of specific interest, and hence 
also their likelihood of indicating current best practice. 
 
3.2 Methods 
 
3.2.1 Selection and Description of Systematic Reviews 
 
The search strategy was refined by obtaining a list of general terms used by Cochrane 
reviewers to refer to randomised trials involving psychotherapy. A list of specific terms 
was not generated because an exhaustive list would have been impractical and a 
selective one might have reduced the breadth of the search. One hundred and 
seventy-five reviews were identified in Issue 4, 2006 of the Cochrane Database of 
Systematic Reviews using keyword searches based on the terms psychotherapy and 
psychological intervention. A refined set of search terms was then created in light of 
the phrases used in the titles and abstracts of these reviews. The Cochrane Database 
of Systematic Reviews was searched again on 19th January 2007 using psychotherap*, 
psychological *, psychosocial * and counsel* and the MeSH terms Psychotherapy and 
Counseling, including all subheadings and subtrees. All searches were restricted to 
reviews and were of titles, abstracts and keywords only. Once duplicate records had 
been removed, attempts were made to download the full-text of the remaining 262 
reviews. Seven of these were classed as withdrawn with the full-text no longer 
available for two, leaving 260 reviews to be assessed for eligibility (see Figure 3.1). 
 
To be eligible for inclusion, reviews had to report meta-analyses of studies involving 
psychotherapy. The full-text of all 260 reviews was inspected to determine whether 
1. One or more study involving psychotherapy had been included 
2. One or more meta-analysis involving these studies had been reported 
Reasons for exclusion were noted. 
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Figure 3.1 Selection of Systematic Reviews 
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A random 10% of the reviews were independently evaluated by a second reviewer 
(TC), with disagreements resolved by discussion and reference to the full-text. A 
further 15 borderline or grey-area reviews were also discussed in detail. The eligibility 
criteria were clarified accordingly: 
 
i) Any experimental or control intervention referred to in any section of the review as 
including psychotherapy or counselling or a psychological, psychotherapeutic, 
psychosocial or behavioural component was accepted as involving psychotherapy 
except where it was made clear that there was no therapist involvement 
ii) Interventions directed at care providers or organisations were excluded as not 
involving psychotherapy 
iii) An intervention accepted as involving psychotherapy in one review was deemed to 
involve psychotherapy in all reviews 
iv) Psycho-education was excluded as a form of education 
v) Psychotherapy could be a primary or a co-intervention 
vi) Studies could be randomised or non-randomised 
vii) Relevant meta-analyses could include both relevant and non-relevant studies but 
must include one or more relevant treatment arms 
 
Eligibility assessment was then repeated for all 260 reviews using the refined criteria. 
Decisions regarding 63 (62%) of the included and 65 (41%) of the excluded reviews 
could have been made using the abstract alone. In no review were studies excluded or 
reported qualitatively due to issues surrounding therapist variation. 
 
  
Page 59 of 238 
Table 3.1 Characteristics of Systematic Reviews Included by their Focus 
 
Focus of Systematic Review 
Psychotherapy  Other 
 
General 
 
Specific 
 
Therapist 
Characteristics 
 
 
Wider 
 
Different 
 
Search Term, n (% total)   
 Psychotherap* 17 (81) 12 (36) 2 (40)  4 (19) 3 (14) 
 Psychological * 18 (86) 16 (48) 1 (20)  7 (33) 9 (43) 
 Psychosocial * 6 (29) 11 (33) 1 (20)  2 (10) 3 (14) 
 Counsel* 4 (19) 6 (18) 5 (100)  8 (38) 8 (38) 
 MeSH Psychotherapy 16 (76) 23 (70) 2 (40)  12 (57) 3 (14) 
 MeSH Counseling 0 (0) 3 (9) 4 (80)  3 (14) 1 (5) 
Cochrane Review Group, n (% total)   
 Depression Anxiety & Neurosis 6 (29) 6 (18) 2 (40)  5 (24) 2 (10) 
 Tobacco Addiction - 5 (15) 2 (40)  2 (10) 4 (19) 
 Schizophrenia 1 (5) 8 (24) -  1 (5) 1 (5) 
 Developmental Psychosocial &   
Learning Problems 
1 (5) 6 (18) -  - 1 (5) 
 Drugs & Alcohol 2 (10) - -  1 (5) 5 (24) 
 Incontinence - 2 (6) -  3 (14) 1 (5) 
 Heart 2 (10) 1 (3) -  - 2 (10) 
 Pregnancy & Childbirth 1 (5) - -  3 (14) 1 (5) 
 Airways 2 (10) - -  - 1 (5) 
 Cystic Fibrosis & Genetic Disorders 1 (5) 1 (3) -  - - 
 Dementia Anxiety & Neurosis - 2 (6) -  - - 
 HIV/AIDS - - -  1 (5) 1 (5) 
 Metabolic & Endocrine Disorders 1 (5) - -  1 (5) - 
 Pain Palliative & Supportive Care 2 (10) - -  - - 
 Stroke - - -  2 (10) - 
 Back - 1 (3) -  - - 
 Breast Cancer 1 (5) - -  - - 
 Consumers & Communication - - -  - 1 (5) 
 Ear Nose & Throat Disorders - 1 (3) -  - - 
 Effective Practice & Organisation 
of Care 
- - 1 (20)  - - 
 Gynaecological Cancer - - -  1 (5) - 
 Injuries - - -  1 (5) - 
 Multiple Sclerosis 1 (5) - -  - - 
 Musculoskeletal - - -  - 1 (5) 
Updated since Cochrane Handbook Version 4.2.5 released, n (% total)   
 Yes – Substantial 7 (33) 17 (52) 1 (20)  5 (24) 7 (33) 
 Yes – Not Substantial 9 (43) 4 (12) 1 (20)  7 (33) 5 (24) 
Trials within Reviews, n (% total)   
 All involve Psychotherapy 18 (86) 32 (97) 4 (80)  3 (14) 1 (5) 
 One or more involve            
Group-Based Interventions 
20 (95) 26 (79) 5 (100)  15 (71) 17 (81) 
 One or more involve              
Cluster Randomisation 
9 (43) 10 (30) 4 (80)  9 (43) 7 (33) 
 One or more are Crossover Trials 1 (5) 5 (15) 0 (0)  2 (10) 4 (19) 
Meta-Analyses within Reviews, n (% total)   
 All involve Psychotherapy 20 (95) 33 (100) 5 (100)  11 (52) 9 (43) 
 One or more involve            
Group-Based Interventions 
18 (86) 24 (73) 4 (80)  12 (57) 14 (67) 
 One or more involve              
Cluster Randomised Trials 
8 (38) 9 (27) 3 (60)  4 (19) 6 (29) 
 One or more involve              
Crossover Trials 
1 (5) 4 (12) 0 (0)  0 (0) 4 (19) 
TOTAL (Unique Systematic Reviews) 21 33 5  21 21 
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Table 3.1 summarises the characteristics of these reviews by their focus. Of the 101 
reviews included, 59 were psychotherapy focused, while the remaining 42 had a focus 
other than psychotherapy. Of the former, 21 focused on psychotherapy generally171-
191, 33 on a specific form of psychotherapy37, 192-223, and 5 on characteristics of the care 
providers224-228. Of the latter, 21 had a wider focus229-249, including psychotherapy but 
also other interventions, and 21 had a different focus, where psychotherapy could be 
regarded as more of an aside250-270. It is evident that the search terms were 
differentially effective for selecting some types of review and that a range of terms 
were required to capture the heterogeneity present. It is also clear that therapist 
variation is an issue for a broad set of reviews, spanning 24 (46%) of the Cochrane 
Review groups. This was especially true for the Depression, Anxiety & Neurosis group 
and for the Tobacco Addiction and Schizophrenia groups, as these three groups 
accounted for almost half of the reviews included. Sixty-three had been updated since 
the release of guidance on handling clustering effects within cluster-randomised and 
crossover trials, with 37 of these making substantial amendments. As such, general 
awareness of clustering was anticipated amongst a sizeable proportion. 
 
There was psychotherapy involvement in every included study within 58 reviews and 
in every reported meta-analysis in 78 reviews. The prevalence of studies with group-
based intervention components was also high, with 83 reviews including at least one 
study and 72 reporting meta-analyses involving such studies. This is in contrast to the 
prevalence of cluster-randomised and crossover trials in these reviews. Only 39 
included cluster-randomised trials, with 30 including one in a reported meta-analysis. 
Likewise, only 12 reviews included crossover trials and only 9 reviews reported meta-
analyses involving them. 
 
Table 3.2 Types of Outcomes in Reported Meta-Analyses 
Focus of Systematic Review  
Outcomes, n (% total) 
Psychotherapy Other 
Overall 
All Binary 15 (25) 22 (52) 37 
    All Relative Risks 
    All Odds Ratios 
    All Peto Odds Ratios 
    Mixed Binary 
6 (10) 
6 (10) 
2 (3) 
1 (2) 
10 (24) 
7 (17) 
5 (12) 
0 (0) 
16 
13 
7 
1 
All Continuous 18 (31) 7 (17) 25 
    All Weighted Mean Differences 
    All Standardised Mean Differences 
    Mixed Continuous 
7 (12) 
8 (14) 
3 (5) 
3 (7) 
3 (7) 
1 (2) 
10 
11 
4 
Mixed Binary & Continuous 26 (44) 13 (31) 39 
TOTAL 59 42 101 
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The types of outcomes reported in the meta-analyses are given by the review’s focus 
in Table 3.2. A higher percentage of those focused on psychotherapy only reported 
continuous outcomes, (31% vs. 17%), while the reverse was apparent for the binary 
outcomes, (25% vs. 52%). A sizeable percentage reported a mixture of continuous 
and binary outcomes. 
 
3.2.2 Selection and Description of Studies within Cochrane Reviews 
 
The Characteristics of Included Studies table in the appendix of each included review 
was used to define the sample of studies. Once duplicate records within reviews had 
been removed, the remaining 1947 records, and associated full-text, were evaluated 
for evidence of psychotherapy involvement using the criteria given above. Figure 3.2 
summarises this process. 
 
Figure 3.2 Selection of Studies Involving Psychotherapy in Reviews 
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Psychotherapy involvement was assessed twice to increase consistency of ratings. It 
became apparent, when comparing ratings across reviews, that reporting of study 
arms was selective for multi-arm studies in some reviews. As a consequence, studies 
were regarded as involving psychotherapy if any rating was positive for a study. As 
the issues arising from therapist variation are equally applicable to education and 
physiotherapy, it was evident they were relevant to the majority of studies included in 
the 101 reviews. 
 
Table 3.3 summarises some of the characteristics of the study sample. While studies 
described as non-randomised were included, they formed less than 5% of the total 
sample. There was some indication that the prevalence of multi-arm parallel-group 
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designs is higher for studies with psychotherapy involvement, and that the reverse is 
true for crossover trials. The overall percentage of cluster-randomised and crossover 
trials in the sample was low at 6% and 2% respectively, compared to 74% involving 
psychotherapy. Owing to the variation in the number of arms per study, the study 
sample sizes are given per arm with crossover trials counted as having a single arm. 
Sample sizes were not reported consistently so the number randomised or enrolled is 
given, if possible, otherwise the number reflects those analysed. It can be seen that 
over half of the studies had sample sizes of 50 or less per arm. There is also some 
suggestion that sample sizes are smaller where there is psychotherapy involvement in 
a study. 
 
Table 3.3 Characteristics of Studies across Reviews 
 Studies involving 
Psychotherapy 
All 
Studies 
Study Design, n (% total)  
  Randomised 1293 (96.1) 1733 (95.4) 
  3+ Arm Parallel-Group 394 (29.3) 489 (26.9) 
  Crossover 9 (0.7) 35 (1.9) 
  Cluster-Randomised 81 (6.0) 111 (6.1) 
Sample Size per Arm, n (% total)  
  <= 10 128 (9.5) 153 (8.4) 
  11 to 20 260 (19.3) 340 (18.7) 
  21 to 50 469 (34.9) 597 (32.9) 
  51 to 100 212 (15.8) 293 (16.2) 
  101 to 200 124 (9.2) 196 (10.8) 
  201 to 500 91 (6.8) 138 (7.6) 
  501+ 61 (4.5) 97 (5.3) 
TOTAL (Unique Studies) 1345 1816 
Note: Sample size was not reported for two cluster-randomised studies which 
did not involve psychotherapy 
 
Included studies in each review were listed together with their references. Where 
more than one citation was given per study, reviewers often starred one to indicate it 
as the main citation. For studies with psychotherapy involvement, the source and year 
of the main citation was recorded along with the source of any other citations. Figure 
3.3(a) gives the age distribution of the included studies by the size of their sample per 
arm. The number of studies increases over time with a time lag indicated in the 
inclusion of more recent studies. The number of larger studies also appears to 
increase, although the proportion of such trials does not do so noticeably. The 1345 
unique studies involving psychotherapy were published in 475 different journals. The 
distribution of the number of studies per journal is given in Figure 3.3(b). It can be 
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seen that the majority of journals were recorded as the source of only one study in 
the sample. Only 12 journals were the source of 20 or more studies (see Table 3.4). 
 
Figure 3.3 Publication of Studies Involving Psychotherapy 
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(b) Number of Studies per Journal
 
 
The Journal of Consulting and Clinical Psychology was the most frequently cited 
journal, being the source of more studies than four major general medical journals 
combined. It was responsible for less than 10% of the study sample, however. Four 
major general psychiatry journals were also only the source of a tenth of the study 
sample, suggesting that single journals and groups of high impact journals do not 
serve as good sampling frames for evaluations of studies involving psychotherapy. 
 
Table 3.4 Journals Publishing Studies Involving Psychotherapy 
 
 
N studies (%)  
Any Reference  
N studies (%)  
Main Reference 
12 Most Frequently Cited Journals:   
  Journal of Consulting and Clinical Psychology 127 (9.4) 114 (8.5) 
  British Journal of Psychiatry 57 (4.2) 44 (3.3) 
  Archives of General Psychiatry 50 (3.7) 42 (3.1) 
  British Medical Journal 42 (3.1) 33 (2.5) 
  Behaviour Research and Therapy 39 (2.9) 34 (2.5) 
  American Journal of Psychiatry 39 (2.9) 25 (1.9) 
  Behavior Therapy 32 (2.4) 29 (2.2) 
  Addictive Behaviors 30 (2.2) 26 (1.9) 
  Preventive Medicine 29 (2.2) 20 (1.5) 
  Psychological Medicine 24 (1.8) 19 (1.4) 
  American Journal of Public Health 21 (1.6) 18 (1.3) 
  Archives of Internal Medicine 20 (1.5) 19 (1.4) 
   
Four Major General Medical Journals 90 (6.7) 75 (5.6) 
Four Major General Psychiatry Journals 153 (11.4) 130 (9.7) 
   
Note: The four major general medical journals were BMJ, Lancet, JAMA and NEJM; the four major general psychiatry journals 
were American Journal of Psychiatry, Archives of General Psychiatry, British Journal of Psychiatry and Psychological Medicine. 
  
Page 64 of 238 
3.2.3 Data Extraction and Analysis 
 
A data extraction sheet was used to record information on reviewers’ awareness of 
the precision, internal and external validity implications of therapist variation, and of 
other sources of clustering effects, for each included review. Quotes were extracted as 
comprehensively as possible in support of positive ratings, and supplemented by 
systematic keyword searches of the electronic full-text. This data was independently 
extracted for a random 10% of reviews by a second reviewer (CR). Disagreements 
were again resolved by discussion and reference to the full-text. During this process it 
became clear that reviewers’ reporting of data structures, cluster sizes, intracluster 
correlations, multiple randomisations, therapist number and characteristics was more 
appropriately recorded at the study level. Therefore, the Characteristics of Included 
Studies table was systematically searched for this information, which was entered 
directly into a database designed for the purpose. This was then supplemented by 
information taken from the data extraction sheets and keyword searches of the text. 
Issues arising at this stage were discussed with a second reviewer (MD), and coding 
schemes refined accordingly. The extraction process was then repeated at the study 
level to improve consistency of ratings across reviews. Analyses of the data were 
descriptive, with themes applied to qualitative data where this helped to structure this 
information. Where the number of quotes is large, example quotes are provided in the 
text with the full quotes given in the appendix (see Section 3.9). 
 
3.3 Recognition of Therapist Variability 
 
Seventeen of the 101 reviews contained some general reference to variation in patient 
outcomes between therapists, with all but two of these having a psychotherapy focus. 
As can be seen from the examples in Box 3.1, these are parenthetical. A number made 
reference to conventional explanations for the consequences of therapist variability 
(see Box 3.2). Again, all but two of these reviews focused on psychotherapy. These 
were classified as relating to (i) treatment standardisation or therapist competence; (ii) 
placebo or non-specific effects; and (iii) process research. In each case the therapist is 
viewed as an aside. Finally, 11 reviews explored therapist characteristics as sources of 
between-arm or between-study heterogeneity (see Box 3.3 for examples), including 
the five reviews focusing on the former224-228. Here, there is specific interest in the 
therapists. 
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It is clear from Boxes 3.1-3.3, and other references to treatment standardisation in the 
reviews, that there is widespread acknowledgment amongst Cochrane reviewers of the 
presence of therapist variability. A deeper consideration of its impact on study designs 
and analyses, in pooled comparisons of arms defined by therapist characteristics, and 
in the analysis of subgroups of studies is also evident. 
 
Box 3.1 Examples of General Awareness of the Presence of Therapist Variability 
 
 
Box 3.2 Conventional Explanations for the Consequences of Therapist Variability 
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Box 3.3 Examples of Therapist Variation as Arm or Study Characteristics 
REVIEWS FOCUSING ON THERAPIST CHARACTERISTICS
Rice VH, Stead LF. Nursing interventions for smoking cessation
225
:
The aim of this review is to examine and summarize randomized clinical trials where nursing 
provided smoking cessation interventions. The review therefore focuses on the nurse as the intervention
provider, rather than on a particular type of intervention.”  “The US Public Health Service clinical 
practice guideline ’Treating Tobacco Use and Dependence’ (AHRQ 2000) used logistic regression to estimate 
efficacy for interventions delivered by different types of providers. Their analysis did not distinguish among 
the non-physician medical healthcare providers, so that dentists, health counsellors, and pharmacists were 
included with nurses. The guideline concluded that these providers were effective (Table 15, OR 1.7, 95% CI 
1.3 to 2.1).” "The evidence suggests that brief interventions from nurses who combine smoking 
cessation work with other duties are less effective than longer interventions with multiple contacts, delivered 
by nurses with a role in health promotion or cardiac rehabilitation."
EXAMPLE FROM OTHER REVIEWS
Hodnett ED, Fredericks S. Support during pregnancy for women at increased risk of low 
birthweight babies
249
:
"Debates have arisen regarding the relative benefits of ’professional’ versus ’peer’ support. 
Social support from a woman in one’s community, who has a similar socioeconomic background and is 
experiencing similar life stresses, may be qualitatively different from support from a healthcare professional, 
who has broad professional knowledge and experience, but may not share the same socioeconomic 
background or life concerns, and who often provides other professional services as well as support. This 
Review includes studies of support by providers with varying backgrounds and qualifications." 
"Secondary objectives were to determine whether effectiveness of support was mediated by...type of 
provider (a healthcare professional or a lay woman)." "A subgroup analysis was planned to 
compare support provided by lay women versus support by healthcare professionals, because another 
Review of support for childbearing women (Hodnett 2003) found differences in the effects of support by 
hospital staff (nurses, midwives) versus support by lay women." "Because there was only one trial in 
which the support was provided by lay women (Spencer 1989), and in another trial the support was 
provided by a multidisciplinary team that included lay women (McLaughlin 1992), the planned subgroup 
analysis was not performed. However, the results of these two trials were remarkably consistent with those 
of the other trials."  
 
 
3.4 Recognition of the Implications for Precision 
 
3.4.1 Reporting of Study Designs and Associated Data Structures 
 
Study designs were principally reported in the Description of Studies section of the 
main text, the Characteristics of Included Studies table in the appendix, or in both of 
these. As details of the designs were not always available or reported in the reviews, 
designs were recorded along with whether they had been reported explicitly, implicitly 
or assumed. In contrast to other designs, crossover trials tended to be over-reported. 
There was evidence of this in five of the reviews177, 217, 221, 244, 264, where a waitlist 
control receiving the intervention at the end of the trial and then followed up was 
confused with random allocation of treatment sequences. Reports were explicit in all 
cases. If there was no indication of whether a study had a crossover or parallel-group 
design the latter was assumed. Table 3.5 summarises reporting of cluster-randomised, 
group-based and therapist designs by the focus of the review. 
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Table 3.5 Overall Reporting of Study Designs 
 
Designs, n reviews 
(% relevant total) 
Assumed 
for all 
studies 
Implicit 
for all 
studies 
Explicit 
for all 
studies 
Either 
Assumed 
or Implicit 
for studies 
Either 
Assumed 
or Explicit 
for studies 
Either 
Implicit or 
Explicit for 
studies 
Either 
Assumed,  
Implicit or 
Explicit  for 
studies 
Total 
Review Focus: Psychotherapy        
Cluster 
Randomisation1 
0 (0) 9 (39) 10 (43) 1 (4) 0 (0) 2 (9) 1 (4) 23 (100) 
Individual or Group-
Based Interventions1 
6 (10) 0 (0) 15 (25) 1 (2) 22 (37) 6 (10) 9 (15) 59 (100) 
Therapists  
Nested or Crossed 
With Interventions2 
28 (47) 0 (0) 0 (0) 9 (15) 8 (14) 0 (0) 14 (24) 59 (100) 
Single or Multiple 
Therapists per Patient2 
23 (39) 1 (2) 2 (3) 7 (12) 11 (19) 2 (3) 13 (22) 59 (100) 
Review Focus: Other       
Cluster 
Randomisation1 
0 (0) 5 (31) 6 (38) 1 (6) 0 (0) 3 (19) 1 (6) 16 (100) 
Individual or Group-
Based Interventions1 
8 (19) 0 (0) 2 (5) 1 (2) 20 (48) 1 (2) 10 (24) 42 (100) 
Therapists  
Nested or Crossed 
With Interventions2 
24 (57) 0 (0) 0 (0) 6 (14) 3 (7) 1 (2) 8 (19) 42 (100) 
Single or Multiple 
Therapists per Patient2 
17 (40) 1 (2) 0 (0) 7 (17) 5 (12) 1 (2) 11 (26) 42 (100) 
1 Based on all 1816 unique studies; 2 Restricted to the 1345 unique studies involving psychotherapy 
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Cluster randomisation was explicitly reported for one or more studies in 59% (10+2+1 
+6+3+1=23/39) of the reviews, implicitly reported for one or more studies in 59% (9 
+1+2+1+5+1+3+1=23/39) and assumed, using information reported elsewhere, for 
one or more studies in 10% (1+1+1+1=4/39). Given the small number of reviews in 
which cluster-randomised trials were observed, there is no evidence to suggest that 
the level of reporting differed according to the review focus. Seven reviews including 
one or more cluster-randomised trial made implicit reference to the co-assignment of 
partners, friends or households183, 187, 192, 207, 247, 249, 261 with 4 of these reviews relating 
to smoking cessation. Together with more overt references, where randomisation was 
described as being by a unit other than the patient, these reports were implicit to the 
extent that reviewers did not refer to designs as cluster-randomised and it was not 
always clear that they considered them as such. Even where the presence of cluster 
randomisation was explicit, the specific design, be it completely-randomised, matched, 
stratified, or crossed, was reported systematically in only 2 reviews227, 232. The unit of 
randomisation was reported more frequently, but not universally, with 12% (13/111) 
of cluster-randomised studies being reported by reviewers without this information. 
 
In contrast to the reporting practices for crossover and cluster-randomised designs, 
those for therapist and group-based interventions did not appear to be reflective of 
reviewers’ awareness of the implications of study design for precision. Instead, these 
aspects tended to be regarded as part of the description of the intervention. Table 3.5 
indicates that group- versus individually-based formats were reported explicitly for one 
or more studies in 84% (15+22+6+9+2+20+1+10=85/101) of the reviews, implicitly 
for one or more studies in 28% (1+6+9+1+1+ 10=28/101) and assumed for one or 
more studies in 76% (6+1+22+9+8+1+20+10=77/101). Although the prevalence of 
group-based designs may be under-estimated, the information provided appeared to 
be sufficient to make this judgement, perhaps with the exception of co-interventions. 
It was not sufficient to determine relationships between interventions and therapists 
and between therapists and patients, however. These were explicitly reported in 34% 
(8+14+3+1+8=34/101) and 45%(2+11+2+13+5+1+11=45/101) of the reviews and 
then only for a proportion of studies involving psychotherapy. Assumptions for these 
design features were prone to considerable error, being based primarily on the type of 
control group or use of co-interventions for the former, the nature of the intervention 
in the latter, and reporting of therapist characteristics in both cases. Better reporting 
of therapist and group-based study designs was indicated for the reviews with a
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Table 3.6 Reporting of Group- and Therapist-Based Interventions 
 
Designs, n reviews 
(% relevant total) 
Assumed 
for all 
studies 
Implicit 
for all 
studies 
Explicit 
for all 
studies 
Assumed 
or Implicit 
for studies 
Assumed 
or Explicit 
for studies 
Implicit or 
Explicit for 
studies 
Assumed,  
Implicit or 
Explicit for 
studies 
 
 
Total 
Individual versus Group-Based Interventions1      
Individual  41 (44) 2 (2) 16 (17) 1 (1) 31 (33) 0 (0) 3 (3) 94 (100) 
Group  1 (1) 4 (5) 56 (72) 0 (0) 1 (1) 10 (13) 6 (8) 78 (100) 
Individual & Group 0 (0) 4 (11) 27 (77) 0 (0) 1 (3) 3 (9) 0 (0) 35 (100) 
Relationship between Interventions and Therapists2    
Nested 51 (55) 1 (1) 0 (0) 15 (16) 8 (9) 2 (2) 16 (17) 93 (100) 
Crossed 58 (76) 0 (0) 5 (7) 3 (4) 7 (9) 0 (0) 3 (4) 76 (100) 
Nested & Crossed 21 (72) 4 (14) 1 (3) 3 (10) 0 (0) 0 (0) 0 (0) 29 (100) 
Relationship between Therapists and Patients2      
Single 49 (51) 3 (3) 1 (1) 19 (20) 10 (10) 1 (1) 14 (14) 97 (100) 
Multiple: Simultaneous 3 (11) 2 (7) 13 (46) 1 (4) 3 (11) 3 (11) 3 (11) 28 (100) 
Multiple: Parallel 28 (58) 1 (2) 6 (13) 4 (8) 7 (15) 2 (4) 0 (0) 48 (100) 
1 Based on all 1816 unique studies; 2 Restricted to the 1345 unique studies involving psychotherapy; In each case, the most complex structure is given per study and then the  
presence of one or more study with each structure is reported; Individual & group and nested & crossed imply multiple intervention components with different structures;  
Simultaneous multiple refers to multiple therapists per patients within an intervention component; Parallel multiple refers to one or more therapists for each of multiple  
intervention components; Where no relevant information was given regarding a study design, the default was to assume an individual intervention, nested therapists and a single  
therapist-per-patient for that study. 
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psychotherapy focus but reporting was poor in all cases. 
 
Table 3.6 summarises the reporting of therapist and group-based data structures for 
the specific designs. The intervention format and the relationship between therapists 
and patients differed across treatment arms in many of the studies. Where this was 
so, the most complex data structure was recorded. While their prevalence remains 
largely uncertain, it is clear that all the conceivable designs were present across the 
reviews. A mixture of designs was evident within reviews, and hence also potentially 
in the meta-analyses. This complexity and variety has repercussions for assessments 
of how the potential clustering effects are handled in study reports and for methods 
that allow for such effects in meta-analyses. 
 
Partial nesting or crossing of therapists and groups with interventions occurs when 
clustering is restricted to a subset of treatment arms within a study. This was not 
explicitly reported in any of the reviews. It was however indicated by the nature of the 
control arms in 93% (94/101) reviews for therapist designs and in 81% (67/83) of the 
reviews for group-based designs. Table 3.7 summarises the extent to which partial 
clustering was indicated by the review focus. 
 
Table 3.7 Implicit Reporting of Partial Clustering within Cochrane Reviews 
Focus of Systematic Review 
Psychotherapy  Other 
 
 
Partial Clustering  
Indicated 
General 
 
Specific 
 
Therapist 
Characteristics 
 
 
Wider 
 
Different 
 
 
 
Overall 
Therapist Variation, n (% total)1    
All Relevant Studies 2 (10) 5 (15) -  5 (24) 4 (19) 16 (16) 
Some Relevant Studies 19 (90) 27 (82) 5 (100)  16 (76) 11 (52) 78 (77) 
No Relevant Studies - 1 (3) -  - 6 (29) 7 (7) 
TOTAL 21 33 5  21 21 101 
Group Variation, n (% total)2    
All Studies 6 (30) 9 (35) 3 (60)  3 (20) 3 (18) 24 (29) 
Some Studies 12 (60) 15 (58) 2 (40)  9 (60) 5 (29) 43 (52) 
No Studies 2 (10) 2 (8) -  3 (20) 9 (53) 16 (19) 
TOTAL 20 26 5  15 17 83 
1 Restricted to the 1345 unique studies involving psychotherapy; 2 Based on all 1816 unique studies  
 
It is evident that the absence of such studies was a particular feature of reviews with 
a different focus. This was because the therapist and group involvement in these 
reviews tended to be in the form of co-interventions representing standard care. 
Where reviews include multi-arm studies, the impact of partial clustering on meta-
analyses depends on which arms are selected. Therefore, while the impact is possibly 
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overstated, it is clear that partial clustering is a common issue for Cochrane reviews 
and meta-analyses of studies involving psychotherapy. 
 
3.4.2 Reporting of the Extent and Handling of Study Clustering Effects 
 
Reviewers reporting of the extent and handling of study-level clustering effects more 
overtly reflected their awareness of the precision implications. Table 3.8 summarises 
reporting of cluster sizes and intraclass correlation coefficients (ICCs) by the source of 
the potential clustering effect. 
 
Table 3.8 Reporting of Cluster Sizes and Intraclass Correlations 
Source of Clustering   
Level of  
Reporting, n (% total) 
Cluster 
Randomisation 
Group-Based 
Intervention 
Therapist 
Variation 
Cluster Size 
Complete: Explicit  6 (15) 7 (8) 0 (0) 
Complete: Via Number of Clusters 4 (10) 0 (0) 3 (3) 
Partial: Explicit 3 (8) 12 (14) 2 (2) 
Partial: Explicit & Via Number of Clusters 5 (13) 3 (4) 2 (2) 
Partial: Via Number of Clusters 7 (18) 1 (1) 23 (23) 
Not reported 14 (36) 60 (72) 71 (70) 
Intraclass Correlation (ICC) 
Partial: Explicit 3 (8) 0 (0) 0 (0) 
Partial: Explicit & Qualitative 1 (3) 0 (0) 0 (0) 
Partial: Qualitative   1 (3) 0 (0) 0 (0) 
Unavailable but Assumptions Explicit 4 (10) 0 (0) 0 (0) 
Not reported 30 (77) 83 (100) 101 (100) 
TOTAL 39 83 101 
 Note: Study ICC estimates could be reported, assumed or reported as completely or specifically unavailable to be counted above 
 
It was apparent that cluster size was viewed as a more general aspect of the study 
description than as a component of its design effect. Cluster sizes were reported or 
deducible in a higher proportion of the reviews than ICCs were for all sources of 
clustering. The number of therapists and the group size tended to be reported rather 
than the size of therapist caseloads or the group number. In some cases, a range of 
cluster sizes were reported, although primarily for group-based designs. In others, 
average cluster sizes were deducible for each study arm. ICCs were either provided 
explicitly or a qualitative statement was made about their size. They were reported in 
nine reviews196, 206, 223, 224, 227, 238, 244, 247, 268, five of these relating to smoking cessation, 
the best example being that of Carr and Ebbert227. None were associated with 
therapist or group variation. The information that was reported is indicative of what is 
available in the study reports. While it is likely that ICC estimates were not generally 
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available, only four reviews stated that this was the case for all, or specific, studies196, 
206, 224, 244. An attempt to contact authors was reported only by Pharoah et al206, and 
again only in relation to clustering associated with cluster-randomisation. 
 
Handling of potential clustering effects associated with therapist and group variation 
was not systematically assessed or reported at the study-level in any of the reviews 
(but see Box 3.4 for sporadic reports). This compared, respectively, to 10 (43%) and 
1 (6%) reviews explicitly or otherwise reporting the inclusion of cluster-randomised 
trials174, 203, 206, 210, 224, 227, 238, 240, 244, 260, 268. Even among these reviews, the level of 
reporting varied with Ebrahim et al260 stating only that the units of randomisation and 
analysis differed, without then documenting whether allowance had been made for 
clustering, how, or whether it was sufficient or even appropriate. Similarly, it was not 
always clear that reviewers understood that clustered studies could be appropriately 
analysed at the individual level (e.g. Brunner et al203). It is apparent from Box 3.4 that 
the use of preliminary tests for the presence of therapist or cohort effects was the 
only statistical method reported in this context. These tests presumably treated the 
therapists and groups as fixed-effects, but further relevant information, including F 
ratios, degrees of freedom and p-values, were not provided. Neither was comment 
made on the low statistical power of such tests, their appropriateness or the likely 
impact absence of adjustment might have on specific study results or conclusions. 
 
Box 3.4 Reporting of Study-Level Handling of Therapist and Group Variation 
 
3.4.3 Handling of Study Clustering Effects within Meta-Analyses 
 
Reviewers’ handling of within-study clustering effects is summarised in Table 3.9. It is 
evident that awareness of the clustering implications generalised only beyond the 
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specific scenarios outlined in the Cochrane Handbook169 in one review207 (see Box 3.5) 
and then only in relation to group variation. The typical use of two or three clusters 
per arm and the common failure to allow for clustering in study analyses was noted. 
However, reviews considered removing studies within a sensitivity analysis rather than 
correcting the original analyses at the study-level prior to pooling them. It is not clear 
what would be gained from a comparison of two meta-analyses, one including and 
one excluding studies unadjusted for clustering effects. Changes found to the pooled 
treatment effect, or to the width of the associated confidence interval, would not be 
attributable to the impact of clustering in these circumstances. The study sample size 
and its treatment effect would influence any changes, irrespective of the size of the 
clustering effect, making interpretation of such changes misleading. 
 
Table 3.9 Handling of Clustering Effects in Cochrane Reviews and Meta-Analyses 
Focus of Systematic Review  
Study Design, n (% total)  Psychotherapy Other 
Overall 
Therapist-Delivered Interventions 0 (0) 0 (0) 0 (0) 
Group-Based Interventions 1 (2) 0 (0) 1 (1) 
  Sensitivity analysis considered 1 (2) 0 (0) 1 (1) 
Cluster-Randomisation 20 (34) 9 (21) 29 (29) 
  Studies excluded 2 (3) 1 (2) 3 (3) 
  Untailored standard paragraph only 6 (10) 1 (2) 7 (7) 
  Tailored standard paragraph only 1 (2) 0 (0) 1 (1) 
  Narrative reporting 2 (3) 2 (5) 4 (4) 
  Subgroup analysis performed 0 (0) 2 (5) 2 (2) 
  Sensitivity analyses excluding studies 3 (5) 1 (2) 4 (4) 
  Weights based on number of clusters  1 (2) 0 (0) 1 (1) 
  Sensitivity analyses including studies 2 (3) 1 (2) 3 (3) 
  Generic inverse variance method only 1 (2) 1 (2) 2 (2) 
  Sensitivity analysis based on largest or  
    Range of plausible clustering effects  
2 (3) 0 (0) 2 (2) 
Crossover 12 (20) 10 (24) 22 (22) 
  Studies excluded 4 (7) 3 (7) 7 (7) 
  Narrative reporting 0 (0) 2 (5) 2 (2) 
  First period data used only 6 (10) 4 (10) 10 (10) 
  Periods combined if minimal carryover 1 (2) 0 (0) 1 (1) 
  First period data & sensitivity analysis  
    excluding other crossover trials 
0 (0) 1 (2) 1 (1) 
  Elbourne (2002) methods 1 (1) 0 (0) 1 (1) 
TOTAL 59 (100) 42 (100) 101 (100) 
 
While the actions taken by reviewers in relation to cluster-randomised studies reflect 
awareness of the impact of study design on meta-analyses, complete understanding 
was not always obvious. Seven (24%) reviews simply included a standard paragraph 
in the Methods section184, 201, 204, 208, 212, 222, 242 (see Box 3.6), with six of these edited by 
the Schizophrenia group and only one including relevant studies222. 
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Box 3.5 Recognition of the Presence and Implications of Group Variation 
PRESENCE
Barlow J, Coren E, Stewart-Brown SSB. Parent-training programmes for improving maternal 
psychosocial health
216
:
"Nixon 1993 also refers to the group process, and the validation of parental feelings through the 
experience of sharing them with other parents. He also discusses the way in which the process of sharing 
feelings with other parents contributes to the normalisation and destigmatisation of such feelings, and of the 
potential for a reduction of negative attributions through comparison with other parents. The extent to which 
these processes influenced some of the outcomes is discussed, as is the lack of validated measures to assess 
outcomes of this nature. It is hypothesised that ’social comparison’ may well be a powerful treatment tool. 
Gammon 1991 cites a number of benefits for parents arising from the use of groups in particular, including 
the possibility for mutual support, the opportunity for learning from each other and for a reduction in 
feelings of isolation...Research is also needed which focuses on the process of programme delivery. Only 
four of the primary studies included in this review made any reference to this issue. Of the programme 
service providers who were contacted, six referred to group factors such as empowerment, support, and 
self-esteem as being important. Two referred to the role of facilitators in promoting positive group 
processes."
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple 
sclerosis
180
:
 “The results of two of the cognitive behavioural therapy trials look encouraging, although with the 
group-based study we are unable to exclude the possibility that it is the group environment that is having 
the effect rather than the therapy per se."
IMPLICATIONS
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation
207
:
"In cases where more than one group method was being compared, and recruitment 
was continuous, participants were generally allocated to treatment groups on the basis of their sequence of 
arrival. The group was then randomized to treatment. In studies in which randomization was individual, 
randomization schedules were in some cases reported to be interrupted in order to allocate families or 
friends to the same group. Both these features mean that people in a particular group may be more similar 
than would be expected by chance. This undermines the statistical assumption used to estimate the 
variance, which is that they are typical of the population as a whole. The same principle also applies when 
patients are treated in groups, because each person’s chance of success may be influenced by the group in 
which they find themselves. The possibility that success rates varied beyond chance between the groups 
given the same treatment can be tested, but the power to detect these differences will generally be very 
low. All these features of group therapy trials are likely to lead to an underestimate of the true variance, and 
therefore to the estimation of confidence intervals which are too narrow. In those trials which randomized 
entire worksites to programme type this factor is even more relevant. The small number of trials in any 
comparison and the fact that studies of the same type tend to share the same shortcomings meant that 
sensitivity analyses based on any quality assessment were impractical." "A limitation of research 
in which participants are treated in groups is that typically there may be only two or three groups in each 
treatment condition. Participants’ chances of success are almost certainly not completely independent. There 
may be variation by the group in which they were treated, due to aspects of the group process. This aspect 
is generally ignored in trial analyses."
 
Box 3.6 Standard Paragraphs on Handling of Cluster-Randomisation 
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Box 3.6 Continued… 
VERSION TWO
"Cluster trials: Studies increasingly employ ’cluster randomisation’ (such as randomisation by 
clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to 
account for intra class correlation in clustered studies, leading to a ’unit of analysis’ error (Divine 1992) 
whereby p values are spuriously low, confidence intervals unduly narrow and statistical significance 
overestimated. This causes type I errors (Bland 1997, Gulliford 1999). Where clustering was not accounted 
for in primary studies, we presented the data in a table, with a (*) symbol to indicate the presence of a 
probable unit of analysis error. In subsequent versions of this review we will seek to contact first authors of 
studies to obtain intra-class correlation coefficients of their clustered data and to adjust for this using 
accepted methods (Gulliford 1999). Where clustering has been incorporated into the analysis of primary
studies, we will also present these data as if from a non-cluster randomised study, but adjusted for the 
clustering effect. We have sought statistical advice and have been advised that the binary data as presented 
in a report should be divided by a ’design effect’. This is calculated using the mean number of participants 
per cluster (m) and the intraclass correlation co-efficient (ICC) [Design effect = 1+(m-1)*ICC] (Donner 
2002). If the ICC was not reported it was assumed to be 0.1 (Ukoumunne 1999). If cluster studies had been 
appropriately analysed taking into account intra-class correlation coefficients and relevant data documented 
in the report, synthesis with other studies would have been possible using the generic inverse variance 
technique."
 
Reporting of cluster-randomisation was implicit in this review, which may account for 
the methods stated not then being implemented. One review215 tailored the standard 
paragraph to reflect their recognition that the methods described were theoretical, as 
no relevant studies were included. Since three reviews excluded cluster-randomised 
studies197, 213, 264, this left 19 (49%) of the 39 reviews which included them describing 
methods for handling associated within-study clustering. 
 
There was some evidence that the specific method reported changed over time, with 
all four cases of narrative reporting174, 218, 240, 258 located in reviews not substantially 
updated since May 2005. Forbes et al (1999)240 intended to report relative risks and 
confidence intervals in the text, but found that only one study had adjusted for 
clustering, and published data were unsuitable for calculating relative risks. Rose et al 
(2002)218 planned to include studies in meta-analyses when guidance was available, 
and the methods had been implemented in RevMan software. Glasscoe and Quittner 
(2003)174 calculated standard errors from adjusted confidence intervals available in the 
original paper, but reported binary outcomes in the text due to software limitations. 
Ekeland et al (2004)258 simply stated that cluster-randomised studies were reported in 
the text due to their design. 
 
The methods described in the remaining 14 reviews can be categorised by how well 
they addressed the precision implications. Two reviews pooled subgroups of studies 
defined by their method of randomisation238, 260 and analysis260 but did not state how, 
or whether, allowance was made for clustering in the standard errors. Four reviews 
excluded cluster-randomised studies in a sensitivity analysis207, 223, 225, 261, comparing 
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the pooled treatment effects207, 225, 261 or their statistical significance223 without making 
allowance for clustering in either analysis. Both methods accordingly fail to tackle the 
precision issue. Of these six reviews, only two223, 260 had been substantially updated 
since May 2005. Five were edited by the Tobacco Addiction group. 
 
Brunner et al (2005)203, in contrast, over-tackled the issue replacing the number of 
patients with the number of clusters when calculating study weights, even where 
published analyses adjusted for clustering and the standard errors were derived from 
these. The final seven reviews196, 206, 210, 224, 227, 244, 247 used the generic inverse variance 
method described in the Cochrane Handbook169 to allow for clustering. Three 
compared primary analyses omitting studies to sensitivity analyses adjusting for 
clustering206, 210, 247. One adjusted primary analyses using the reported ICC estimates 
then performed a subgroup analysis on the basis of the method of randomisation227. 
Another assumed an ICC of 0.1 as realistic for all cluster-randomised studies, and 
adjusted the primary analyses on this basis244. And two performed sensitivity analyses 
assuming the largest plausible196, 224 ICC and a range224 of feasible ICC estimates 
based on Ukoumunne et al (1999)271, comparing the p-values of the pooled treatment 
effects. Five196, 203, 206, 227, 244 of these eight reviews had been substantially updated 
since May 2005. 
 
The level of recognition of the implications for crossover trials was comparable. Ten 
reviews171, 172, 180, 184, 185, 220, 250, 252, 255, 267, spanning six Cochrane Review groups, simply 
stated that data from only the first treatment period would be eligible or analysed in 
the Eligibility or Methods section. Crossover trials were identified in only three of 
these220, 250, 267. As a further seven reviews from five Cochrane Review groups 
excluded crossover trials176, 179, 182, 218, 236, 239, 263, in two cases because the design was 
considered inappropriate179, 182, this left 8 (67%) of the 12 reviews including them 
reporting methods for handling within-patient clustering. The published data were 
viewed as insufficient in both cases of narrative reporting231, 265. Adjusted confidence 
intervals were available in one231, but washout periods were not reported, and the 
reviewers cited software limitations. The correlation in patient outcomes between 
periods required for the methods described by Elbourne et al156 was not available in 
the other265. Brunner et al203 intended to pool periods, where the design ensured 
minimal carryover, but did not state whether or how this applied to the cluster-
randomised crossover study they included. Glazener et al269 used first period data 
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where available, and then performed sensitivity analyses comparing the significance of 
meta-analyses including the remaining crossover trials, as if they had a parallel-group 
design, to the primary analyses excluding them. Only one review214 reported utilising 
the methods described by Elbourne et al156. 
 
3.5 Use and Relevance of Quality Assessment Tools 
 
All Cochrane reviews contain a Methodological Quality section in which reviewers are 
intended to summarise the internal and external validity of included studies along with 
any variability found in these aspects between studies169. Quality assessment is 
considered essential to “limit bias in conducting the systematic review, gain insight 
into potential comparisons, and guide interpretation of findings” (p.79)169. While the 
use of scores derived from scales or checklists is not advocated169, assessment of the 
potential for selection, performance, attrition and detection biases is. Fifty-two of the 
101 reviews explicitly stated using the internal validity criteria recommended in the 
Cochrane Handbook when assessing study quality. However, the version cited varied 
from Mulrow and Oxman (1996)272 through to Higgins and Green (2005)169, with only 
10 of the reviews196, 201, 206, 212, 222, 230, 234, 242, 249, 263 specifically referring to the latter, all 
being updated since May 2005, although one not substantially249.  
 
Box 3.7 Example Comments on the Use of Published Quality Assessment Tools 
 
The other frequently cited criteria were those of Jadad et al273 used in 15 of the 
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reviews. When adopting these approaches, reviewers often paid particular attention to 
allocation concealment citing Schulz et al274 and Juni et al275 in support of doing so. 
The use of standard Cochrane Review group criteria was apparent within the Back276, 
277, Depression, Anxiety and Neurosis278, Effective Practice and Organisation of Care, 
and Incontinence279 groups, with specific scales developed and recommended by the 
former two. Sporadic use was found234, 240 of the UK NHS Centre for Reviews and 
Dissemination guidance280, 281. Use of Downs and Black282 and scales derived from 
Kenardy and Carr283 and previous reviews284, 285 was reported175, 218, 235, 244. However, 
none of these tools explicitly address issues arising from therapist or group variation, 
neither were the more general items extended to do so. Comments were made on the 
use of quality assessment tools for studies involving psychotherapy, with additional 
items being used in some reviews (see Boxes 3.7 and 3.8 respectively for examples). 
 
Box 3.8 Additional Quality Criteria for Studies Involving Psychotherapy 
  
Based on the following reviews: 171, 172, 174, 180, 183, 185, 192, 194, 195, 198, 213, 218-222, 227, 228, 239, 260, 264  
 
Blinding of non-pharmacological interventions was seldom considered possible173, 183, 
185, 190, 195, 201, 203, 208, 217, 221, 222, 224, 226-228, 230, 233, 234, 242, 249, 254, 256, 258-261, 264, 266, 270. This was 
used simply as a justification for excluding blinding as a quality criterion by some 
reviewers. Others questioned the relevance or appropriateness of published quality 
assessment tools on this basis (see Box 3.7). A subset suggested alternative criteria 
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for assessing the extent and impact of performance biases (see Box 3.8), the most 
common of these being the evaluation of therapist adherence or fidelity. While issues 
relating to the lack of blinding received most attention, a range of additional criteria 
were discussed, with exemplars in Abbass et al221, Buckley and Pettit222, Eccleston et 
al183, Hajek and Stead192, Huibers et al228, Hunot et al185 and Littell et al213. 
 
3.6 Recognition of the Implications for Internal Validity 
 
Possible confounding of treatments and therapist characteristics was discussed in six 
of the reviews (see Box 3.9). Their titles indicate that five were primarily interested in 
comparisons of different therapeutic approaches, with the other emphasising the 
comparison of therapist characteristics and packages of the two. As such, imbalance in 
the characteristics of the therapists across the arms within studies was an issue for 
internal validity in five183, 192, 207, 210, 222 with disparities in the therapeutic approaches 
used threatening internal validity in the other224. Recognition of this is clear in four of 
the quotes (Box 3.9), the two exceptions being those of Lancaster and Stead210 and 
Stead and Lancaster207, which imply awareness of the potential for confounding across 
but not within studies. The relationship between interventions and therapists, whether 
it be nested or crossed, was highlighted in three of the reviews183, 192, 222. 
 
Box 3.9 Confounding of Treatments and Therapist Characteristics 
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Box 3.9 Continued… 
unlikely to believe both to be equally likely to produce improvement. Indicators of therapist allegiance, not 
reported in any of the trials in this review, may be used to examine this. It is more common, however, for 
different therapists to be assigned to the treatment conditions according to their skills, with the result that 
differences between therapists appear as differences between treatments. For six of the trials this did not 
apply, since the control condition was a waiting list (Barry 1997; Fentress 1986; Labbe 1984; Labbe 1995; 
Osterhaus 1997; Sanders 1989). For nine studies, therapists were specific to treatment or reporting was 
unclear. Three studies addressed the issue: McGrath 1988 used three therapists equally and Larsson 1990 
used one across treatment conditions; Larsson 1987a used two therapists for both conditions and one for 
the control only."
Hajek P, Stead LF. Aversive smoking for smoking cessation
192
:
"Studies in which different therapists run different conditions may be comparing the 
efficacy of the therapists rather than the efficacy of the methods. Even where the same therapist runs 
different treatments, the fact that the therapist is not blind and usually believes that one treatment is 
superior to others can introduce a ’performance bias’. The better studies try to tackle this problem by having 
several therapists, each running all treatments...Only one of the studies in this review (Hall 1984a) avoids 
the most glaring methodological problems. All the others present most or all of the following problems: 
validation not done or incomplete, outcome assessor not blind to subject allocation, different therapists for 
different treatments or only one therapist involved, no information on continuous abstinence, and very small 
sample sizes (usually around 20 subjects per condition). Most of these methodological shortcomings can be 
expected to influence the results in favour of the treatment’s efficacy...The poor methodological quality of 
this body of literature is explained by its age. The methodology of research in smoking cessation has 
developed considerably over the last 10 to 15 years. Most aversive treatment studies are over 20 years old."
"These statistical results must be interpreted in the light of methodological considerations before 
drawing final conclusions." "The results of the existing trials suggest that this may be effective, but 
the evidence is not conclusive because most of the studies of this approach have methodological problems."
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation
210
:
"One problem in assessing the value of individual counselling is that of confounding with other 
interventions. For example, counselling delivered by a physician in the context of a clinical encounter may 
have different effects from that provided by a non-clinical counsellor. One approach to this problem is to 
employ statistical modelling (logistic regression) to control for possible confounders, an approach used by 
the US Public Health Service in preparing clinical practice guidelines (AHCPR 1996; AHRQ 2000). An 
alternative approach is to review only unconfounded interventions. This is the approach we have adopted in
the Cochrane Tobacco Addiction Review Group. In this review, we therefore specifically exclude counselling 
provided by doctors or nurses during the routine clinical care of the patient, and focus on smoking cessation 
counselling delivered by specialist counsellors."
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation
207
:
"The US Public Health Service Guideline, Treating Tobacco Use & Dependence (Fiore
2000)...authors stress that the strength of evidence underlying recommendations...is not of the highest level 
because of the correlation of the types of counselling and behavioural therapies with other treatment 
characteristics such as programme length or type of therapist. The conclusions of this Cochrane review are 
consistent with the Guideline finding in relation to the inclusion of general problem-solving components, and 
are strengthened by being limited to unconfounded comparisons."
Thompson RL, Summerbell CD, Hooper L, Higgins JPT, Little PS, Talbot D, Ebrahim S. Dietary 
advice given by a dietitian versus other health professional or self-help resources to reduce 
blood cholesterol
224
:
"The service delivery methods also differed between the studies. Those participants 
seen by a doctor tended to have less frequent appointments or less time at appointments than those seen 
by a dietitian (Caggiula 1996; Gosselin 1996; Luepker 1978; Smith 1976)." "It is not possible to 
distinguish whether the difference in blood cholesterol was a result of advice from a different health 
professional or from more contact with the health professional. Participants randomised to the dietitian 
generally received more time with a health professional than those randomised to the doctor."  
 
While all argued that the choice of design was important, there was disagreement 
about which design was considered superior. Also, while strongly alluded to, a clear 
distinction was not made, following Wilkins140, between the function of stable and 
situation-dependent therapist characteristics when considering one design over the 
other. As a result, the studies were assessed largely in terms of which design they 
adopted rather than by whether the design was consistent with their research question 
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or with the associated risk of bias. Buckley and Pettit’s222 concern was chiefly with 
treatment-dependent factors, leading them to favour a nested design. In contrast, 
Eccleston et al183 and Hajek and Stead192 put greater emphasis on therapists’ general 
skill level, and therefore preferred a crossed design. 
 
Imbalance in therapist attributes and behaviours between arms could pose a threat to 
internal validity, leading to bias, at any stage in the conduct of a study286. The quotes 
in Box 3.9 all relate to therapist-level performance biases. A number of reviewers also 
considered the possibility of detection biases, with twelve184, 190, 192, 198, 201, 204, 208, 212, 214, 
215, 222, 242 explicitly connecting them to therapist involvement, and two186, 213 stating 
that therapists performed outcome assessments. Marshall et al287 was frequently 
quoted, in reviews edited by the Schizophrenia group, when excluding outcomes 
assessed by the therapists. The general problem of rater variation was briefly outlined 
in Glasscoe and Quittner174, Hajek and Stead192 and Uman et al181. For example, 
 
“There were severe limitations to the method of scoring which involved interviewing skills 
and subjective judgement on the part of the raters with consequent differences in 
individual style of delivery. There was an acknowledgement that these differences…may 
have influenced the results." Glasscoe and Quittner174 (pp.12-13) 
 
This has many parallels with therapist and group variation, and indeed these sources 
of variation may even be aliased in some circumstances286. 
 
One implication of therapist and group-based intervention studies is that they entail 
multiple allocations of treatments to experimental units286. For instance, the simplest 
nested therapist designs necessitate allocation not only of interventions to patients but 
of interventions to therapists and of therapists to patients. Each of these allocations 
may be random or non-random, concealed or unconcealed, with selection bias arising 
potentially from any non-random or unconcealed allocation. The impact this has on 
the validity of interpretations at the study-level will depend on the match between the 
research question and the chosen design286. It is influenced in a systematic review by 
the compatibility between the designs of included studies and the research question of 
the review. 
 
Instances of multiple randomisations found in the 101 reviews are given in Box 3.10. 
These were found in the Characteristics of Included Studies table in the appendix of 
each review unless stated otherwise. None of the instances reported were associated 
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with assignment of groups in group-based intervention studies. Hunot et al185 was the 
only review to report the presence of multiple randomisations systematically. Given 
the emphasis on single randomisations, individual- or cluster-, it is likely that other 
instances went unreported. Hunot et al185 did not report what was randomly allocated 
to what; this had to be confirmed by referring back to the original papers. None of the 
reviews recorded whether the additional allocations were concealed, or the methods 
reported for doing so. There was no discussion of the consequences of this aspect of 
the study design for the interpretation of the results either. 
 
Box 3.10 Reporting of Multiple Randomisations 
MULTIPLE RANDOMISATION: INTERVENTIONS TO PATIENTS & INTERVENTIONS TO 
THERAPISTS
Hajek P, Stead LF, West R, Jarvis M, Lancaster T. Relapse prevention interventions for smoking 
cessation
247
:
1) Hall 1984 "Randomization: method NS...Therapists: 2 psychologists, randomly assigned to groups"
2) Killen 1984 "Randomization: method NS (married couples allocated to same condition)...Behaviour 
therapy provided by 2 psychologists, 1 MSW, assigned randomly to treatment conditions"
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation
207
:
1) Gruder 1993 "Randomization: to group or no-group at time of registration. No details on method. 1205 
subjects assigned to a group condition, and attempts made to contact them to schedule group meetings. 
Randomization between the two group conditions was by site...Therapists: Mainly nurses and health
educators randomly assigned and trained to lead either Social Support or Discussion meetings."
2) Hall 1984 "Randomization: randomly assigned, no details...Therapists: 2 psychologists, randomly assigned 
to groups"
3) Killen 1984 "Randomization: Method not stated. individual randomization...Therapists: 3: 2 psychologists, 
1 medical social worker, assigned randomly to treatment conditions"
MULTIPLE RANDOMISATION: INTERVENTIONS TO PATIENTS & THERAPISTS TO PATIENTS
Crawford-Walker CJ, King A, Chan S. Distraction techniques for schizophrenia
204
:
Tarrier 1993 "Allocation: randomly allocated to a treatment group and a psychologist."
Hunot V, Churchill R, Silva-de LM, Teixeira V. Psychological therapies for generalised anxiety 
disorder
185
:
"Design: All the studies included in the review were described as randomised 
controlled trials, with randomisation at the patient (n=16) or patient and therapist level (n=9)."
1) Arntz 2003 "Allocation: randomised at patient and therapist level - method not reported"
2) Barlow 1992 "Allocation: randomly assigned to treatment condition and to available therapists"
3) Blowers 1987 "Allocation: randomised at patient and therapist level - method not reported"
4) Borkovec 1987 "Allocation: randomised in 3 waves at patient and therapist level - no further information 
reported"
5) Butler 1991 "Allocation: randomised at patient and therapist level - method not reported”
6) Durham 1987 "Allocation: randomised at patient and therapist level - method not reported"
7) Durham 1994 "Allocation: randomised at patient and therapist level - method not reported”
8) Gath 1986 "Allocation: randomised at patient and therapist level - method not reported”
Littell JH, Popa M, Forsythe B. Multisystemic Therapy for social, emotional, and behavioral 
problems in youth aged 10-17
213
:
Borduin 1995 "Random assignment to treatment conditions and to therapist within conditions."
 
As there was no recognition of either the precision or selection bias implications due 
to therapists, it is unsurprising that the impact of withdrawals and losses to follow-up 
was overlooked at this level either. Barlow et al216 discussed an association between 
therapist inexperience and patient withdrawals from parent-training programmes, and 
drew attention to the importance of intention-to-treat analyses for limiting attrition 
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biases. However, they did not consider the contribution of excluding patient outcomes 
linked with particular therapists or therapist turnover as potential sources of attrition 
bias. Where aspects of the design are observational, the role of intention-to-treat 
analyses is less clear. While further methodological work is needed in this area, it is 
evident that the role of therapist-level attrition also deserves attention. 
 
3.7 Recognition of the Implications for External Validity 
 
Twenty-eight of the 101 reviews referred to therapist characteristics in their eligibility 
criteria (see Box 3.11 for examples), 22 (79%) of these had a psychotherapy focus. It 
is of note that therapists’ professional background, qualifications and training were the 
characteristics reviewers mentioned, with supervision arrangements referred to in 5 of 
the reviews182, 199, 213, 236, 239. None included the level, or relevance, of therapists’ 
experience, or whether they were employed as research therapists. The rationale for 
the choice of criteria was not always clear, as little indication was often given of the 
therapist population of interest to the review, be it expert or representative of clinical 
practice. The basis on which criteria were assessed was not always apparent either. 
 
Box 3.11 Examples of Inclusion of Therapist Characteristics in Review Eligibility 
Criteria 
 
 
 
 
Some simply stated that therapists had to be trained or qualified, without then giving 
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sufficient detail to specify the therapist population or facilitate replication. Examples of 
more precise criteria were found in Bower and Rowland37 and in Littell et al213. Even 
here, little or no information was given about the therapists delivering the control, any 
co-interventions or standard care. 
 
Characteristics of the therapist samples were reported in the text, the Characteristics 
of Included Studies table, or in both of these, for one or more of the included studies 
involving psychotherapy in 78 (77%) reviews. Examples of statements found in the 
text are given in Box 3.12. Barbato and D’Avanzo211 was the only review to refer to 
therapist characteristics in the eligibility criteria without giving details of the therapist 
samples included in the studies. James et al199 included a brief description of the 
therapist sample in the text but did not report study-level characteristics. Of the 77 
reviews that did, 24 (31%) also included a statement in the text. These suggest that, 
while this information was often in the study reports, the descriptions were not always 
adequate, a pattern of reporting mirrored in the reviews themselves. The statements 
were mainly located in the Description of Studies section185, 188, 195, 201, 210, 217, 221, 223-227, 
229, 236, 243, 245, 248, 249, 251, 259, 268, but were also found in the Abstract259, Methodological 
Quality183, 199, Results37, 259, Discussion173, 226, 259 and Conclusions173 sections. 
 
Box 3.12 Examples of Reporting of Therapist Samples in the Review Text 
 
 
Only 30 of the reviews systematically reported therapist characteristics at the study 
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level (Table 3.10), with reporting for non-experimental interventions being particularly 
poor. Five reviews reported the number of therapists systematically per study37, 192, 228, 
229, 246. Where recorded, this ranged from 1 to 156, with most studies involving less 
than 10 therapists. The level of reporting was not clearly associated with the focus of 
the review. Reviewers’ awareness of the implications for external validity was overtly 
reflected in their discussion of whether the results could be generalised beyond the 
therapists involved in the studies. Twenty-one reviews made relevant comments in 
their Discussion or Conclusions sections; 10 reviews (48%) referred to therapists in 
the eligibility criteria37, 180, 201, 210, 222, 224, 226, 228, 229, 248 and 11 had not172, 173, 185, 194, 197, 214, 
215, 217, 225, 254, 261. Seventeen reviews (81%) focused on psychotherapy. Examples of 
the comments are categorised in Box 3.13 by whether the recognition was explicit or 
implicit. 
 
Table 3.10 Study-Level Reporting of Therapist Number and Characteristics  
Focus of Systematic Review 
Psychotherapy  Other 
Level of  
Reporting 
General 
 
Specific 
 
Therapist 
Characteristics 
 
 
Wider 
 
Different 
 
Overall 
Number of Therapists by Study, n (% total)   
Systematic and complete 0 (0) 1 (3) 1 (20)  1 (5) 0 (0) 3 (3) 
Systematic but incomplete 0 (0) 1 (3) 0 (0)  1 (5) 0 (0) 2 (2) 
Unsystematic 0 (0) 4 (12) 0 (0)  1 (5) 1 (5) 6 (6) 
Minimal  7 (33) 4 (12) 1 (20)  2 (9) 3 (14) 17 (19) 
Not reported 14 (67) 23 (70) 3 (60)  16 (76) 17 (81) 73 (72) 
Therapist Characteristics by Study, n (% total)   
Systematic and complete 2 (9) 2 (6) 3 (60)  7 (33) 2 (10) 16 (16) 
Systematic but incomplete 2 (9) 6 (18) 2 (40)  1 (5) 3 (14) 14 (14) 
Unsystematic 6 (29) 7 (21) 0 (0)  3 (14) 4 (19) 20 (20) 
Minimal  10 (48) 6 (18) 0 (0)  8 (38) 3 (14) 27 (27) 
Not reported 1 (5) 12 (36) 0 (0)  2 (10) 9 (43) 24 (24) 
TOTAL  21 33 5  21 21 101 
Note: This is restricted to studies involving psychotherapy  
 
The limitations associated with studies recruiting highly expert or research therapists 
were highlighted in 7 of the reviews173, 185, 194, 197, 217, 222, 228. Another 4 raised the issue 
of access to therapists with the required training in clinical practice. None indicated 
whether their comments applied equally to the interpretation of all the meta-analyses 
reported, or concluded that external validity had been established. 
 
Box 3.13 Examples of the Discussion of Generalisation of Results to Therapist 
Populations 
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Box 3.13: Continued… 
 
 
 
3.8 Conclusions 
 
It is clear from the quotes extracted in this review that some Cochrane reviewers are 
aware of the complexities arising from therapist variation and have highlighted those 
of particular relevance to their research questions. It can be concluded, therefore, that 
they are aware of the methodological literature published over the past 60 years in 
subject-specific journals. There was no suggestion, in contrast, that they were familiar 
with the more recent statistical literature on therapist-related clustering effects81-84, or 
that they recognised its implications for assessing study quality or meta-analyses. This 
is unsurprising because the guidance available in the Cochrane Handbook169 reflects 
the emphasis given to specific trial designs and the precision implications in the 
statistical literature. This was generalised in just one207 of the 101 reviews, and then 
only to the groups in studies of group-based interventions. None of them made any 
reference to care providers, outcome assessors, or clinical services as sources of 
treatment-related clustering. Likewise none mentioned more efficient methods for 
incorporating repeated measurements, at baseline149, 150 or follow-up. The reporting 
guidelines for systematic reviews and meta-analyses288 overlook within-study 
clustering as well. Perhaps it is now time to start bringing the emerging statistical and 
the wider methodological literatures together. 
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A number of recommendations could be made on the basis of this review. Firstly, both 
the multi-component nature of complex interventions and the multilevel nature of their 
trial designs should be considered throughout; they have implications for the research 
questions of a systematic review or meta-analysis, its eligibility criteria, data collection, 
quality assessment, choice of summary measure, methods of synthesis, presentation 
and interpretation of results. Secondly, given the complexities inherent in the structure 
of the data, the current absence of accepted statistical methods for handling many of 
them, and the likelihood that important information won’t be easily accessible, it would 
be worthwhile obtaining the individual-patient-data in future. This would not only give 
those performing meta-analyses greater flexibility in their choice of approach, but also 
avoid the need for review conclusions to be conditioned on assumptions about missing 
data, e.g. ICC estimates or cluster size distributions. 
 
Further research is also needed to address many of the issues raised by these reviews. 
In particular, statistical methods are required that permit treatment-related clustering 
effects to be incorporated into meta-analyses. These will differ, to some extent, by the 
specific multilevel trial designs and their associated data structures. However, as some 
of these designs are special cases of others there is the scope to develop more general 
methods. Similarly, although a new scale has recently been published for assessing the 
quality of psychotherapy trials289, it was derived solely from the psychotherapy-specific 
literature. Since all of the issues generalise beyond psychotherapy, combining scales of 
this kind for all complex interventions and then regularly updating them in light of new 
developments, might avoid duplication of effort and encourage efficient and timely use 
of the entire methodological literature. 
 
Although now obvious in retrospect, it became increasingly apparent during the course 
of this review that the data to be synthesised were qualitative rather than quantitative. 
While best practice for carrying out systematic reviews was followed as far as possible, 
it remains an open question as to whether it could be regarded an exemplary example 
of a systematic narrative review. As the aim was to explore the range and complexity 
of issues in Cochrane reviews and their recognition by Cochrane reviewers, difficulties 
encountered when estimating the prevalence of specific study designs is an outcome 
rather than a limitation. It is reasonable to expect reviewers to report information as 
unavailable-those reporting characteristics systematically did just this. Further research 
is required, however, with the study reports and contact with authors as the data, for 
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prevalence estimates to inform the priorities for future methodological research in this 
currently fast moving field. 
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3.9 Appendix: Full Quotes taken from Cochrane Reviews 
 
Box 3.14 General Awareness of the Presence of Therapist Variability 
Abbass AA, Hancock JT, Henderson J, Kisely S. Short-term psychodynamic psychotherapies for 
common mental disorders
220
:
"...variability in treatment delivery and treatment quality may limit the reliability of estimates of 
effect for STPP."
Barlow J, Coren E, Stewart-Brown SSB. Parent-training programmes for improving maternal 
psychosocial health
215
:
"Whilst the results of this review are positive overall, some studies showed no effect. Further 
research is needed to assess which factors contribute to successful outcomes in these programmes with 
particular attention being paid to the quality of delivery." "Research has shown that failure...to 
persist through the programme itself, is associated with therapist inexperience (Frankel 1992). These 
problems surrounding the issue of...drop-outs point to the importance of evaluating the results of trials on 
an intention-to-treat basis which would limit bias arising from this source." 
Buckley LA, Pettit T. Supportive therapy for schizophrenia
221
:
 “Psychotherapy relies on the uniqueness of the clinician-patient relationship, and ways of 
measuring outcome which take account of this need to be developed (Holmes 2000).”
Ebrahim S, Beswick A, Burke M, Davey SG. Multiple risk factor interventions for primary 
prevention of coronary heart disease
259
:
"It is likely that the quality of the intervention, in terms of...person carrying out 
activities...will determine the impact of intervention."
Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in 
adults
216
:
"The nursing home environment and the attitudes of staff are likely to impact on the patients’ 
ability to maintain continence on admission and these are issues that deserve investigation."
Hajek P, Stead LF. Aversive smoking for smoking cessation
190
:
"it is generally believed that the same method can achieve different results when 
applied by different therapists."
Hay PJ, Bacaltchuk J, Stefano S. Psychotherapy for bulimia nervosa and binging
189
:
 “the specialist clinic care in Durand 2003 may have been of variable quality”
Huibers MJH, Beurskens AJHM, Bleijenberg G, Schayck CP van. Psychosocial interventions 
delivered by general practitioners
227
:
"The effectiveness of any intervention is influenced by the triad of the intervention-receiver (e.g. 
the patient), the intervention-giver (e.g. the GP) and the intervention itself. These three factors are 
inevitably linked, and any disturbance in this relation at any point can result in negative effects."
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation
209
:
"Although we cannot exclude the possibility that small differences in...the therapists’ training or 
skills, have an effect on the outcome, it is not possible to detect such differences in the meta analysis."
Littell JH, Popa M, Forsythe B. Multisystemic Therapy for social, emotional, and behavioral 
problems in youth aged 10-17
212
:
"Considerable attention has been paid to the transportability and dissemination of MST, and to 
the fidelity of MST replications (e.g., Henggeler 2002b, Schoenwald 2000b, Schoenwald 2001)." 
"The decision to pool results was driven by claims that positive effects of MST are reliable ’across problems, 
therapists, and settings’ (Kazdin 1998) and the practice of combining outcomes across populations and 
comparison conditions in previous reviews of MST (e.g., Curtis 2004)." 
Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 
60+
196
:
 “Homogeneity: Specific cognitive-behavioural interventions and the mode and quality of therapist 
delivery vary somewhat. It may be that these differences can explain some of the heterogeneity in these 
results.”
O'Connor AM, Stacey D, Entwistle V, Llewellyn TH, Rovner D, Holmes RM, Tait V, Tetroe J, Fiset 
V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions
253
:
"As well, satisfaction could be more strongly affected by the relationship with the practitioner 
than the decision aid"
Rice VH, Stead LF. Nursing interventions for smoking cessation
224
:
"In some studies the proposed intervention was not delivered consistently to all 
participants...Almost all the intensive interventions were delivered by either dedicated project staff or nurses  
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with a health promotion role. Most studies in which an intensive intervention was intended to be delivered by  
a nurse with other roles, reported problems in delivering the intervention consistently. None showed a 
statistically significant benefit of intervention.
Rose S, Bisson J, Churchill R, Wessely S. Psychological debriefing for preventing post traumatic 
stress disorder (PTSD)
217
:
"...it is difficult to see how a shame based reaction could be elicited without a skilled, attuned and 
sensitive therapist. It may however, indicate that a ’safer’ way of handling early psychological interventions 
is to elicit a client led narrative without insisting on a clinician led re-exposure to the event."
Spector A, Orrell M, Davies S, Woods B. Reality orientation for dementia
218
:
"the entire concept of assessing the success of any psychological therapy can be highly 
problematic, as it is not possible to account for variables such as the therapeutic alliance between patients 
and therapists, and the sensitivity with which the therapy is given. It is difficult to assess the more subjective 
aspects of RO just by reading a written account, yet it may be these very variations which produced 
variations in results." "As with all psychological interventions, the success of RO may be 
dependent on it being used at the appropriate time, by a sensitive and experienced practitioner, to a 
receptive patient."
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple 
sclerosis
178
:
"a number of methodological challenges were evident...The type of intervention, content, 
theoretical basis, intensity, duration, length of each session, whether one-to-one or in groups can vary, as 
can the profession and experience of the person delivering the intervention, and the location. This 
heterogeneity could make it difficult to combine the results from different studies."
Woods B, Spector A, Jones C, Orrell M, Davies S. Reminiscence therapy for dementia
219
:
"In the UK the development of the ’Recall’ tape-slide package (Help the Aged 1981) meant that 
reminiscence triggers were widely available in day care centres, care homes and hospitals, leading many 
staff to establish some form of reminiscence work of variable quality."  
 
Box 3.15 Conventional Explanations for the Consequences of Therapist Variability 
TREATMENT STANDARDISATION AND THERAPIST COMPETENCY
Hackett ML, Anderson CS, House AO. Interventions for treating depression after stroke
239
:
"For psychotherapy trials, there is also good evidence that efficacy is linked to delivery of an 
adequate exposure to the intervention. This means that therapists should be trained and supervised in the 
therapy they are delivering, and use a standardised, pre-specified, framework for therapy. To achieve this in 
psychotherapy trials, the therapy is often manualised and the research therapists are trained and supervised 
in the use of the manual. Success in brief therapy is linked to adherence to the therapeutic model as well as 
to the therapists’ characteristics. Future stroke psychotherapy trials should also adhere to these standard 
psychotherapy research guidelines if there is to be any probability of demonstrating consistency and 
response."
Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care
37
:
"A distinction can be made between explanatory and pragmatic RCTs. The former seek to impose 
the highest practical levels of control on variables (e.g. length of treatments, expectancy effects) in order to 
isolate the key ’active ingredients’ and provide a valid test of whether a specific intervention is influencing 
outcome. Such trials focus on the internal validity of the study. In contrast, pragmatic trials seek to 
determine the relative ’value’ of treatments as they would be provided in routine care settings, and seek to 
increase external validity without significantly compromising internal validity. In primary care, this means 
that interventions are not highly standardised, so as to reflect the clinical variation that exists in routine care 
contexts."
Huibers MJH, Beurskens AJHM, Bleijenberg G, Schayck CP van. Psychosocial interventions 
delivered by general practitioners
228
:
"Although explanatory studies serve the objective of this review best, pragmatic trials were also 
eligible for entry in the review as long as the psychosocial intervention was standardised to some degree"
“NON-SPECIFIC” OR PLACEBO EFFECTS
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple 
sclerosis
180
:
 “Psychological interventions are complex in that they usually consist of a number of different 
elements. Some of these elements will be active ingredients specifically included because they are based on 
psychological theory. Other elements may not be specific to psychological interventions and may be common 
to many different types of intervention (such as interacting with other people with MS in a group). Still other 
elements will be specific to individual therapists (for example the therapist’s experience and enthusiasm, and 
the way the therapist interacts with the client).”  
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Merry S, McDowell H, Hetrick S, Bir J, Muller N. Psychological and/or educational interventions 
for the prevention of depression in children and adolescents
245
:
"Psychological interventions may appear to be effective ”not because of the theories or 
therapeutic procedures but because of underlying, unspecified or not clearly determined non-specific effects“ 
(Shapiro 1997 p103). This is of relevance in prevention programs where interventions designed to appeal to 
participants and introduced by enthusiastic research teams could lead to reduction in depression, at least in 
the short-term. Improvement in mood may then be attributed to the content of the program. Ideally, as in 
medication trials, the intervention should be compared with a comparison condition that resembles the 
intervention but without the elements thought to be actively therapeutic (Shapiro 1997). At the least there 
should be some attempt to ensure that participants in the study do not know whether they are subjects or 
controls. If this is not done it is difficult to ensure that effects reported are not placebo effects."
Uman LS, Chambers CT, McGrath PJ, Kisely S. Psychological interventions for needle-related 
procedural pain and distress in children and adolescents
181
:
"nonspecific-treatment or “attention-placebo” control...a group that engages in all of the 
accouterments of the intervention (e.g., meeting with a therapist, receiving an explanation for the problem) 
but not the key components of the intervention; used to determine if the effects of the intervention are due 
to nonspecific treatment components (Kazdin 2003)."
Glazener CMA, Evans JHC, Cheuk DKL. Complementary and miscellaneous interventions for 
nocturnal enuresis in children
231
:
"One factor which makes interpretation of trials of complementary treatment problematic is that it 
is often difficult to disentangle the effect of time spent with a therapist (ie the placebo or psychological 
support provided) from the actual treatment being tested."
Hajek P, Stead LF. Aversive smoking for smoking cessation
192
:
"The task of the review was to see if aversion therapy has a specific effect, i.e. an effect over and 
above non-specific factors inherent in therapist contact. Comparisons of aversion treatment with no 
treatment were not included. In most studies there were ’attention placebo’ or other controls roughly 
matched for therapist contact, although in a few the aversion treatment subjects had up to twice as many 
treatment sessions as controls."
Abbot NC, Stead LF, White AR, Barnes J. Hypnotherapy for smoking cessation
209
:
"Comparison needs to be made with active interventions, preferably matching for therapist 
contact time."
Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP. Interventions for 
helping people recognise early signs of recurrence in bipolar disorder
173
:
"Two studies included psychological intervention that did not include EWS component along with 
TAU (Colom 2003c; Colom2003b) to control for the non-specific effects of psychological treatment, including 
time spent with therapists."
Gold C, Wigram T, Elefant C. Music therapy for autistic spectrum disorder
214
:
"In the broader field of psychotherapy research, similar constructions of “placebo” therapy to 
control for the therapist’s attention and the non-specific elements have been broadly used (Kendall 2004, pp. 
20-21). However, recent research on the common factors in psychotherapy raise the question of how 
adequate it is conceptually, and also whether it is technically possible, to separate the active from the non-
active elements of therapy (Lambert 2004, pp. 150-152). In any case, the results of the included studies are 
likely to underestimate the true effects of music therapy, because the control conditions contain a number of 
potentially efficacious techniques which are also used in music therapy."
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation
207
:
"...as with all behavioural as opposed to pharmacological therapies, the choice of an appropriate 
control condition presents problems when evaluating efficacy. There is no obvious equivalent for the drug 
placebo to control for the non-specific effects of a treatment method. Evaluating group therapies against a 
waiting list control does not provide very good evidence for the specific effect of the group format."
Buckley LA, Pettit T. Supportive therapy for schizophrenia
222
:
"Thirteen of the twenty-one studies attempted to match experimental and control 
psychosocial interventions for amount of therapist contact (Eckman 1992, Falloon 1982, Haddock 1999, 
Kemp 1996, Levine 1998, Lewis 2002b, Pinto 1999, Sensky 2000b, Spaulding 1999, Tarrier 1998, Telles 
1995, Turkington 2000, Wirshing 1991). In contrast, four studies took the approach that different 
interventions by their nature involve different amounts of therapist contact (Dincin 1982, Hogarty 1997-study 
1, Hogarty 1997-study 2, Stanton 1984). The other studies did not report on this matter."
“PROCESS” RESEARCH
Barlow J, Coren E, Stewart-Brown SSB. Parent-training programmes for improving maternal 
psychosocial health
216
:
"There is very little research available to date addressing the role of ’process’ factors, such as the 
way in which the programme is delivered, in producing positive outcomes with regard to parental 
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Box 3.17 Comments on the Use of Published Quality Assessment Tools 
Abbass AA, Hancock JT, Henderson J, Kisely S. Short-term psychodynamic psychotherapies for 
common mental disorders
221
:
CCDAN Quality Rating Scale (Moncrieff 2001) criteria were used to determine external validity and 
study quality. This scale had 23 items with a maximum possible score of 46. Parameters included clarity of 
objectives, sample size, duration, power calculation, method of allocation, concealment of allocation, 
treatment description, blinding, source of subjects, use of diagnostic criteria, record of exclusions, sample 
description, blinding of assessors, assessment of compliance, side effects, withdrawals, description of 
outcome measures, adjustments for differences, inclusion of withdrawals in analysis, presentation of results, 
statistical analysis, justification of conclusions and declaration of interests. Each study was rated on 23 items 
to give a score ranging from 0 to 46.”  “Some of the elements of the CCDAN scale
were not relevant to this type of treatment research. There was no blinding of psychotherapy subjects and
specific “side effects” were reported.” "The studies were of variable quality...Manuals and 
adherence measures were not employed in each study calling into question the quality of psychotherapy 
provided. Therapist experience was in question in many studies, raising the chance that the therapy was not
provided in an optimal fashion...The CCDAN Quality Rating System we used did not include ratings on these 
parameters, which were relevant to the interpretation of psychotherapy study quality”
Eccleston C, Yorke L, Morley S, Williams AC, Mastroyannopoulou K. Psychological therapies for 
the management of chronic and recurrent pain in children and adolescents
183
:
"None of the studies was double blind. It is rarely possible to blind participants or 
therapists to psychological interventions, so the application of trial quality assessment tools, such as the 
Oxford scale (Jadad 1996) nor other widely used quality scales (Juni 2001), was not appropriate.”  
Jeffery DP, Ley A, McLaren S, Siegfried N. Psychosocial treatment programmes for people with 
both severe mental illness and substance misuse
190
:
 “The Jadad scoring focuses on not only randomisation but also blindness of rating at 
outcome and description of the reasons for leaving the study early...In retrospect it may have been 
inadvisable to use this scoring system for these sorts of studies where blinding is rare and particularly 
difficult. Nevertheless this scale was validated using trials from several specialities including mental health 
(Moher 1998).”
Ostelo RWJG, van-Tulder MW, Vlaeyen JWS, Linton SJ, Morley SJ, Assendelft WJJ. Behavioural 
treatment for chronic low-back pain
195
:
"The methodological quality of the RCTs was independently assessed...using a criteria list (Table 
01) recommended by the Cochrane Back Review Group (van Tulder 1997b; van Tulder 2003)...As it is 
difficult to blind patients for behavioural treatment, we redefined the criterion regarding the blinding of 
patients. If blinding was not feasible, item 4 of the criteria list was scored positive if the credibility of the 
treatments was evaluated and treatments were equally credible and acceptable to patients (Turk 1993).”
Rose S, Bisson J, Churchill R, Wessely S. Psychological debriefing for preventing post traumatic 
stress disorder (PTSD)
218
:
"The third was a scale derived from Kenardy 1996a giving proposed quality standards for trials of 
psychological debriefing." “The differences between the more general Moncrieff 2001 
and the specific Kenardy 1996a scales reflect that fact that the Moncrieff 2001 scale emphasises general 
methodological issues relevant to all clinical trials, with a particular emphasis towards pharmacological trials, 
albeit relevant to psychiatry. The Kenardy 1996a scale gives more weight to specific issues concerning 
debriefing, and in particular the content of debriefing.”  
 
Box 3.18 Inclusion of Therapist Characteristics in Review Eligibility Criteria 
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OTHER EXAMPLES
Anderson CS, Hackett ML, House AO. Interventions for preventing depression after stroke
236
:
"(2) A comparison between a psychological therapy and standard care (or attention control) for the 
prevention of depression associated with stroke...All interventions had to...be delivered by somebody with 
some explicitly stated training and supervision in therapies"
Baldwin C, Parsons T, Logan S. Dietary advice for illness-related malnutrition in adults
202
:
"Dietary advice was defined as instruction in modification of food intake given with the aim of 
improving nutritional intake by a dietitian or other health care professional."
Barbato A, D'Avanzo B. Marital therapy for depression
211
:
"Types of intervention: Inclusion criteria: 1. Marital therapy, for the purpose of this review, was 
defined as a structured psychological intervention in which a trained therapist met both partners in a couple, 
in regular sessions, with the explicit aim of modifying dysfunctional patterns of interaction."
Buckley LA, Pettit T. Supportive therapy for schizophrenia
222
:
"As we were unable to find a widely accepted definition of supportive therapy, we developed our 
own...This includes interventions that require a trained therapist, such as supportive psychotherapy, as well 
as other interventions that require no training, such as ’befriending’."
Carr AB, Ebbert JO. Interventions for tobacco cessation in the dental setting
227
:
"We included any intervention...which included a component delivered by a dentist, dental 
hygienist, dental assistant or office staff in the dental practice setting and any combination of these, as well 
as the same individuals providing intervention as part of a community effort...Interventions aimed at the 
training of dental health professionals were included."
den-Boer PCAM, Wiersma D, Russo S, van-den-Bosch RJ. Paraprofessionals for anxiety and 
depressive disorders
226
:
"Inclusion criteria: Randomised controlled trials that used symptom measures, and compared the 
effects of any kind of psychological treatment given by paraprofessionals with psychological treatments given 
by professionals, or with waiting list or placebo condition."
Dennis CL, Creedy D. Psychosocial and psychological interventions for preventing postpartum 
depression
188
:
"Any form of standard or usual care compared to a variety of non-pharmaceutical interventions...by 
a professional (nurse, midwife, childbirth educator, physician) or lay person (a specially trained woman from
the community, a student)”.
Doggett C, Burrett S, Osborn DA. Home visits during pregnancy and after birth for women with 
an alcohol or drug problem
259
:
"Home visits...by teams or individuals consisting of doctors (obstetricians, general practitioners or 
pediatricians), nurses (midwives, drug and alcohol workers or early childhood nurses), social workers, 
counselors, or trained lay people...Studies that detailed timing of visits, frequency of visits, the type of home 
visitors, the interventions and co-interventions were included."
Eccleston C, Yorke L, Morley S, Williams AC, Mastroyannopoulou K. Psychological therapies for 
the management of chronic and recurrent pain in children and adolescents
183
:
"No restrictions were placed on where or who delivered the therapy."
Hackett ML, Anderson CS, House AO. Interventions for treating depression after stroke
239
:
"(3) a comparison between a psychological therapy and standard care for the treatment of 
depression associated with stroke…All interventions had to...be delivered by somebody with some explicitly 
stated training and supervision in therapies."
Hay PJ, Bacaltchuk J, Stefano S. Psychotherapy for bulimia nervosa and binging
191
:
"Cognitive behaviour psychotherapy: For the purpose of this review, this is a psychotherapy that 
uses the specific techniques and model, but not necessarily the number of sessions or specialist expertise, of 
the cognitive and behavioural therapy therapy for bulimia nervosa as described by Fairburn and colleagues 
(CBT-BN; Fairburn 1993b)...In the analyses comparing CBT to pure self-help, guided self-help when guided 
by someone with some expertise, is thus “allowed” as CBT"
Hodnett ED, Fredericks S. Support during pregnancy for women at increased risk of low 
birthweight babies
249
:
"The programs may be delivered by multidisciplinary teams of health professionals, by specially 
trained lay workers, or by a combination of lay and professional workers. This Review includes all acceptably 
controlled trials of such programs."
Huibers MJH, Beurskens AJHM, Bleijenberg G, Schayck Cv. Psychosocial interventions delivered 
by general practitioners
228
:
"3) To assess the effectiveness of psychosocial interventions by general practitioners compared to 
the reference treatment (whether ’usual care’ or another experimental intervention) by reviewing the clinical 
outcomes of the selected studies." "In a second included study (Lidbeck 1997), the 
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therapist performing all interventions was a physician trained in family medicine as well as internal and social 
medicine who worked in a preventive medicine unit in primary care, which raised our doubts whether this 
therapist could be classified as a typical general practitioner. However, since the study formally met our 
inclusion criteria, we decided to include the study in the review."
James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children 
and adolescents
199
:
"Types of intervention: Manualised CBT of at least eight sessions provided by trained therapists 
under regular supervision."
Joy CB, Adams CE, Rice K. Crisis intervention for people with severe mental illnesses
201
:
"i. Crisis intervention: any type of crisis-orientated treatment of an acute psychiatric episode by 
staff with a specific remit to deal with such situations, in and beyond ’office hours’."
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation
210
:
"In this review, we therefore specifically exclude counselling provided by doctors or nurses 
during the routine clinical care of the patient, and focus on smoking cessation counselling delivered by 
specialist counsellors." "This review specifically excludes studies of counselling delivered by doctors 
and nurses as part of clinical care, which are covered in separate reviews (Rice 2004; Silagy 2004)."
Martinez DP, Waddell A, Perera R, Theodoulou M. Cognitive behavioural therapy for tinnitus
200
:
"Cognitive behavioural therapy (...by a qualified practitioner) versus no treatment or other 
treatments."
Perkins SJ, Murphy R, Schmidt U, Williams C. Self-help and guided self-help for eating 
disorders
248
:
"(b) Guided self-help: For the purpose of this review, this refers to the above self-help definition, 
plus contact with a ’therapist’ who may be a mental health professional or lay person."
Ray KL, Hodnett ED. Caregiver support for postpartum depression
229
:
"All types of professional and/or social support including emotional support, counselling, tangible 
assistance and information..."
Rees K, Bennett P, West R, Davey SG, Ebrahim S. Psychological interventions for coronary heart 
disease
176
:
"All non-pharmacological psychological interventions delivered by health care workers with specific 
training in these techniques were considered."
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple 
sclerosis
180
:
"Interventions could have been delivered by psychologists, counsellors, medical staff, nurses,
occupational therapists or other health professionals..."
Thompson RL, Summerbell CD, Hooper L, Higgins JPT, Little PS, Talbot D, Ebrahim S. Dietary 
advice given by a dietitian versus other health professional or self-help resources to reduce 
blood cholesterol
224
:
"Accepted interventions included dietary advice given by a dietitian or a nutritionist compared with 
another health professional (e.g. doctor or nurse) or self-help resources. Nutritionists as well as dietitians 
have been included as in different settings and different countries the terms dietitian and nutritionist may 
both be used to describe a health professional trained to give dietary advice."
Uman LS, Chambers CT, McGrath PJ, Kisely S. Psychological interventions for needle-related
procedural pain and distress in children and adolescents
181
:
"Interventions administered by any qualified health-care professional (i.e., doctor, nurse, 
psychologist, technician), family member, caregiver, or by the child him/herself after being trained by a 
parent or professional, or both were included."
Woods B, Spector A, Jones C, Orrell M, Davies S. Reminiscence therapy for dementia
220
:
Eligibility "Types of intervention:...Only trials where...sessions were led by professional staff (psychologists, 
occupational therapists, nurses etc.) or by care-workers with training from professional staff were included."
Yorke J, Fleming SL, Shuldham CM. Psychological interventions for adults with asthma
182
:
"Any type of psychological intervention used in the treatment of asthma in adults was considered 
for this review...These interventions will be delivered by a trained practitioner or in consultation or 
supervision by a trained practitioner."  
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Abbass AA, Hancock JT, Henderson J, Kisely S. Short-term psychodynamic psychotherapies for 
common mental disorders
221
:
"Eleven of these studies described using experienced therapists, but it was often 
unclear whether the therapists were experienced in the specific brief therapy approach versus other 
psychotherapy models."
Anderson CS, Hackett ML, House AO. Interventions for preventing depression after stroke
236
:
"The interventions were delivered by a variety of trained professionals, including 
specialist nurses (Forster 1996; House 2000) and a mixed team of therapists (Goldberg 1997)."
Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care
37
:
"Types of practitioner: A range of practitioners offered a range of counselling interventions. In seven 
of the trials, all the professionals had the necessary qualifications and experience to be accredited by the 
BACP (Boot 1994, Harvey 1998, Hemmings 1997, Friedli 1997, King 2000, Simpson 2000, Barrowclough
2001). In one trial, it was not clear whether all the included counsellors met the criteria for BACP 
accreditation (Chilvers 2001), although correspondence with the authors indicated that a significant 
proportion did, and all were highly experienced."
Doggett C, Burrett S, Osborn DA. Home visits during pregnancy and after birth for women with 
an alcohol or drug problem
259
:
"Three studies (Black 1994; Butz 1998; Quinlivan 2000) used nurses to provide home visits...No 
study reported using trained social workers to provide home visits...Dakof 2003 provided a manualised 
home-based, goal-orientated program administered by trained ’black’ specialists with prior experience in 
drug treatment services...Two studies (Grant 1996; Schuler 2000) reported home visits by trained lay 
workers...No study reported using a multidisciplinary team to provide home visits."
Eccleston C, Yorke L, Morley S, Williams AC, Mastroyannopoulou K. Psychological therapies for 
the management of chronic and recurrent pain in children and adolescents
183
:
"Therapist training and competence: The trials employed a variety of therapists 
ranging from undergraduate assistants to experienced psychological and medical personnel, but mainly 
graduate trainees in clinical psychology. Other trials employed non-psychologists specifically trained for the 
trials (eg, school nurses and teachers) to deliver structured interventions. The level of therapist training was 
not stated in six trials. Only three trials explicitly mentioned that therapists received supervision during the 
trials. This, coupled with the general failure to note whether checks on adherence were made, must be 
considered a weakness when judging the overall quality of the trials."
Hunot V, Churchill R, Silva-de LM, Teixeira V. Psychological therapies for generalised anxiety 
disorder
185
:
"The therapists employed to conduct psychological therapy treatments were 
predominantly qualified professionals, consisting of clinical psychologists (n=11), doctoral/senior/advanced 
level CBT therapists (n=5) and experienced therapists/therapists (n=5). A small number of studies used 
graduates/advanced graduates (n=3). One study did not describe the therapists used to conduct the 
treatment (Lavallee 1993)."
James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children 
and adolescents
199
:
"Therapists were mostly post doctorate psychologists"
Ostelo RWJG, van-Tulder MW, Vlaeyen JWS, Linton SJ, Morley SJ, Assendelft WJJ. Behavioural 
treatment for chronic low-back pain
195
:
"There were 15 RCTs that specifically mentioned the qualification of therapists and six 
RCTs that did not mention the therapists' qualifications (Altmaier 1992; Bru 1994; Donaldson 1994; 
Lindström 1992; Newton-John 1995; Stuckey 1986). An example of sufficient description of qualifications of 
therapists was 'psychologist who had had five years of experience with chronic pain patients since 
completing his clinical qualifications' (Nicholas 1991). An example of insufficient description was 'a physical 
therapist' (Lindström 1992)."
Rice VH, Stead LF. Nursing interventions for smoking cessation
225
:
"We determined whether the nurses delivering the intervention were providing it 
alongside clinical duties that were not smoking related, were working in health promotion roles, or were 
employed specifically as project nurses. Of the high intensity intervention studies, five used nurses for whom 
the intervention was a core component of their nursing role (Hollis 1993; DeBusk 1994; Allen 1996; Carlsson 
1997; Terazawa 2001). In six studies the intervention was delivered by a nurse specifically employed by the 
project (Taylor 1990; Rice 1994; Rigotti 1994; Miller 1997; Lewis 1998; Canga 2000). In three of these, the 
same nurse provided all the interventions (Rigotti 1994; Lewis 1998; Canga 2000). In only three studies 
were intensive interventions intended to be delivered by nurses for whom it was not a core task (Lancaster 
1999; Bolman 2002; Curry 2003). In the last of these the intervention was given either by paediatric nurses 
or by health educators. All the low intensity interventions were delivered by primary care or outpatient clinic 
nurses.”
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Box 3.20 Discussion of Generalisation of Results to Therapist Populations 
EXPLICIT COMMENTS
Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care
37
:
"The practices and GPs recruited to the studies were ’volunteers’ rather than a random sample. 
The doctors who participated may have been particularly interested in the research question and may have 
used therapeutic techniques to a greater extent than is usual, thus reducing the additional effect of 
counselling (Friedli 1997). In addition, in one trial (Hemmings 1997), GPs participated in an Action Learning 
programme, in which they learned about counselling and counselling skills. This may have effected their 
consultation style and referral practices." "The results can only be generalised to similar patients 
and counsellors. This means that the evidence is restricted to counsellors with BACP accreditation or 
equivalent."
Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in 
adults
217
:
"External validity has been weakened due to the use of research staff to implement the 
intervention in four of the trials (Hu 1989; Ouslander 2005; Schnelle 1989; Schnelle 2003). The other trials 
have demonstrated that it is possible to use direct caregivers during the trial period (Engberg 2002; Linn 
1995; Smith 1992; Surdy 1992; Schnelle 1983). Reliability checks were performed for the wet checks in
seven trials, which may be partly responsible for the compliance of staff with the programme. Two trials did 
not report reliability checks (Linn 1995; Smith 1992). Without robust trials that address these issues, our 
understanding of the factors that influence the successful management of urinary incontinence will remain 
unclear. Nevertheless, these trials are important for exposing the multidimensional aspects of managing 
incontinence in a frail, elderly population. Therefore, this work adds to the literature on behavioural 
treatment of urinary incontinence, but the body of knowledge remains incomplete, especially within the 
nursing home environment."
Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic 
disorder with or without agoraphobia
172
:
"generalisability of the present findings beyond specialist psychiatric settings is not 
straightforward. Only one study (Sharp 1996) was conducted in the primary care setting but in this study 
patients were seen in their local GP clinics but by qualified clinical psychologists. Only two studies in this 
review assessed a psychological approach other than CBT. Where CBT therapists were not available, the 
research evidence, as accumulated and presented in this systematic review, would not be readily applicable 
to clinical practices."
Huibers MJH, Beurskens AJHM, Bleijenberg G, Schayck CP van. Psychosocial interventions 
delivered by general practitioners
228
:
"These findings should be interpreted with considerable caution: the two studies on PST were 
conducted by the same research team and groups consisting of only 30 to 40 patients were treated by a 
small number of experienced research GPs…This finding exposes an interesting problem in primary care and 
general practice research: in order to have a large sample size, investigators are often forced to recruit a 
large number of GPs who can select patients for the trial and perform the intervention. However, there are 
many objections to having a large number of GPs actively participating in the trial: patient recruitment by 
GPs is usually slow, accurate training and supervision of a large number of GPs is time-consuming and costly 
and GPs do not build experience if they only apply the intervention to a small number of patients (Van der 
Windt 2000). A solution to this problem is the deployment of a small number of research GPs who have 
(unfamiliar) patients assigned to them for the purpose of the trial. These research GPs tend to be highly 
motivated, highly trained and highly experienced. Consequently, findings from studies in which a small 
sample of research GPs performs the intervention should be interpreted with caution, since research GPs 
might not represent the typical GP and treatment effects might therefore be an overestimation of the effects 
in daily practice. In this review, of the six studies that have a small number of GPs delivering the 
intervention, four studies use research GPs instead of the regular GP of patients. Although treatment by the 
regular GP versus treatment by an unfamiliar research GP was not associated with outcome, these 
circumstances make the available evidence even harder to interpret. Of course, this highly qualitative 
analysis of comparing study characteristics in relation to outcome lacks a clear validity basis due to the small 
number of selected studies. Nevertheless, the potential influence of factors like these, especially the 
influence GP-factors (number, type, training, experience), should be explored in future research." 
"Problem-solving treatment by highly experienced GPs seems a promising tool in the treatment of depressed 
patients, although the effectiveness of this intervention by regular GPs in routine care remains to be 
demonstrated."
Hunot V, Churchill R, Silva-de LM, Teixeira V. Psychological therapies for generalised anxiety 
disorder
185
:
"Since 79% of therapists and counsellors in UK primary care are person-centred or integrative in 
theoretical orientation and CBT is only practiced by 10% of therapists (Stiles 2006), the evidence produced 
in this review could be regarded as of limited applicability. Furthermore, in the majority of studies, the 
therapists employed were highly qualified and experienced practitioners, who may not be representative of 
practitioners employed in real world clinical settings."
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Box 3.20 Continued… 
Jones C, Cormac I, Silveira-da-Mota-Neto-JI, Campbell C. Cognitive behaviour therapy for 
schizophrenia
197
:
"For clinicians: Presently, cognitive behavioural therapy is a scarce commodity, often provided by 
highly skilled and experienced therapists. Therefore, its application in day-to-day practice may be restricted 
by the availability of suitably qualified practitioners. The present data provides little indication of how 
effective cognitive behavioural therapy procedures might be when they are applied by less experienced 
practitioners." "Cognitive behavioural therapy (CBT) is one of the talking therapies that is 
suggested to be of value to people with schizophrenia. This review suggests that it may well be of value, at 
least in the short term. Cognitive behavioural therapy should be further evaluated in various clinical settings 
and comparing effects for both expert and less skilled practitioners."
Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking 
cessation
261
:
"Nicotine gum and transdermal patches were more effective when offered to volunteer smokers 
recruited from the community or those attending specialized clinics than if offered to smokers in primary 
care. These findings are likely to be partly explained by the high motivation to quit among many of the 
smokers in the community who volunteer for trials in response to media advertisements and, similarly, 
among those participants who are recruited as a result of their attendance at specialized smoking cessation 
clinics. The latter group also have access to trained therapists who specialize in assisting smokers to quit. 
However, given the limited number of specialized smoking cessation clinics, access will be restricted to a 
small proportion of smokers wanting help to quit. In contrast, most of the smokers recruited into trials 
conducted in primary care settings were unselected, and hence may be less motivated to quit. In addition, 
the treating physician or practice nurse had frequently received little training in smoking cessation skills. As a 
result, compliance with NRT among smokers treated in primary care is reported to be lower than in other 
settings (Lam 1987)."
IMPLICIT COMMENTS
Buckley LA, Pettit T. Supportive therapy for schizophrenia
222
:
"Future trials should clearly explain whether practitioners who deliver supportive therapy have 
been specifically trained, and if so how. It may make the results more applicable if the therapists are trained 
but in the context of routine career development, rather than specific highly-trained specialised
practitioners."
den-Boer PCAM, Wiersma D, Russo S, van-den-Bosch RJ. Paraprofessionals for anxiety and 
depressive disorders
226
:
"Significant questions remain about the conditions under which paraprofessionals can be 
effective. Most studies mention some selection, training and supervision of paraprofessionals. If 
paraprofessionals, volunteers or patients, can be effective therapists (with no training or minor initial 
training), or can offer support because of their personal experience with the underlying problem, this will 
bring psychological treatment within the scope of psycho-education or education alone. The evidence 
presented so far may justify the development of new programs incorporating paraprofessionals."
Gold C, Heldal TO, Dahle T, Wigram T. Music therapy for schizophrenia or schizophrenia-like 
illnesses
215
:
"The specific techniques of music therapy, including, among others, musical improvisation and 
the discussion of personal issues related to the musical processes, require specialised music therapy training. 
Both training courses and qualified music therapists are available in many countries, but in some countries 
there may be a need for development of good quality training."
Gold C, Wigram T, Elefant C. Music therapy for autistic spectrum disorder
214
:
"When applying the results of this review to practice, it is important to note that the application of 
music therapy requires an academic and clinical training in music therapy. Trained music therapists are 
available in many countries. Training courses in music therapy teach not only the clinical music therapy 
techniques as described in the background of this review, but also aim at developing the therapist’s 
personality and clinical sensitivity, which is necessary to apply music therapy responsibly. Academic training 
courses in music therapy exist in many countries, and information is usually available through the 
professional associations." "When applying the results of this review to practice, it is important to 
note that the application of music therapy requires specialised academic and clinical training."
Joy CB, Adams CE, Rice K. Crisis intervention for people with severe mental illnesses
201
:
"It is unfortunate that no data are available for staff satisfaction. Issues such as staff recruitment, 
despondency and burnout are essential to the successful implementation of home care packages. Several of 
the studies mentioned these as notable problems affecting the running of the project. If such problems were 
prominent in these usually well-resourced and well-motivated research teams, they may amount to 
insurmountable obstacles to the implementation of similar projects in routine psychiatric settings."
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation
210
:
"Implications for practice: Counselling interventions given outside routine clinical care, by 
smoking cessation counsellors including health educators and psychologists, assist smokers to quit."  
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Box 3.20 Continued… 
Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP. Interventions for 
helping people recognise early signs of recurrence in bipolar disorder
173
:
"Perry 1999 was the only trial that used therapists with little previous experience to deliver the 
intervention. Therefore, successful EWS interventions seem to require around 12 sessions of therapist time 
and involve therapists of high competency...The one EWS intervention that used a less experienced and, 
therefore, less expensive therapist only showed a benefit against manic type recurrences and function, 
without any effect against depressive type recurrence. The relative cost-effectiveness of interventions 
involving more experienced versus less experienced therapists is a topic for further research." 
"The means by which EWS interventions could be efficiently delivered within existing health service systems 
is not clearly established."
O'Connor AM, Stacey D, Entwistle V, Llewellyn TH, Rovner D, Holmes RM, Tait V, Tetroe J, Fiset 
V, Barry M, Jones J. Decision aids for people facing health treatment or screening decisions
254
:
"However, several conditions are necessary to implement decision aids in practice. These 
include:...b) practitioners willing to try decision aids in their practice;...d) practitioners and health care 
consumers who are skilled in shared decision making."
O'Kearney RT, Anstey KJ, von SC. Behavioural and cognitive behavioural therapy for obsessive 
compulsive disorder in children and adolescents
194
:
"Applicability of results: The BT/CBT interventions reviewed are similar, with three of the four 
using a standard protocol for the BT/CBT treatment of OCD in children and adolescents. While the protocol 
and manuals are readily available (March 1998), training and supervision in its delivery are less accessible.” 
"An equally important area of research arising from the results would be an examination of how 
well BT/CBT could be disseminated and implemented in non-specialist centres or non-academic settings, as 
often the main limitation to offering BT/CBT is availability of skilled therapists."
Perkins SJ, Murphy R, Schmidt U, Williams C. Self-help and guided self-help for eating 
disorders
248
:
"It remains uncertain whether and how much guidance is needed and from whom."
Ray KL, Hodnett ED. Caregiver support for postpartum depression
229
:
"As with other studies of support for childbearing women, e.g. Cochrane Review 'Caregiver 
support for women during childbirth’ (Hodnett 2001), questions remain about the relative benefits of social 
(for example, lay person) versus professional (health visitor, nurse, midwife) support.”
Rice VH, Stead LF. Nursing interventions for smoking cessation
225
:
"Additionally, controlled studies are needed that carefully examine the effects of ‘brief advice by 
nursing’ as this type of professional counselling may more accurately reflect the current standard of care.”
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple 
sclerosis
180
:
"There are a number of issues that need to be addressed in relation to the delivery of 
psychological treatment. For example,…What is the potential for professions other than psychologists, such 
as nurses and occupational therapists, to conduct psychology-based interventions?...Two of the studies 
qualifying for this review used interventions that were delivered by nurses. Psychologists working in the 
acute hospital setting in the NHS are in short supply. Training and supporting other health professionals to 
deliver psychology-based interventions, or to deliver interventions that incorporate psychological principles, 
could be useful. This would need to be corroborated by research evidence.”
Thompson RL, Summerbell CD, Hooper L, Higgins JPT, Little PS, Talbot D, Ebrahim S. Dietary 
advice given by a dietitian versus other health professional or self-help resources to reduce 
blood cholesterol
224
:
"Further work is needed on which elements of dietary advice make it effective, e.g….level of 
belief of practitioner, level of training of practitioner...”
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4 ILLUSTRATIVE EXAMPLE: COUNSELLING IN 
PRIMARY CARE  
 
4.1 Introduction 
 
The Cochrane reviews included in Chapter 3 provided the sampling frame for selecting 
an illustrative example for the remainder of the thesis. Bower and Rowland’s37 review, 
on the clinical and cost-effectiveness of counselling in primary care, was chosen on the 
basis of the following three criteria. Firstly, the review topic had to be clearly oriented 
towards psychotherapy. Secondly, the data structure of the studies involved in at least 
one meta-analysis had to highlight the heteroscedasticity issues in a relatively intuitive 
manner. Finally, the individual-patient-data (IPD) had to be accessible. The aim of this 
chapter was to introduce the example, providing an overview of the Cochrane review, 
the randomised trials included, the patient-level data obtained, and the practical issues 
arising from the information that was available. 
 
4.2 The Cochrane Review 
 
4.2.1 Background 
 
The principal point of contact for patients presenting in primary care is their general 
practitioner (GP) and associated primary care team. One in three are estimated to be 
affected by mental health problems290. By 2005, there were more people receiving 
benefits for incapacity through mental ill-health than the total number unemployed290. 
The case for providing psychological therapies, including counselling, within the NHS 
has been made recently by five leading mental health charities291, as part of a wider 
drive to improve access to these forms of treatment290, 292-294. Reimbursement for the 
cost of employing counsellors in general practice has been available since 1990295. The 
intervening period has seen a rapid rise in counselling in primary care296, 297, with half 
the general practices in England estimated to have a counsellor attached by 2000298. 
Counselling is defined in this context as “a systematic process which gives individuals 
an opportunity to explore, discover and clarify ways of living more resourcefully, with a 
greater sense of well-being. Counselling may be concerned with addressing and 
resolving specific problems, making decisions, coping with crises, working through 
conflict, or improving relationships with others.” (p.9)299 
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Table 4.1 What is essential and desirable in a counsellor in primary care 
Criteria Essential Desirable 
Education and  
professional qualifications 
450 hours training BACP accreditation or 
equivalent 
Knowledge One theoretical approach to  
counselling 
Psychosomatic disease and 
psychology of chronic or 
terminal illness 
BACP code of ethics – 
particularly about 
confidentiality 
Variety of counselling theories 
and methods 
Psychotrophic drugs and their 
side effects 
 
Psychopathology by visiting 
admission unit of psychiatric 
hospital 
Experience 250 hours supervised 
counselling over 2 years 
At least 300 hours gained over 
at least 3 years 
Personality Dependable 
 
Considered approachable by a 
wide range of patients? 
Aware of boundaries around 
punctuality 
Friendly 
Physical attributes Good enough health and 
sufficient sight and hearing 
not to make special 
demands on clients 
Able to work under pressure 
and to monitor and manage 
own stress level 
Special circumstances A constructive member of a 
multidisciplinary team 
Understanding of culture of 
medical settings and 
willingness to develop 
appropriate counselling skills 
among team members 
Reproduced from Table 1.3 in Bond T. The nature and role of counselling in primary care. In: Keithley J., Bond T, Marsh G (eds) 
Counselling in Primary Care. Oxford University Press: Oxford, 2002. Updated from The Counselling in Primary Care Trust criteria300. 
 
The background of counsellors working in this setting is variable296. While the NHS has 
not set specific training standards301, the most widely accepted are those required for 
accreditation by the British Association for Counselling and Psychotherapy (BACP), 
leading to registration with the United Kingdom Register of Counsellors296. Professional 
recognition is acquired through membership of the Faculty of Healthcare Counsellors 
and Psychotherapists, the Association of Counsellors and Psychotherapists in Primary 
Care, or the Counselling Psychology Section of the British Psychological Society296. The 
essential and desirable criteria set out by the Counselling in Primary Care Trust were 
updated by Bond296 and are given in Table 4.1. In contrast to the BACP requirement of 
450 hours of supervised practice, these only regard 250 hours as essential. There is 
also no mention of having received personal counselling, which is necessary for BACP 
accreditation. In a move to professionalise counselling in primary care, guidelines for 
employment of counsellors302, appropriate referral of patients303, and good practice304 
have been disseminated. Concerns about the competency of practice counsellors305-309 
prompted Mellor-Clark et al298 to conduct a national survey. Of the 1031 responding, 
75% held the recommended counselling diploma and 32% also had relevant Masters 
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or Bachelors degrees. Eighty-three percent had at least two years post-qualification 
experience, with 76% also having a minimum of two years in a medical setting. All but 
two counsellors stated having regular individual or group supervision. 
 
Counselling is typically brief, usually involving 6 to 10 sessions, each of 50 minutes310. 
Additional sessions may be offered as necessary, providing the resource is available296. 
The counselling process is characterised by three stages, operating by means of the 
relationship between the counsellor and the patient296. The focus is initially on building 
trust, with the counsellor employing many strategies and techniques to this end. The 
counsellor encourages the patient to describe the situation that is affecting them and 
makes a systematic assessment. The emphasis then turns to creating changes which 
give the patient additional resources they can subsequently draw upon. The way this 
is done by the counsellor depends on the theoretical model they are applying. Finally, 
alternative means of using the resources are considered, put into action and reflected 
upon. Regular meetings of the primary care team ensure the counsellor is not working 
in isolation296. The curriculum for training doctors now includes training in counselling 
and communication skills311. As a consequence, the separation between the respective 
roles of the counsellor and the GP may be blurred to varying degrees. 
 
The nature of GP referrals reflects the diversity of patients encountered in a practice, 
the counsellor’s specific competencies298, patient and GP choice, and the availability of 
other services37. It is usual for counsellors to apply eclectic therapeutic approaches for 
a wide range of social and clinical problems. These include depression, anxiety, and 
bereavement, relationship difficulties, stress, and adjustment to physical ill-health296, 
298, 301. The popularity of counselling amongst GPs and patients justifies the need for 
an evidence-base supporting its use. The rise in its availability, together with current 
moves to increase access still further, makes this all the more important. In line with 
proposals to identify empirically supported therapies312, psychotherapy trials tend to 
focus interest on discrete therapeutic approaches for distinct diagnostic problems298. 
This runs counter to clinical practice in this example, however. As such, any attempts 
to restrict the severity or range of patient referrals beyond that accepted within good 
practice guidelines limits the generalisability of research findings. Restrictions based on 
the theoretical models counsellors are able to apply, their professional background, or 
the nature of the therapeutic relationship, the number and frequency of sessions also 
would have implications for generalisation. 
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4.2.2 Review Methodology 
 
Bower and Rowland37 searched MEDLINE, EMBASE, PsycINFO and CINAHL, together 
with the general and specific Cochrane trials registers, using an explicit and detailed 
search strategy. Studies were considered eligible if they met the following inclusion 
criteria 
 
i) Source   Published prior to July 2005 
ii) Study design  Randomised controlled trial 
iii) Setting   Primary care, including at home if referral from GP 
iv) Patient characteristics  Psychological or psychosocial problems regarded as 
suitable for counselling, including situational or life-
adjustment problems not leading to a formal diagnosis 
v) Counselling Distinct and separate treatment, potentially based on a 
variety of theoretical models, given as a series of 
sessions following an assessment to generate a plan, but 
not including specialist counselling interventions 
vi) Control Usual care representing a mixture of interventions 
patients would typically receive, including GP referral to 
NHS psychotherapy services 
vii) Care providers Counselling provided by professionals, possibly from a 
variety of backgrounds, with formal training equivalent 
to the requirements for BACP accreditation 
viii) Outcomes Self-report or interviewer-rated 
a. Mental health symptoms 
  b. Social and occupational functioning 
  c. Patient satisfaction 
  d. Costs 
 
and eight studies were included313-320. A variety of control interventions were used with 
counselling compared to usual GP care in six studies314, 316-320, to cognitive behavioural 
therapy in two313, 319 and to GP-prescribed generic antidepressant treatment in one315. 
Included studies were rated using the Moncrieff et al278 scale for their methodological 
quality. Items relating to side effects and the blinding of subjects and assessors were 
excluded as they were not regarded to be relevant. 
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4.2.3 Original Analysis 
 
The reviewers summarised clinical effectiveness quantitatively and cost effectiveness 
in the text. All the published meta-analyses made use of continuous outcome scales. 
As different measurement scales were used across studies, the summary statistics 
extracted from each study were all standardised mean differences (SMDs). Outcomes 
were collected over an extended follow-up period, categorised as short-term (1 to 6 
months), long-term (7 to 12 months) or very long-term (>12 months). The principal 
meta-analysis compared counselling to usual care, using the short-term outcomes that 
measured the extent of mental health symptoms. This was supplemented by an 
analysis comparing counselling to all forms of GP care, and by others based on long-
term and other outcomes. Additional analyses were performed assessing how robust 
the principal analysis was to the exclusion of studies with compromised concealment 
of random allocations and patients presenting with chronic symptoms. In each case, 
the primary analysis assumed a common underlying treatment effect across studies. 
Evidence of between-study heterogeneity in the treatment effect was investigated with 
a chi-square test and the I2 statistic321. Sensitivity analyses were performed using the 
random-effects model, assuming that the population treatment effects were normally 
distributed across studies. None of the meta-analyses made any allowance for within-
study clustering or between-arm heteroscedasticity. 
 
4.2.4 Published Results 
 
Bower and Rowland37 highlighted a number of limitations to the quality of the studies. 
Problems with the allocation procedure were reported in two trials314, 318 contributing to 
imbalance in the number of patients assigned to each arm. In both cases, difficulties 
with concealment were attributed to a single GP. Boot et al314 chose to retain affected 
patients in analyses, while Hemmings318 excluded them. Volunteer GP practices were 
used to recruit patients in all eight trials. None reported what proportion of eligible 
patients were randomised, and only four were regarded as having provided adequate 
information on the characteristics of patients313, 315, 319, 320. This placed restrictions on 
the assessment of external validity. Neither Barrowclough et al313 nor Boot et al314 
reported a power calculation, and additional information had to be sought from Harvey 
et al317 and Hemmings318 in order to perform the meta-analyses. None of the Moncrieff 
et al278 items were extended to encompass the precision, internal or external validity 
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implications of therapist variation. 
 
The principal meta-analysis gave a pooled estimate of -0.28 (95% CI -0.43 to -0.13) 
for the SMD in short-term outcome for counselling versus usual GP care. This indicates 
that counselling reduces mental health symptom scores by an average of around 0.3 
standard deviations, when compared to usual GP care in the short term. Excluding the 
studies that reported compromised concealment of random allocations314, 318 gave very 
similar results (pooled SMD -0.27, 95% CI -0.45 to -0.09). Excluding the study focused 
on patients with chronic symptoms increased the pooled SMD estimate to -0.36 (95% 
CI -0.53 to -0.19). The meta-analysis comparing counselling to all forms of GP care, 
including data from Chilvers et al315, is given in Table 4.2. This analysis was chosen to 
illustrate the methods within the remainder of the thesis. It is broadly consistent with 
the principal meta-analysis. 
 
Table 4.2 Counselling compared to all GP care, short-term mental health outcomes 
Counselling No Counselling  
Trial N Mean (SD) N Mean (SD) 
 
w 
 
SMD (95% CI fixed) 
Boot 1994 67 6.21  (6.97) 41 10.56  (8.97) 12.5 -0.55 (-0.95 to -0.16) 
Chilvers 2001 39 15.20  (11.60) 44 14.80  (10.05) 10.5 0.04 (-0.39 to 0.47) 
Friedli 1997 59 11.70  (7.70) 51 15.60  (10.50) 13.6 -0.43 (-0.80 to -0.05) 
Harvey 1998 77 7.29  (4.57) 38 8.23  (5.05) 12.9 -0.20  (-0.59 to 0.19) 
Hemmings 1997 114 0.98  (0.66) 40 1.03  (0.82) 15.0 -0.07  (-0.43 to 0.29) 
King 2000 62 11.50  (7.70) 62  17.20  (11.90) 15.1 -0.57  (-0.92 to -0.21) 
Simpson 2000 82 16.00  (9.30) 79  16.00  (8.10) 20.4 0.00  (-0.31 to 0.31) 
TOTAL (95% CI) 500  355  100 -0.24 (-0.38 to -0.10) 
Test for heterogeneity: 
2χ =11.29  df =6  p =0.08  2I =46.8% 
Test for overall effect: z =3.43  p =0.0006 
Note: This meta-analysis was published in Bower and Rowland37 as Analysis 02.01 (p.56); w = weight; SD = standard deviation; CI = 
confidence interval; SMD = standardised mean difference; the outcome for Chilvers 2001, Friedli 1997, King 2000 and Simpson 2000 
was the Beck Depression Inventory (BDI), for Boot 1994 it was the General Health Questionnaire (GHQ), for Harvey 1998 it was the 
Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), and for Hemmings 1997 it was the Symptom Index (SI). 
 
Heterogeneity of the sample variances across arms is evident for a number of trials, 
but most notably for King et al319 and Friedli et al316. The sample variances were larger 
in the control arm in five314, 316-319 of the seven trials. Unequal patient ratios favoured 
the counselling arm in three trials314, 317, 318. The trial sample sizes, while small, were all 
of a comparable magnitude, exceeding 30 per arm. While only marginally significant, 
there is some evidence of heterogeneity in the SMDs between trials. Moderate effect 
sizes were observed in King et al319, Boot et al314 and Friedli et al316, but no discernible 
effects were detected in Simpson et al320, Chilvers et al315 and Hemmings318. The 95% 
confidence intervals included moderate to large effects in all but Chilvers et al315. 
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4.3 The Randomised Trials 
 
4.3.1 Trial Methodology 
 
The research question implicit in all seven trials314-320 was whether counselling given by 
qualified counsellors in addition to GP care is more effective than GP care in reducing 
psychological distress. Interest was therefore in packages of therapeutic approaches 
and care provider characteristics. While six trials314-319 framed the comparison in terms 
of counselling versus GP care, it is possibly more accurate to consider GP care a co-
intervention, with the focus being on counselling versus no counselling. Patients were 
recruited through a GP in their local GP practice. The pre-existing allocation of GPs to 
patients suggests that the GP could be considered a patient characteristic, and hence 
a potential stratification factor. None of the trials stated that GPs were crossed with 
intervention arms, but this is a reasonable assumption in the circumstances. All seven 
trials individually randomised the treatment packages to patients. Patients expressing 
a strong preference could be assigned their preferred treatment in Chilvers et al315 and 
King et al319 under a patient preference design322. King et al319 modified the allocation 
procedure mid-recruitment to add a third option of a two-way randomisation between 
counselling and cognitive behavioural therapy. The meta-analyses reported by Bower 
and Rowland37 excluded these additional arms. 
 
The region, GP practice, GP and counsellor were all potential sources of within-study 
clustering, giving rise to the idealised data structure depicted in Figure 4.1. Each trial 
was carried out in one or more regions within the United Kingdom. A number of GP 
practices were selected within each region, with one or more GPs nested within each 
practice. The patients in each trial therefore constitute clustered samples of patients 
within the United Kingdom. Once selected, patients were then randomly allocated an 
intervention; with those assigned counselling in turn allocated a counsellor. In clinical 
practice, counsellors would already be attached to one or more GP practices within a 
region. Those in Harvey et al317 and Simpson et al320 were already in post, but those in 
Boot et al314 and Hemmings318 were recruited and placed for the trial. The counsellors 
in Friedli et al316 were peripatetic, while those in Chilvers et al315 and King et al319 came 
from a mixture of sources. As a consequence, some of the counsellors in some of the 
trials were crossed with GP practices, while others were nested. The cluster sampling 
of patients, together with the non-random allocation of counsellors to patients, could 
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lead to clustering, regardless of whether or not patients attended treatment. Blinding 
providers of co-interventions to the intervention arm justifies the assumption that the 
underlying treatment-related clustering is homogeneous across arms. As none of the 
GPs were blinded, the possibility remains that treatment effects were heterogeneous 
across GPs due to performance bias. The between-arm differences in the nature of GP 
care in Chilvers et al315 suggest that GP care is part of the treatment package, rather 
than being a co-intervention. This questions the relevance of performance bias for the 
GPs. For simplicity, however, the focus was placed on the counsellor-related clustering 
in subsequent chapters. 
 
Figure 4.1 Idealised Data Structure for Counselling in Primary Care 
 
 
The trial designs, patient populations, treatments and data collected are summarised 
in Table 4.3. In accordance with clinical practice, the patient populations sampled in 
Boot et al314, Friedli et al316, Harvey et al317 and Hemmings318 were broad, determined 
by GP referrals. In contrast, criteria were restricted in Chilvers et al315, King et al319 and 
Simpson et al320 to patients with clinical depression, neither the severity or duration of 
which being reflective of referrals in clinical practice. The counselling provided varied 
across the trials, both in terms of the degree of standardisation and theoretical model 
applied. Between-study differences in the degree of treatment standardisation and the 
breath of the patient population may contribute to between-study heterogeneity in the 
size of the clustering effect because clustering is indexed by the ratio of the between-
counsellor and the total variances. 
 
The timing of the short-term outcome ranged from six weeks314 to six months320. As
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Table 4.3 Trial Characteristics 
 
Trial Design Patients Intervention Control Data Collection 
Boot et al 
1994 
1) Parallel-group RCT 
2) Treatments randomly allocated to 
patients 
1) Broad range  
2) Acute but not severe 
psychological or 
psychosocial problems 
3) GP referral 
1) Generic counselling 
2) No standardisation or manual 
3) BAC accredited/accreditable 
counsellors 
4) 6 1-hr weekly sessions 
Usual GP care 
 
1) GHQ-28 
2) Patient satisfaction 
3) Psychotropic drug use 
4) GP Referral to outside 
agencies 
1) Baseline 
2) 6 wks 
Chilvers et 
al 2001 
1) Parallel-group RCT 
2) Treatments randomised to patients 
using stratified block randomisation 
with GP practices as strata 
3) Additional preference arms 
1) Major depression 
2) Research Diagnostic 
Criteria (Spitzer et al, 
1978) 
1) Generic counselling 
2) No standardisation or manual 
3) Counsellors with 2000+ hrs of 
supervised experience or in role 
already 
4) 6 50-min weekly sessions 
Routine GP 
antidepressant 
drug treatment  
 
(written protocol 
for guidance) 
1) BDI 
2) Global outcome 
3) Time to remission 
4) Research diagnostic 
criteria 
5) SF-36 
6) Costs 
1) Baseline 
2) 8 wks 
3) 12 mths 
Friedli et al 
1997 
1) Parallel-group RCT 
2) Treatments randomised to patients 
using block randomisation 
1) Broad range 
2) Emotional difficulties GP 
regarded suitable 
1) Non-directive psychotherapy 
(Rogerian model) 
2) Standardised training & 
verification of therapy delivered 
3) BAC accreditable counsellors 
4) 6/12 50-min weekly sessions 
Usual GP care  
 
(discouraged 
from referring to 
counsellors) 
1) BDI 
2) BSI 
3) CIS-R 
4) SAS-M 
5) Patient satisfaction 
6) Costs 
1) Baseline 
2) 3 mths 
3) 9 mths 
Harvey et 
al 1998 
1) Parallel-group RCT 
2) Treatments randomised to patients 
using block randomisation, ratio 2:1 
1) Broad range  
2) Emotional or relationship 
problems 
3) GP referral 
1) Generic counselling 
2) No standardisation or manual 
3) BAC accredited or diploma-level 
counsellors 
4) 6 50-min weekly sessions 
Usual GP care 1) HADS 
2) COOP/WONCA 
3) Delighted/terrible faces 
4) SF-36 (Swansea only) 
5) Costs 
1) Baseline 
2) 4 mths 
 
Hemmings 
1997 
1) Parallel-group RCT 
2) Treatments randomised to patients, 
ratio 2:1 
1) Broad range 
2) Appropriate referrals 
negotiated between GPs 
and counsellors 
1) Generic Counselling 
2) No standardisation or manual 
3) BAC accredited counsellors 
Usual GP care 1) Symptom Index 
2) IIP-32 
3) Repertory Grids 
4) Patient satisfaction 
1) Baseline 
2) 4 mths 
3) 8 mths 
King et al  
2000 
1) Parallel-group RCT 
2) Treatments randomised to patients 
using stratified block randomisation 
with severity (BDI score) as strata 
3) Additional intervention (CBT), 2-way 
randomisation, and preference arms 
1) Depression or depression/ 
anxiety 
2) GP diagnosis/referral 
3) >= 14 on BDI 
1) Non-directive counselling 
(Rogerian model) 
2) Manual & verification of therapy 
delivered 
3) BAC accreditable counsellors  
4) 6/12 sessions 
Usual GP care 
 
(discouraged 
from referring to 
counsellors or 
prescribing 
antidepressants) 
1) BDI 
2) BSI 
3) SAS-M 
4) Patient satisfaction 
5) Costs 
1) Baseline 
2) 4 mths 
3) 12 mths 
Simpson et 
al 2000 
1) Parallel-group RCT 
2) Treatments randomised to patients 
using random number tables 
1) Depression or depression/ 
anxiety 
2) GP referral/BDI screening 
3) Duration 6 mths to 5 yrs  
4) >= 14 on BDI 
1) Counselling (psychodynamic/ 
cognitive-behavioural models) 
2) No standardisation or manual 
3) BACP accredited counsellors 
4) 6/12 50-min sessions 
Usual GP care 
 
(not able to refer 
to practice 
counsellor) 
1) BDI 
2) BSI 
3) IIP-32 
4) SAS-M 
5) Costs 
1) Baseline 
2) 6 mths 
3) 12 mths 
 Page 110 of 238 
Table 4.4 Published Summary Data and Analyses 
Baseline Short-Term Outcome 
Counselling No Counselling Counselling No Counselling Trial 
N (%)  Mean (SD) N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD) 
Model Summary 
Beck Depression Inventory (BDI)  
Chilvers et 
al 2001 
50  (96) 27.1 (8.0)    49 (96) 27.0 (8.0) 39 (75) 15.2 (11.6) 44 (86) 14.8 (10.1) Unadjusted independent 
samples t-test on 
outcome scores 
MD=-0.4, 95% CI -4.4 to 5.1, p=0.88 
Friedli et al 
1997 
70  (100) 19.3 (8.9)    66 (100) 21.8 (9.3) 59 (84) 11.7 (7.7) 51 (77) 15.6 (10.5) ANCOVA using mean of 
two follow-up scores 
adjusting for baseline 
p=0.10 
King et al  
2000 
67  (100) 25.4 (8.6)    67 (100) 26.5 (8.9) 62 (93) 11.5 (7.7) 62 (93) 17.2 (11.9) General linear model with 
between-subjects factors 
for randomised group (3 
levels) and site (2 levels) 
and a within-subjects 
factor for time (3 levels)  
Group: F=1.41, df=2,191, p=0.25; 
Time: F=135.90, df=2, 190, p=0.000; 
Group-by-Time: F=3.874, df=4, 380, 
p=0.004 
Simpson et 
al 2000 
92  (100) 21.5 (6.0)    89 (100) 19.9 (5.7) 82 (89) 16.0 (9.3) 79 (89) 16.0 (8.1) ANCOVA on outcome 
scores adjusting for 
baseline 
Effect=0.95, 95% CI –3.3 to 1.42, p=0.43 
Hospital Anxiety and Depression Scale – Depression Subscale (HADS-D)  
Harvey et 
al 1998 
99  (89) -    47 (92) - 82 (74) - 39 (76) - Unadjusted independent 
samples t-test on change 
scores 
Effect=-0.7, 95% CI -2.6 to 1.1, p=0.43 
General Health Questionnaire (GHQ)  
Boot et al 
1994 
124  (100)  15.7 (6.8)    68 (100) 16.6 (6.6) 67 (54) 6.2 (7.0) 41 (60) 10.6  (9.0) Unadjusted independent 
samples t-test on 
outcome scores 
t=2.82, df=106, p=0.01 
Symptom Index  
Hemmings 
1997 
136  (94) 1.6 (0.7)    52 (98) 1.5 (0.9) 114 (79) - 40 (75) - MANOVA of the change 
scores with treatment, 
practice and gender as 
factors and initial EPQ 
score as a covariate 
F<1 
Note: Harvey et al summarised the baseline data as counselling median=10.5, range 1 to 21, no counselling median=12.0, range 2 to 19. The short-term outcomes were summarised as change scores with counselling mean= 
2.7 95% CI 1.6 to 3.7, no counselling mean=3.4, 95% CI 1.8 to 4.9; Hemmings summarised the short-term outcomes as adjusted mean change with counselling=0.54 and no counselling=0.52. 
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one might expect the treatment effect to vary over this timescale, particularly given 
the treatment duration, this could explain some of the heterogeneity in the treatment 
effects between studies. The predominant primary outcome was the Beck Depression 
Inventory323 (BDI), used within four315, 316, 319, 320 of the seven trials. Harvey et al317 
used the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), 
Boot et al314 the General Health Questionnaire (GHQ), and Hemmings318 the Symptom 
Index. The GHQ and the Symptom Index encompass more diverse symptom sets. 
 
4.3.2 Published Analyses 
 
The published summary data and analyses that pertain to the Bower and Rowland37 
meta-analysis (see Table 4.2) are given in Table 4.4. No allowance was made in any of 
the analyses for clustering of outcomes within counsellors. Nor was the extent of the 
clustering effect reported, or any consideration given to clustering when determining 
sample size. Despite this, some awareness of the implications of therapist variability 
was indicated in four of the reports314, 318-320 (see Box 4.1). Boot et al314 and King et 
al319 alluded to standardising treatments to remove between-therapist variability. This 
was achieved by selecting counsellors with similar expertise314, or by restricting the 
theoretical model counsellors could apply319. Simpson et al320 noted that the treatment 
delivered varied not only by randomised group but also with the theoretical model, 
categorising counsellors on this basis, and investigating the differences. Hemmings318 
reported using a preliminary test, but did not give any further details. In each case, 
there was a sense that more could have been done; Boot et al314 and Simpson et al320 
pointing to restrictions of sample size, and King et al319 to the methodology available. 
 
Box 4.1 Reported Handling of Clustering within Studies 
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Box 4.1 Continued… 
 
324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334    
It is clear from Table 4.4 that a number of the trials were subject to sizeable missing 
data problems. Last observation carried forward (LOCF) was used in King et al319, with 
analysis of complete cases used in the other trials. Neither approach is ideal, but for 
simplicity, and to be consistent with the published meta-analysis, the latter approach 
was adopted in subsequent chapters. Similarly, five of the trials described departures 
from the randomised intervention policies316-320, while Boot et al314 and Chilvers et al315 
did not report on this. No further consideration will be given to this within the thesis. 
 
4.4 The Individual-Patient-Data (IPD) 
 
The individual-patient-data relating to the seven trials in the example meta-analysis 
(Table 4.2) were sought from the trial teams. The Central Office for Research Ethics 
Committees (COREC) advised that ethical review was not required and that consent 
from the original researchers would be adequate. The Research and Development 
(R&D) office covering the South London & Maudsley NHS Trust and the Institute of 
Psychiatry confirmed that R&D approval would not be required. Consent was given for 
access to the Boot et al314 data by Pamela Gillies and to the Chilvers et al315 data by 
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Clair Chilvers. Peter Bower had used the individual-patient-data relating to Friedli et 
al316, Harvey et al317, King et al319 and Simpson et al320 previously335 and Chris Roberts 
had used a subset of the King et al319 data for a presentation336. Consent to access 
these datasets was given by Ian Harvey, Roslyn Corney, Sharon Simpson, Karin Friedli 
and Michael King. Counsellor identifiers were not available in the Friedli et al316 or 
Harvey et al317 data held by Peter Bower. They were imputed in the latter, using the 
GP practice as a proxy, based on a personal communication from Ian Harvey. Karin 
Friedli suggested that identifiers had been entered, but further communication with 
Michael King indicated they were no longer available electronically. Approval was given 
by the Patient Information Advisory Group (PIAG) to access identifiable data to re-
enter it in an anonymous form. This was used to create electronic datasets from the 
paper questionnaires archived by Michael King in relation to Friedli et al316, and by 
Adrian Hemmings in relation to Hemmings318. 
 
4.5 Summary of the Illustrative Example 
 
Accordingly, the illustrative example is characterised by the inclusion of randomised 
trials with partially nested designs. These create an intermediate level in the analysis 
between patients and studies in the intervention arm only. As none of the original 
analyses addressed the related clustering or between-arm heteroscedasticity, there is 
uncertainty over the accuracy of the published meta-analyses. With four of the trials 
including the Beck Depression Inventory, it was possible to demonstrate methods for 
combining standardised and absolute mean differences using the same example. The 
differences in treatment standardisation and the patient populations across studies 
meant that heterogeneity in the clustering effects was of interest. The main practical 
issue highlighted was the absence of estimates of the intra-counsellor correlation in all 
of the original papers, coupled with no details of the preliminary test carried out by 
Hemmings318. The consequences of this are considered in the next chapter. 
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5 META-ANALYSIS OF INTRACLASS CORRELATION 
COEFFICIENTS FROM NESTED THERAPIST DESIGNS 
 
5.1 Introduction 
 
Statistical dependence is created amongst the outcomes in randomised trials by cluster 
sampling of patients or by cluster allocation or delivery of treatments. The implications 
of clustering associated with therapists for the precision of treatment effect estimates 
have already been discussed in some detail286 (see Chapter 2). In brief, the penalties 
Cornfield337 described in relation to the cluster randomisation of treatments also apply 
where cluster allocation of treatments is non-random or multiple randomisations138 are 
employed. Additional sampling variation and reduced degrees of freedom are therefore 
expected. The argument has been made, principally by Crits-Christoph80, 97, that these 
penalties can be avoided in the design by “standardizing treatments through the use 
of treatment manuals and selection, training, certifying, monitoring, and supervising 
therapists before and during the conduct of an efficacy trial”97 (p. 520). If the therapist 
is to be included as a random effect, early advice79, 80 was to design a trial to include a 
large number of therapists. More recently, it has been recommended that researchers 
make appropriate allowance for therapist variation in their sample size calculations81-84, 
96, 97, 286, 336. If a trial has already been designed and analysed ignoring the potential 
clustering effects, re-analysis might be carried out with a view to assessing the 
sensitivity of the conclusions to the presence of clustering. This could be done for a 
particular trial, or in the context of a systematic review and meta-analysis of treatment 
effects. The size of the clustering effect may also be of interest in its own right. In 
each case estimates of the direction and magnitude of the clustering effect are needed 
which treat therapists as random effects, indexed by intraclass correlation coefficients 
(ICCs). 
 
Three empirical reviews have been published of the methods used to handle therapist 
variation in study reports. Martindale79 included psychotherapy studies published in the 
Journal of Abnormal Psychology during 1973 and 1974, and the Journal of Consulting 
and Clinical Psychology during 1975, but excluded brief and case reports. A decade on, 
Crits-Christoph and Mintz80 reviewed comparative studies of psychosocial interventions 
published between 1980 and February 1990 in the Journal of Consulting and Clinical 
Psychology, excluding 26 (19%) for completely confounding treatment and therapist 
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by involving one therapist per treatment or study. More recently, Lee and Thompson82 
reviewed all individually-randomised trials published in the British Medical Journal in 
2002. In contrast to previous reviews, they covered a broader range of medical areas 
and considered all sources of clustering. The principal action noted in all three reviews 
was for the studies to overlook therapists in analyses. Martindale79 found that 21 of 33 
studies (64%) did so. Crits-Christoph and Mintz80 reported a similar percentage (68%) 
for their 114 studies. Of the 17 studies with clustering by care provider located by Lee 
and Thompson82, all but one338 (94%) ignored it in their analysis. Nearly all the other 
studies carried out preliminary tests79, 80, 82, consistent with the early advice79, 80, 97, 
treating the therapist as a set of fixed effects. It is likely that some preliminary tests 
also went unreported by study investigators78. None of the reviews stated if details of 
the tests were given, or if the ICC or another proportion-of-variance-explained 
measure96, 339-344 was available. Nevertheless, it can be inferred that reporting of ICC 
estimates in the principal reports of psychotherapy trials is likely to be limited, a recent 
exception being found in Goodyer et al345. As a consequence, individual-patient-data 
(IPD) would ideally be sought to retrospectively estimate the ICC. 
 
A separate literature has developed within the psychotherapy field on therapist effects. 
This comprises case studies (e.g. Ricks54 and Strupp346-349), observational studies (e.g. 
Howard et al55, Orlinsky & Howard56, Brooker & Wiggins57 and McLellan et al60), as well 
as secondary analyses of randomised trials (e.g. Shapiro et al61, Blatt et al350, Project 
MATCH351 and Huppert et al352). The methods of analysis used are diverse, ranging 
from descriptive to fixed- and random-effects analyses. Measures of therapist effect 
are similarly diverse, with ICC estimates rarely reported. In 1997, a series of articles 
were published50, 353-357 highlighting the therapist as a neglected variable. Lambert and 
Okiishi356 suggested that the naturalistic datasets, collected by managed health care 
companies within the US, provide an opportunity that has been previously unavailable, 
owing to the much larger numbers of therapists and patients. Since then, Okiishi62, 358, 
Wampold and Brown64, Schoenwald et al359, Baldwin et al67, Lutz et al66, Stiles et al360 
and Dinger68 have analysed large naturalistic samples, contributing to a rising interest 
in the use of multilevel models in this context. This is echoed in recent re-analyses of 
the Treatment for Depression Collaborative Research Program trial and the associated 
commentaries69-77, 361. Accordingly, therapist ICC estimates are becoming increasingly 
available outside principal trial reports, offering a supplementary source when IPD are 
inaccessible. 
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A recent review of cluster-randomised trials found that 46% (27 of 59) involved fewer 
than 10 clusters per arm362. The widespread adoption of Crits-Christoph’s80, 97 advice to 
use standardisation to avoid clustering penalties means that the percentage of nested 
psychotherapy trials with less than 10 therapists per arm is likely to be higher. This is 
unfortunate because the precision of ICC estimates is a function of the number of 
clusters. Non-random allocation of psychotherapies to therapists along with differences 
in the therapist skills required means that between-treatment heterogeneity is to be 
anticipated in ICCs. Thus, while the assumption of a common ICC justifies pooling data 
across arms in cluster-randomised trials, this is more difficult to defend in randomised 
psychotherapy trials, adding to the imprecision with which ICCs are estimated in this 
context. One way of alleviating the limitations of single estimates might, therefore, be 
to pool them across studies. 
 
Blitstein et al38 described a random-effects meta-analytic approach for pooling multiple 
independent ICC estimates across cluster-randomised studies. This has the advantage 
of weighting each estimate by its precision incorporating between-study heterogeneity. 
It fails to consider a number of potential biases in the study estimates however, and to 
allow for variation in cluster sizes within the studies. It also assumes the within-cluster 
variance in each study is known. The aim of this chapter was therefore to extend and 
illustrate methods of obtaining and pooling ICC estimates arising from nested therapist 
designs. In each case, the proposed methods are contrasted with those used by Crits-
Christoph et al363 and Baldwin et al364, and illustrated using the counselling in primary 
care example introduced in Chapter 4. 
 
5.2 Strategies for Obtaining ICC Estimates 
 
The scarcity of published therapist ICC estimates led Crits-Christoph et al363 and more 
recently Baldwin et al364 to obtain the IPD relating to a number of psychotherapy trials. 
Crits-Christoph et al363 wished to summarise and explore predictors of the magnitude 
of ICC estimates. Baldwin et al364 started a public database, following similar efforts in 
other settings271, 365-376. In both cases the scope was deliberately broad. Crits-Christoph 
et al363 did not describe the criteria used to select the 15 studies they included; their 
sample was most probably chosen for reasons of convenience. In contrast, Baldwin et 
al364 specified their eligibility and search criteria. To be eligible, studies had to involve 
one or more interventions aimed to reduce an emotional or behavioural problem, each 
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with at least two therapists and two patients per therapist. Searches were of the 2003 
and 2004 issues of 8 journals for psychotherapy research. Of 38 studies identified, the 
authors of 19 (50%) supplied the summary data they requested. One study was then 
added to give a total of 20 studies. Crits-Christoph et al363 reported summary statistics 
only, so the best source of published ICC estimates is currently Baldwin et al364. Their 
search was limited however, placing restrictions on the completeness of their sample. 
Researchers wishing to use their database for a specific purpose are, therefore, still 
faced with issues of missing data. 
 
Heterogeneity is anticipated between ICC estimates for a variety of reasons, statistical 
and substantive. Numerous potential predictors of ICC estimates have been identified. 
For cluster-randomised studies, Blitstein et al38 suggested the outcome, its method of 
measurement, the patient and cluster samples, study design and method of estimation 
whilst Campbell et al367 considered the study setting, cluster size, type of outcome, its 
prevalence and method of measurement. In the psychotherapy setting, Crits-Christoph 
et al363 explored use of a treatment manual, average level of therapist experience, and 
length and type of treatment. The duration of follow-up may also be a factor. Although 
many of these predictors are at the study-level, therapist- and patient-level predictors 
are also possible. Eligibility criteria applied for a specific purpose are therefore likely to 
be narrower to ensure estimates are matched more closely to the planned or existing 
study and analysis. If these more restrictive criteria exclude all the published estimates 
additional assumptions will be required to make use of the database in Baldwin et 
al364. Even where some of the estimates do match criteria, researchers are faced with 
a trade-off between precision and validity. 
 
An alternative approach is to reduce the scope of the eligibility criteria, but extend the 
search, and obtain IPD in the context of systematic reviews. For counselling in primary 
care, for example, eligibility criteria for the studies mirror those used in the Cochrane 
review37. As none of the trials included in the review appear in Baldwin et al364, none 
of their estimates are strictly relevant for this example. As counselling involves the use 
of eclectic therapeutic approaches for a wide range of social and clinical problems, the 
study criteria relating to the treated problem and the treatment type might be relaxed. 
Large naturalistic studies could also be included. Fortunately, the main outcome in the 
example meta-analysis (Table 4.2) does appear in Baldwin et al364. As other outcomes 
do not, outcome criteria could be extended to include all scales measuring depression 
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and general mental health symptoms in the short-term. To justify the assumption that 
ICC estimates are independent, if multiple outcomes are available for a treatment arm 
within a study, the closest to the example meta-analysis might be included, excluding 
outcomes available for multiple informants, e.g. in Couples Therapy. Finally, to ensure 
the ICC reflects the example meta-analysis, it should have been estimated without any 
covariate adjustment. Estimates of this kind are “external” to the example and differ in 
their validity. Conversely, those found “internally”, in this case from the IPD, are valid 
but may be limited in their precision, even when pooled. In the example, two trials315, 
319 used a patient preference design322, so additional counselling arms were available. 
Precision could thus be maximised by extending the eligibility in the internal studies or 
by combining internal and external sources of ICC estimates. 
 
5.3 Methods for Pooling ICC Estimates 
 
5.3.1 Blitstein et al’s Random-Effects Meta-Analytic Approach 
 
Blitstein et al38 proposed the following random-effects meta-analysis model for cluster-
randomised trials, 
 
Hhehhh ,,1,ˆ K=++= ερρ     (5.1) 
 
where hρˆ  is the ICC estimate observed within study h . Under this model, each study 
has an associated population ICC hρ , which differs from the mean population ICC ρ , 
by hε  such that { }( )2,0~ hNh ετε , and from the observed ICC hρˆ  by he  such that 
{ }( )2,0~ heh Ne σ . Consequently, hε  denotes random variation at the study-level and he  
the sampling error, with { } in the subscript referring to the quantity the variance is 
of. The total variation of hρˆ  is thus { } { } { }222ˆ hhh eστ ερ +=Τ  where { }
2
hε
τ  and { }
2
he
σ  represent 
the between- and within-study variances respectively. 
 
In practice, Blitstein et al38 replaced the study estimate hρˆ  in (5.1) by 
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where hA,ρˆ  is the one-way analysis of variance (ANOVA) estimator given by 
 
( ) hhh
hh
hA MSWmMSB
MSWMSB
1
ˆ
,
−+
−
=ρ     (5.3) 
 
hMSB  and hMSW  are the mean squares between and within clusters, hm  is the 
cluster size, assumed to be equal within studies, and hF  is the F-ratio within study h . 
As Blitstein et al38 pooled transformed study estimates, hγˆ , not raw study estimates 
hρˆ , their meta-analysis model is more accurately 
 
Hhehhh ,,1,ˆ K=++= εγγ     (5.4) 
 
where { }( )2,0~ hNh ετε , { }( )2,0~ heh Ne σ  and { } { } { }222ˆ hhh eστ εγ +=Τ . 
 
The rationale Blitstein et al38 gave for using hγˆ  in place of hρˆ  was that, because hρˆ  is 
a proportion, its variance is a function of the parameter hρ . One consequence of this is 
that the pooled estimate can be unduly affected by a single study with a small ICC if 
raw estimates are meta-analysed371. Murray et al371 used the sample estimate in place 
of the population value when estimating the sampling variance. An alternative might 
have been to use an iterated estimate, replacing the population value by the latest 
pooled estimate in the second and subsequent iterations. Blitstein et al38 avoided the 
need for this, using a transformation intended to stabilise the variance across hρ . They 
gave the sampling variance of hγˆ , for cluster-randomised trials, as 
 
{ } ( ) { }SSBhh dfkfh
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2
ˆ
2
ˆ
=
−
=γσ      (5.5) 
 
where hf  is the number of trial arms and hk  is the number of clusters per arm, 
assumed equal across arms within studies, and { }SSBdf  are the degrees of freedom 
relating to the between-cluster sums of squares. 
 
The transformation in (5.2) closely resembles Fisher’s transformation377, given for one-
way ANOVA estimates as 
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Fisher377 suggested that the sampling distribution of hAz ,ˆ  approaches normality as the 
number of clusters hk  contributing to the estimate increases, with hk  given irrespective 
of the number of arms. Fisher377 gave the approximate sampling variance of hAz ,ˆ  as 
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While alternative approximations have been reported378, 379, they are also functions of 
the cluster size, reflecting the imprecision in the within-cluster variance contributing to 
the ICC. If ( )2−hk  in (5.7) is taken to be equal to { }SSBdf  then 
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Omitting the factor ( )( )1−hh mm will have little impact when cluster sizes are extremely 
large, as is often the case in cluster-randomised studies of communities, for example. 
However, it notably underestimates the sampling variance (>1%) if cluster sizes are 
less than 100, and does so by a sizeable amount (>10%) if they are less than 10. 
 
Blitstein et al38 estimated the between-study variance { }
2
hε
τ using DerSimonian-Laird’s380 
(D-L) method of moments estimator 
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which assumes the Q-statistic has an approximate non-central chi-squared distribution 
with 1−H  degrees of freedom and expectation { } { } ( )12ˆ −+ Hhh εγ τη . In this setting, 
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where hγ is the arithmetic mean of hγˆ  and the variation in the precision of the study 
estimates between studies is indexed by 
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It is evident from (5.10) and (5.11) that the D-L between-study variance estimate is a 
function of the absolute and relative sampling variance estimates { }
2
ˆ
he
σ  and { }hγη ˆ , 
respectively, and of the deviations of the study estimates from their mean, weighted 
by their estimated precisions, denoted by { }hQ γˆ . It is thus vulnerable to bias in the 
estimate of the sampling variance arising from the use of (5.5) when the cluster sizes 
are small or variable across studies. 
 
Blitstein et al38 gave the pooled estimate of γ  as the precision-weighted sum 
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estimating the study-specific weights and precisions respectively by 
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They then back-transformed the pooled estimate γˆ  onto the raw scale using38 
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taking variation in the cluster sizes between studies into account using38 
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5.3.2 Biases in Study Estimates 
 
5.3.2.1 Method of Estimation 
 
Although ANOVA estimates of the ICC are frequently used, Fisher381 originally derived 
the exact distribution of a pairwise estimator, given as the product-moment correlation 
averaged over all possible pairs of observations within clusters. This is the maximum-
likelihood estimator (MLE) if cluster sizes are equal within studies382. Fisher381 showed 
that this estimator has a negative bias arising from the “method of calculation” that is 
independent of the underlying ICC. He377 gave this for clusters of all sizes as 
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and suggested (pp. 224-5) that it arises because the ratio of the sums of squares, and  
by extension hzˆ , differs by a ratio of ( )1−hh kk  from the MLE to the ANOVA estimate. 
Wang et al383 have elaborated upon this explanation. 
 
Fisher377 gave the large-sample properties of the ANOVA estimate but did not consider 
a further bias in this case379, 383. One arises because the numerator and denominator of 
the ICC are not independent so the expectation of the ratio is not equal to the ratio of 
the expectations384. Ginsburg385 obtained the exact bias, but a simple approximation to 
this has been derived by Ponzoni and James384 as 
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assuming a one-way ANOVA with equal cluster sizes. It is generally negative, tending 
to zero as the number of clusters increases, but it can be positive if 0<hρ . In contrast 
to the previous bias, this is given on the raw scale and depends on the underlying ICC. 
It is affected by the number of clusters but also by their size. Wang et al383 showed 
that (5.17) performs well as an approximation with as few as five clusters, except if 
hρ  is also between 0.1 and 0.6. They went on to argue that the total bias for the MLE 
is given on the raw scale as 
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where hAhML ,, ˆˆ ρρ −  on the raw scale precisely equals (5.16) on Fisher’s z scale. 
It is apparent that both estimators tend to underestimate the population ICC when the 
number of clusters hk  is small. The extent of this bias varies according to the method 
of estimation but is consistently larger for the MLE383, 386. It is usually less than 10% 
for ANOVA estimates, even in small samples386. Fisher381 regarded the impact of the 
bias in (5.16) as relatively unimportant for single estimates, it being of higher order 
than the standard error, but did see it as a concern when 
 
“accurate comparisons are made between correlations, and especially averages of 
correlations, which have perhaps been calculated from samples of different sizes, 
or by different methods.” (Fisher381 p.235) 
 
Ponzoni and James384 have expressed a similar view in relation to (5.17). Corrections 
could be made for these biases by subtracting the relevant bias from the raw estimate. 
As (5.17) depends on the underlying ICC, the study estimates could be used initially in 
place of the population parameter, with subsequent iterations substituting the pooled 
estimate for the population parameter. 
 
5.3.2.2 Skewed Sampling Distribution 
 
Fisher’s transformation377, 381 is helpful not only in stabilising the asymptotic variance, 
but also in normalising the asymptotic sampling distribution, that is otherwise skewed. 
Konishi387 showed that Fisher’s transformation simultaneously achieves these two aims 
only when the clusters are of size two. He derived a normalising transformation for the 
general case, which Konishi and Gupta388 then used to recommend a modification to 
Fisher’s transformation377 where the ICC is estimated using maximum-likelihood. They 
adopted a different but equivalent parameterisation for hMLz ,ˆ  in which 
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with variance 
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They388 gave the bias in the expectation of hKGz ,ˆ  as 
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and suggested ( )hKGhKG zBiasz ,, ˆˆ −  as a modified transformation. 
 
It is apparent from (5.21) that the normal approximation of Fisher’s transformation377 
becomes less effective, not only as the number of clusters decreases377, but also as 
their size increases387. As such, the rate at which normality is approached using the 
classical transformation is less rapid when cluster sizes are greater than two377. The 
effect of the skew is to bias the ICC downward. As the approximate sampling variance 
Fisher377 gave depends on the validity of the normality assumption377, skew will affect 
its accuracy. In turn, the validity of the chi-squared test based on the Q-statistic, and 
the estimate of the between-study variance, will also be affected. 
 
If the Konishi-Gupta bias in (5.21) was simply a reflection of the skew in the sampling 
distribution it would equal zero when 2=hm . It is equal to hk21−  however, because 
Konishi387, 388 used the MLE in (5.19). The implication of this is that bias arising from 
the skew is given by 
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irrespective of the method of estimation. A correction could be made by subtracting 
the bias in (5.22) from Fisher’s classical transformed study estimate in (5.6). Similarly, 
the skew bias could be subtracted from the transformed method-corrected raw study 
estimate, giving a doubly-corrected estimate. The options are summarised in Table 5.1 
using Fisher’s parameterisation for ANOVA estimates. 
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Table 5.1 Bias Corrections for ANOVA Study Estimates 
Option Transformed Study Estimate 
No 
Correction 
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5.3.2.3 Bounds on Negative ICC Estimates 
 
The range an ICC takes depends on the model in which it is defined386. If a variance 
components model is adopted, the total outcome variance is given as the sum of the 
between- and within-cluster variances, and the ICC is defined as the proportion of this 
total that is between clusters, 
22
2
whbh
bh
h σσ
σρ
+
=  (5.23) 
 
As the between-cluster variance cannot be negative, neither can the ICC, so its range 
lies between zero and one. In the more general “common correlation model”389, 390, the 
ICC is specified directly (see Table 5.2). It is the design effect that cannot be negative 
here, so the lower limit of the ICC falls where the design effect is zero, i.e. where 
hρ ( )1/1 −−= hm . If clusters are of size two, the range of the ICC is 1± , but as the 
cluster size increases the minimum approaches zero. The models are equivalent when 
0≥hρ , making the choice of model irrelevant391. In general, however, the common 
correlation model is to be preferred because it allows for uncertainty in the direction of 
the underlying ICC. 
 
Table 5.2 Model Comparison based on a One-Way Analysis of Variance 
Expected Mean Squares Source of 
Variation 
Degrees of 
Freedom 
Mean 
Squares Under VCM Under CCM 
Between Clusters 1−hk  hMSB  22 bhhwh m σσ +  ( )( )hhth m ρσ 112 −+  
Within Clusters ( )1−hh mk  hMSW  2whσ  ( )hth ρσ −12  
Note: VCM is the Variance Components Model; CCM is the Common Correlation Model 
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The range estimates can take depends on the method of estimation386. The likelihood 
of obtaining negative ANOVA estimates due to sampling error is considerable when the 
population ICC is small and the number of clusters is too392. Negative ICC estimates 
are possible because ANOVA estimation is consistent with common correlation models. 
Restricting the mean squares to be non-negative is equivalent to restricting the design 
effect to be so, because the total variance is non-negative by definition. More extreme 
negative values are to be expected when cluster sizes are small because the minimum 
ICC estimate varies as a function of the cluster size. 
 
It is common for researchers to omit to report negative estimates or to censor them at 
zero393. One rationale for doing this could be to ensure consistency between the range 
of the estimates and that of the underlying parameter. Another could be to protect the 
Type I error rate. Murray et al394 have shown that nominal Type I and II error rates 
are obtained only when negative ICC estimates are allowed in the analysis. The reason 
for this can be seen in the simulations reported by Wang et al386. They compared 
ANOVA estimates to their exact distributions in small to moderate samples. Omitting 
negative estimates or censoring them at zero produced upward biases, which were 
substantial for small population ICCs and small samples. The total bias observed was a 
trade-off between the upward bias arising from bounding negative estimates and the 
downward bias arising from the method of estimation. Wang et al386 recommended 
that negative ICC estimates are reported and incorporated when pooling estimates. As 
only bounded estimates may be available, a comparison between this recommendation 
and the inclusion of censored estimates is of interest. 
 
5.3.3 Variability in Cluster Sizes within Studies 
 
The methods described thus far have all assumed the cluster sizes are equal within the 
studies. This is important because all the transformed study estimates are functions of 
the ratio hh MSWMSB which is distributed as ( )1,1 −− hhh mkkF  if this is the case. Where the 
clusters vary in size, this distributional property is lost unless 0=hρ , because hMSB  is 
no longer distributed as 2 1−hkχ . Extensions are therefore required for 0≠hρ . 
 
Wang et al386 suggested replacing hm  by 
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in the expectations for hMSB  (Table 5.2) and thus by extension in (5.3), (5.6), (5.7), 
(5.17) and (5.18). A similar suggestion has been made by Konishi et al395 and Donner 
and Zou396 in relation to (5.19) to (5.21). While estimates of the variance components 
provided using (5.24) are unbiased397, the ratio of mean squares is only approximately 
distributed ( )1,1 −− hhh mkkF . Thomas and Hultquist
398 proposed an alternative approximation 
to ( )1,1 −− hhh mkkF  in which hm  is replaced by the harmonic mean 
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and the sample variance of the cluster means replaces hMSB  in the numerator of F . 
As a variance cannot be negative, this approximation is appropriate only when 0ˆ ≥hρ . 
Both approximations were compared to the exact results399, 400 by Donner et al401 for 
unequal family sizes. They found that (5.24) was increasingly unsatisfactory as the ICC 
increased, the reverse being true for (5.25). Both approximations were less adequate 
when the degree of imbalance increased. 
 
Baldwin et al364 replaced hm  by the harmonic mean. It is unclear whether hMSB  was 
also replaced by the sample variance of the cluster means. While exact results would 
be ideally used401, hm0ˆ  was substituted here because it involves a simple modification, 
the ICC is expected to be small and negative ICC estimates are likely. It is of note that 
the arithmetic mean of the cluster sizes hm  will be close to hm0ˆ  unless there is 
substantial variability in the cluster sizes. 
 
5.4 Application to Counselling in Primary Care 
 
The methods described apply to cluster-randomised trials, where the assumption that 
the ICC is common to all treatment arms permits pooling across arms within studies. A 
trivial extension, when between-arm heterogeneity is anticipated, is to restrict the data 
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on an arm-by-arm basis and calculate treatment-specific estimates. As counsellors are 
involved in the counselling but not the control arms, the methods were applied only to 
the counselling arms. Consequently, the number of study arms 1=hf  and hk  refers to 
the number of counsellors per study. 
 
5.4.1 External Study Estimates 
 
The first step was to extract relevant ICC estimates from Baldwin et al364 (see Table 
5.3). Of the 343 estimates reported, 322 (94%) were excluded (172 for adjusting for 
the corresponding baseline, 134 for having dissimilar outcomes, and 16 to avoid there 
being multiple estimates for arms within studies). The 21 remaining estimates related 
to 14 psychotherapy studies. The outcome that was most frequently observed was the 
Beck Depression Inventory (BDI). The Symptom Checklist-90, Brief Symptoms Index, 
and Life Style Questionnaire are comparable to the Symptom Index. The studies were 
predominantly small and the number of therapists per arm ranged from 2 to 581. The 
mean cluster size across arms ranged from 2.5 to 18.4 and the estimates ranged from 
-0.23 to 0.53. By far the most precise ICC estimate is given by Wampold and Brown64. 
They censored their sample excluding data linked to therapists who saw less than four 
patients. This apart, it is perhaps the most relevant external estimate for counselling in 
primary care. This is because the treatments were heterogeneous, as were the treated 
problems. US outpatient psychotherapy services also broadly resemble the counselling 
services in primary care in the UK. 
 
5.4.2 Internal Study Estimates 
 
The second step was to obtain ICC estimates relating to the example meta-analysis37 
(see Table 5.4)*. To begin with this was accomplished with the sample variances in the 
published reports and an estimator proposed by Kwong and Higgins39. Subsequently, 
the IPD was used to estimate the ICC directly. Due to the convergence problems that 
were encountered using ML and restricted ML estimation in this context, ANOVA is the 
only method reported. As further data was available within the studies, the third step 
was to obtain ICC estimates for all the available data. These are given in the appendix 
(see Section 5.6). The ten patients Hemmings318 had omitted were included, as were
                                          
* Counsellor IDs were missing for 7 and 11 patients with outcome data for King et al319 and 
Simpson et al320 respectively. These patients were excluded from all analyses of the IPD. 
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Table 5.3 Relevant External ICC Estimates taken from Baldwin et al364 
Study Study Type hN  hik  hm  Treated Problem Manual  Used Outcome Treatment 
ρ  
(Residual Error) 
BDI Intensive Exposure 0.183  (53.16) 
Abramowitz et al402 Efficacy 40 5.0 2.87 
Obsessive Compulsive 
Disorder 
Yes 
BDI Twice-Weekly Exposure 0.532  (50.44) 
Carlbring et al403 Efficacy 30 3.0 7.43 Panic Disorder Yes 
BDI Internet Cognitive 
Behavior Therapy 
-0.137  (75.32) 
Ehlers et al404 Efficacy 28 3.0 8.31 
Posttraumatic Stress 
Disorder 
Yes 
BDI 
Cognitive Therapy -0.093  (43.39) 
BDI 2-Session Motivational 
Enhancement Therapy 
0.022  (68.81) Marijuana Treatment  
Project Research 
Group405 
Efficacy 276 12.0 7.04 Cannabis Dependence Yes 
BDI 9-Session Motivational 
Enhancement Therapy 
-0.022  (58.91) 
BDI EMDR 0.005  (76.72) 
BDI Exposure 0.130  (134.11) Taylor et al406 Efficacy 60 2.0 7.75 
Posttraumatic Stress 
Disorder 
Yes 
BDI Relaxation -0.180  (191.82) 
BDI Cognitive Therapy -0.208  (52.28) 
van Minnen et al407 Efficacy 15 5.0 2.51 Trichotillomania Yes 
SCL-90 Behavior Therapy -0.226  (1259.54) 
BDI Cognitive Behavior 
Therapy 
-0.013  (133.30) 
Watson et al408 Efficacy 66 7.5 4.25 Depression Yes 
BDI Process-Experiential 
Therapy 
0.021  (125.74) 
Kuyken409 Effectiveness 105 20.0 3.32 Depression Yes BDI-II Cognitive Therapy 0.051  (153.78) 
Lincoln et al410 Effectiveness 147 9.5 2.92 Social Phobia No 
BDI Cognitive Behavior 
Therapy 
-0.133  (81.00) 
Merrill et al411 Effectiveness 186 8.0 17.19 Depression Yes BDI Cognitive Therapy 0.028  (104.55) 
Trepka et al412 Effectiveness 30 6.0 4.18 Depression Yes BDI Cognitive Therapy 0.183  (127.06) 
Lange et al413 Efficacy 69 18.0 2.92 
Posttraumatic Stress 
Disorder 
Yes 
SCL-90 
Depression 
Interapy 0.058  (117.86) 
BSI 
Structural Ecosystems 
Therapy 
-0.054  (0.61) 
Szapocznik et al414 Efficacy 129 3.0 18.40 
HIV-Positive African 
Americans: Distress, 
Hassles, Support 
Yes 
BSI 
Person Centered 
Approach 
-0.023  (0.43) 
Wampold & Brown64 Effectiveness 6146 581.0 9.68 Mixed No LSQ Treatment as Usual 0.078 (288.59) 
 
Note. All studies have nested or partially nested designs. Nh = total sample size; khi = Mean number of therapists contributing to any given ICC; hm  = Mean number of patients per therapist 
contributing to any given ICC; ρ =ICC post-treatment; BDI = Beck Depression Inventory; SCL-90 = Symptoms Checklist-90; BSI = Brief Symptoms Index; LSQ = Life Style Questionnaire 
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Table 5.4 Internal ICC Estimates for the Short-Term Mental Health Outcomes reported in Bower & Rowland37 
Non-Censored Estimates:   
Raw Scale  Transformed Scale 
Study 
Kwong & 
Higgins 
Estimate 
ANOVA 
Estimate 
Method 
Corrected 
ANOVA 
Estimate  
Kwong & 
Higgins 
Estimate 
ANOVA 
Estimate 
Method 
Corrected 
ANOVA 
Estimate 
Skew 
Corrected 
ANOVA 
Estimate 
Doubly 
Corrected 
ANOVA 
Estimate 
Boot 1994 -0.659 -0.029 -0.029  - -0.217 -0.220 -0.098 -0.101 
Chilvers 2001 0.249 0.290 0.308  0.318 0.370 0.394 0.385 0.409 
Friedli 1997 -0.842 -0.023 -0.023  - -0.162 -0.163 -0.015 -0.016 
Harvey 1998 -0.220 0.090 0.094  - 0.308 0.320 0.369 0.381 
Hemmings 1997 -0.621 -0.022 -0.022  - -0.774 -0.781 -0.558 -0.564 
King 2000 -1.622 -0.140 -0.144  - -0.296 -0.306 -0.269 -0.279 
Simpson 2000 0.275 0.045 0.047  0.733 0.172 0.180 0.241 0.249 
Negative Raw Estimates Censored at Zero:  
 
 
Raw Scale  Transformed Scale 
Study 
Kwong & 
Higgins 
Estimate 
ANOVA 
Estimate 
Method 
Corrected 
ANOVA  
Estimate  
Kwong & 
Higgins 
Estimate 
ANOVA 
Estimate 
Method 
Corrected 
ANOVA 
Estimate 
Skew 
Corrected 
ANOVA 
Estimate 
Doubly 
Corrected 
ANOVA 
Estimate 
Boot 1994 0.000 0.000 0.001  0.000 0.000 0.004 0.118 0.122 
Chilvers 2001 0.249 0.290 0.308  0.318 0.370 0.394 0.385 0.409 
Friedli 1997 0.000 0.000 0.001  0.000 0.000 0.007 0.147 0.154 
Harvey 1998 0.000 0.090 0.094  0.000 0.308 0.320 0.369 0.381 
Hemmings 1997 0.000 0.000 0.000  0.000 0.000 0.005 0.216 0.221 
King 2000 0.000 0.000 0.001  0.000 0.000 0.002 0.027 0.029 
Simpson 2000 0.275 0.045 0.047  0.733 0.172 0.180 0.241 0.249 
 
Note. The study ICC estimates were used in place of the population parameter in the bias for the method of estimation384. The formulae used to implement 
the bias corrections can be found in Table 5.1. The raw scale refers to the ICC scale; the transformed scale refers to Fisher’s classical z scale.   
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patients in the patient preference arms of Chilvers et al315 and patients that had been 
randomised between counselling and cognitive behavioural therapy in King et al319. As 
data was available for multiple time-points and for other outcomes, this was included 
as well, although not in the meta-analyses which follow. The counsellors in Chilvers et 
al315 and King et al319 delivered counselling in all the counselling arms in those studies. 
The same was true of the psychotherapists and cognitive behavioural therapy for King 
et al319. Data in these arms were pooled to avoid creating a spurious rise in the 
number of clusters and dependencies between the clusters. The effect this had was to 
increase the cluster sizes in these studies. As this, in turn, affects the range estimates 
can take, they were brought towards the null. It is apparent from the cluster size 
averages given in the appendix that variable cluster sizes were an issue for Chilvers et 
al315 and King et al319. 
 
The estimator suggested by Kwong and Higgins39 for the clustered arm of a partially 
nested trial is given by 
2
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2
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h
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h
s
ss −
=ρ      (5.26) 
 
where 21hs  refers to the naïve variance in the clustered arm and 
2
0hs  to the variance in 
the non-clustered arm. The conditions under which (5.26) was recommended are very 
restrictive, however. Kwong and Higgins39 argued that 20hs  estimates
2
1whσ , the within-
cluster variance in the clustered arm, when a random coefficient model is appropriate 
(see Model 2.6), and that 21hs  estimates
2
1thσ , the total variance in the clustered arm, 
when the cluster sizes are approximately equal, the ICC is not large and the number of 
clusters is not small. The rationale for the latter is that the bias in 21hs  will be small in 
these circumstances, as can be seen from its expectation 
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with 1hn  denoting the sample size in the clustered arm. This resembles the expectation 
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of the pooled naïve variance given assuming a random intercept model (Model 2.2) by 
White and Thomas42 (p.151) and Hedges415 (p.156). When the cluster sizes vary, 1hm  
is replaced in (5.27) by 
 
1
1
2
1
1
h
k
j
jh nm
h
∑
=
     (5.28) 
 
where (5.28) is a simple adaptation of Formula (15) in Hedges416. 
 
On the basis of their simulation study, Roberts and Roberts84 advised against adopting 
a random coefficient model for partially nested trials. It is clear from (5.26) that when 
2
0
2
1 hwh ss <  the estimate will be biased downwards and when 
2
0
2
1 hwh ss >  it will be biased 
upwards. If 2 1whs  is unknown, the extent of this bias is also. While misspecification of 
the model clearly affects the magnitude of the estimate, it also affects the limits it can 
take. These are wider for (5.26) than they are for the underlying ICC, in part because 
of sampling variation. It is evident from (5.27) that the direction of the bias in 21ˆ thσ  
depends on the direction of 1hρ , which is also unknown. Its impact is less conspicuous, 
having opposite effects in the numerator and denominator of (5.26). While (5.26) has 
an obvious practical appeal, these biases make it a theoretically unattractive estimator. 
The other properties of its sampling distribution are also unclear. 
 
The one-way ANOVA estimator in the clustered arm i  of study h  is given by 
 
( ) hihihi
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hiA MSWmMSB
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1ˆ
ˆ
0
,
−+
−
=ρ    (5.29) 
 
It can be seen in Table 5.4 that the raw estimates were negative in a number of trials, 
partly accounting for the computational problems experienced. The estimates obtained 
using Kwong and Higgins’39 estimator differ considerably from the ANOVA estimates. 
In five of the seven trials, they were below the theoretical lower limit of ( )1ˆ/1 0 −− him , 
so that Fisher’s transformation cannot be applied. The bias was downward for all but 
Simpson et al320. It was least extreme for Chilvers et al315. These results support the 
recommendation given by Roberts and Roberts84 to adopt a two-level heteroscedastic 
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model (Model 2.7) for partially nested trials. They also show that access to the IPD is 
likely to be necessary to accurately estimate internal ICCs. 
 
The fourth step was to obtain unbiased study estimates to combine on Fisher’s z-scale. 
While this was done for the internal and the external estimates, it is illustrated for the 
internal estimates relating to the example meta-analysis only (Table 5.4). The negative 
estimates were censored at zero. Censored and non-censored ANOVA estimates were 
then corrected for the bias arising from the method of estimation and the skew in the 
sampling distribution. The former was done on the raw scale. The estimates were then 
transformed onto Fisher’s z scale, and the skew corrected on this scale. In the case of 
the external estimates, the corrected estimates were also averaged across arms on the 
z-scale within studies. Only a simple mean was possible, because Baldwin et al364 gave 
the size and number of clusters averaged across arms. 
 
Bias arising from the method of estimation had little impact on the ANOVA estimates, 
as was expected. Use of study estimates in place of population values, and of Ponzoni 
and James’384 approximation as opposed to the exact bias, leads to some residual bias, 
but this is not expected to be important383. The differences that were observed largely 
reflect the size and direction of the ANOVA estimates. The impact of this bias in this 
example would have been comparable for all of the studies if a common ICC had been 
assumed. Bias arising from the skew had a more discernible effect, particularly where 
trials had larger cluster sizes. The average cluster size him0ˆ was very small in Chilvers 
et al315 and King et al319, which is why the bias is less appreciable in these trials. The 
small number of large clusters in Hemmings318 is why the bias is most extreme in this 
trial. Censoring negative estimates at zero decreased the variation in the estimates 
across studies. The upward bias that resulted partly offset the downward bias from the 
skew. The doubly-corrected non-censored ANOVA estimates are theoretically the least 
biased on the z-scale. As such, they are the preferred estimates for pooling. 
 
5.4.3 Sampling Variances of the Transformed Study Estimates 
 
The fifth step was to obtain sampling variances for the study estimates on the z-scale. 
Again, this was done for the internal and the external estimates. It is illustrated for the 
internal estimates relating to the example meta-analysis in Table 5.5. The transformed 
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scales are not the same in Blitstein et al38 (5.5) and Fisher377 (5.7). The former is given 
on Fisher’s z-scale to allow the comparison to be direct.  
 
Table 5.5 Sampling Variances of the Transformed Study Estimates 
Blitstein et al38 Fisher377 
Study ( )12
1
−hh kf
 ( )( )212 −− hh
h
km
m
 
Ratio 
Boot 1994 0.125 0.181 0.69 
Chilvers 2001 0.038 0.066 0.58 
Friedli 1997 0.167 0.272 0.61 
Harvey 1998 0.063 0.081 0.77 
Hemmings 1997 0.250 0.514 0.49 
King 2000 0.042 0.063 0.66 
Simpson 2000 0.071 0.094 0.76 
 
It is clear from Table 5.5 that Blitstein et al’s38 estimator underestimates the sampling 
variance to differing degrees across the studies, as a function of both the number of 
clusters and their size. This is important because studies are weighted by the inverse 
of these estimates. The choice of estimator affects the relative weight of each study, 
with Blitstein et al’s38 estimator giving more weight to Hemmings318 but less weight to 
Boot et al314, Harvey et al317 and to Simpson et al320. 
 
5.4.4 Comparison of Pooled Estimates 
 
The final step was to pool the study estimates (Table 5.6). The naïve method used by 
Crits-Christoph et al363 was to average the ICC estimates within the studies, and then 
across them. This is compared to the method proposed by Blitstein et al38 and used by 
Baldwin et al364. The first modification was to replace the sampling variance suggested 
by Blitstein et al38 with the approximation suggested by Fisher377. Subsequently, study 
estimates were additionally replaced by their bias-corrected counterparts. Fisher’s377 z-
scale was used throughout, to again enable the comparisons to be direct. In each case 
the pooled estimate is given on the transformed scale, together with its standard error 
and the D-L380 estimate of between-study heterogeneity. The Q-statistic is given with 
its associated degrees of freedom and p-value as well. The z-transformation was then 
inversed, with the respective pooled estimate inserted to give the pooled ICC estimate. 
This process was repeated for censored and non-censored estimates and for the four 
sources of ICC estimates. 
 
The pooled ICC estimates vary according to the method used. It can be seen that use
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Table 5.6 Pooled ICC Estimates for the Short-Term Mental Health Outcomes reported in Bower & Rowland37 
Non-Censored Censored 
Transformed Scale Transformed Scale 
Method 
Pooled 
Estimate 
Standard 
Error 
Between-Study  
Heterogeneity  
2
zˆτ  
Pooled 
ICC 
Estimate 
Pooled 
Estimate 
Standard 
Error 
Between-Study  
Heterogeneity 
2
zˆτ  
Pooled 
ICC 
Estimate 
SOURCE: INTERNAL #1 (MAIN COUNSELLING ARM)     
Naïve - - - 0.030 - - - 0.061 
Blitstein et al  0.000 0.151 0.075 (Q(6)=11.93, p=0.06) 0.000 0.173 0.101 0.000 (Q(6)=2.81, p=0.83) 0.036 
Fisher’s Transformation 0.038 0.143 0.028 (Q(6)=7.49, p=0.28) 0.007 0.172 0.124 0.000 (Q(6)=1.79, p=0.94) 0.036 
Method-Corrected 0.046 0.140 0.023 (Q(6)=7.20, p=0.30) 0.009 0.181 0.124 0.000 (Q(6)=1.66, p=0.95) 0.038 
Skew-Corrected 0.106 0.127 0.005 (Q(6)=6.24, p=0.40) 0.021 0.230 0.124 0.000 (Q(6)=1.37, p=0.97) 0.050 
Doubly-Corrected 0.112 0.124 0.000 (Q(6)=6.02, p=0.42) 0.022 0.239 0.124 0.000 (Q(6)=1.33, p=0.97) 0.052 
SOURCE: INTERNAL #2 (ALL AVAILABLE COUNSELLING ARMS)     
Naïve - - - 0.011 - - - 0.029 
Blitstein et al  0.036 0.107 0.014 (Q(6)=7.24, p=0.30) 0.006 0.132 0.093 0.000 (Q(6)=1.57, p=0.95) 0.023 
Fisher’s Transformation 0.064 0.107 0.000 (Q(6)=5.35, p=0.50) 0.011 0.137 0.107 0.000 (Q(6)=1.20, p=0.98) 0.024 
Method-Corrected 0.068 0.107 0.000 (Q(6)=5.05, p=0.54) 0.011 0.142 0.107 0.000 (Q(6)=1.11, p=0.98) 0.025 
Skew-Corrected 0.116 0.107 0.000 (Q(6)=3.94, p=0.68) 0.020 0.189 0.107 0.000 (Q(6)=0.96, p=0.99) 0.035 
Doubly-Corrected 0.120 0.107 0.000 (Q(6)=3.73, p=0.71) 0.021 0.193 0.107 0.000 (Q(6)=0.96, p=0.99) 0.036 
SOURCE: EXTERNAL (VARIOUS TREATMENTS)     
Naïve - - - 0.009 - - - 0.059 
Blitstein et al  -0.069 0.198 0.466 (Q(13)=212.81, p<0.01) -0.019 0.134 0.095 0.066 (Q(13)=41.41, p<0.01) 0.042 
Fisher’s Transformation -0.049 0.220 0.553 (Q(13)=185.45, p<0.01) -0.014 0.136 0.106 0.074 (Q(13)=36.15, p<0.01) 0.043 
Method-Corrected -0.033 0.211 0.503 (Q(13)=169.69, p<0.01) -0.009 0.159 0.092 0.043 (Q(13)=26.55, p=0.01) 0.051 
Skew-Corrected 0.034 0.182 0.351 (Q(13)=122.49, p<0.01) 0.010 0.279 0.029 0.000 (Q(13)=12.90, p=0.46) 0.097 
Doubly-Corrected 0.050 0.174 0.311 (Q(13)=109.92, p<0.01) 0.015 0.282 0.029 0.000 (Q(13)=9.03, p=0.77) 0.098 
SOURCE: COMBINED (INTERNAL #2 PLUS EXTERNAL)     
Naïve - - - 0.010 - - - 0.049 
Blitstein et al  -0.047 0.136 0.304 (Q(20)=207.52, p<0.01) -0.010 0.133 0.070 0.042 (Q(20)=46.23, p<0.01) 0.032 
Fisher’s Transformation -0.026 0.149 0.348 (Q(20)=179.63, p<0.01) -0.006 0.138 0.078 0.044 (Q(20)=40.26, p<0.01) 0.034 
Method-Corrected -0.012 0.144 0.316 (Q(20)=164.96, p<0.01) -0.003 0.156 0.070 0.027 (Q(20)=32.45, p=0.04) 0.039 
Skew-Corrected 0.059 0.123 0.206 (Q(20)=114.26, p<0.01) 0.013 0.273 0.028 0.000 (Q(20)=14.79, p=0.79) 0.074 
Doubly-Corrected 0.072 0.117 0.181 (Q(20)=102.85, p<0.01) 0.017 
 
0.276 0.028 0.000 (Q(20)=11.57, p=0.93) 0.075 
Note: The first iteration pooled estimate was used in place of the population parameter in the Ponzoni and James384 approximation to the bias arising from use of ANOVA as a method of estimation.  
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of Blitstein et al’s38 estimate of the sampling variance of the transformed ICC estimates 
inflates the Q-statistic, and hence the D-L380 estimate of between-study heterogeneity. 
To a lesser extent so does bias in the transformed ICC estimates. In this example, the 
consequence is that the pooled ICC estimate is biased downward. Censoring negative 
ICC estimates at zero had the reverse effect, upwardly biasing the pooled estimate. 
This is because of the upward bias in the study estimates and an artificial reduction in 
between-study heterogeneity. It is of note that there was no heterogeneity between 
studies, in the internal estimates relating to the example meta-analysis, when the bias 
was removed. This implies that the range of ICC estimates observed is compatible 
with sampling variation alone, and that a fixed-effects meta-analysis model may be 
sufficient. 
 
The non-censored doubly-corrected pooled ICC estimates do not vary much according 
to the source. When comparing the internal estimates, a trade-off is apparent between 
the impact of misspecifying the sampling variance and the skew that appears to cancel 
out in this example. Larger cluster sizes in the available internal data reduce bias from 
the former but increase it from the latter. Nevertheless, they do increase the precision 
of the pooled estimates. The naïve estimates can be seen to be both downwardly and 
upwardly biased, and to vary more according to the source. This is because they take 
no account of the relative precisions of the estimates or of the shape of their sampling 
distribution, so are more sensitive to outliers and to the extent of the skew. The clear 
heterogeneity amongst the external and combined studies is investigated next. 
 
5.4.5 Sources of Between-Study Heterogeneity 
 
The external estimate given by Wampold and Brown64 could be regarded an outlier, in 
the sense that treatment standardisation is minimal due to the naturalistic setting, but 
also because the number of contributing clusters exceeds that for all the other studies 
combined. At 0.078 it is also almost four times larger than the pooled internal estimate 
of 0.022. As such, its inclusion is one likely explanation for the heterogeneity apparent, 
so it was excluded (see Table 5.7). The other obvious reason for heterogeneity is the 
mixture of outcomes. Since the BDI is the predominant outcome, its ICC is of specific 
interest. The estimates relating to the BDI are therefore given in Table 5.8. It can be 
seen in Table 5.7 that excluding Wampold and Brown64 removed all the heterogeneity 
beyond that compatible with sampling variation. The pooled external ICC estimate 
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Table 5.7 Pooled ICC Estimates: Excluding Wampold & Brown64 
Non-Censored Censored 
Transformed Scale Transformed Scale 
Method 
Pooled 
Estimate 
Standard 
Error 
Between-Study 
Heterogeneity 
2
zˆτ  
Pooled 
ICC 
Estimate 
Pooled 
Estimate 
Standard 
Error 
Between-Study 
Heterogeneity 
2
zˆτ  
Pooled 
ICC 
Estimate 
SOURCE: EXTERNAL (VARIOUS TREATMENTS)  
Naïve - - - 0.004 - - - 0.057 
Blitstein et al  -0.043 0.100 0.060 (Q(12)=24.60, p=0.02) -0.013 0.096 0.065 0.000 (Q(12)=3.94, p=0.98) 0.031 
Fisher’s Transformation -0.015 0.097 0.032 (Q(12)=16.70, p=0.16) -0.005 0.094 0.077 0.000 (Q(12)=2.61, p=1.00) 0.030 
Method-Corrected 0.001 0.090 0.019 (Q(12)=14.80, p=0.25) 0.000 0.109 0.077 0.000 (Q(12)=2.86, p=1.00) 0.036 
Skew-Corrected 0.050 0.084 0.009 (Q(12)=13.41, p=0.34) 0.016 0.152 0.077 0.000 (Q(12)=3.65, p=0.99) 0.051 
Doubly-Corrected 0.062 0.077 0.000 (Q(12)=11.93, p=0.45) 0.020 0.167 0.077 0.000 (Q(12)=4.39, p=0.98) 0.057 
SOURCE: COMBINED (INTERNAL #2 PLUS EXTERNAL)  
Naïve - - - 0.006 - - - 0.047 
Blitstein et al  -0.016 0.074 0.040 (Q(19)=31.92, p=0.03) -0.003 0.108 0.053 0.000 (Q(19)=5.44, p=1.00) 0.026 
Fisher’s Transformation 0.013 0.070 0.014 (Q(19)=22.26, p=0.27) 0.003 0.109 0.062 0.000 (Q(19)=3.75, p=1.00) 0.027 
Method-Corrected 0.028 0.064 0.003 (Q(19)=19.60, p=0.42) 0.006 0.119 0.062 0.000 (Q(19)=3.83, p=1.00) 0.029 
Skew-Corrected 0.074 0.062 0.000 (Q(19)=17.52, p=0.55) 0.018 0.165 0.062 0.000 (Q(19)=4.57, p=1.00) 0.042 
Doubly-Corrected 0.083 0.062 0.000 (Q(19)=15.48, p=0.69) 0.020 
 
0.175 0.062 0.000 (Q(19)=5.20, p=1.00) 0.045 
Note: The first iteration pooled estimate was used in place of the population parameter in the Ponzoni and James384 approximation to the bias arising from use of ANOVA as a method of estimation. 
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Table 5.8 Pooled ICC Estimates: Restricted to the Beck Depression Inventory (BDI) 
Non-Censored Censored 
Transformed Scale Transformed Scale 
Method 
Pooled 
Estimate 
Standard 
Error 
Between-Study  
Heterogeneity 
2
zˆτ  
Pooled 
ICC 
Estimate 
Pooled 
Estimate 
Standard 
Error 
Between-Study  
Heterogeneity 
2
zˆτ  
Pooled 
ICC 
Estimate 
SOURCE: INTERNAL #1 (MAIN COUNSELLING ARM)  
Naïve - - - 0.043 - - - 0.084 
Blitstein et al  0.044 0.179 0.063 (Q(3)=6.09, p=0.11) 0.015 0.172 0.120 0.000 (Q(3)=2.00, p=0.57) 0.061 
Fisher’s Transformation 0.046 0.171 0.025 (Q(3)=3.80, p=0.28) 0.015 0.163 0.149 0.000 (Q(3)=1.20, p=0.75) 0.058 
Method-Corrected 0.051 0.170 0.024 (Q(3)=3.76, p=0.29) 0.017 0.174 0.149 0.000 (Q(3)=1.15, p=0.77) 0.062 
Skew-Corrected 0.091 0.167 0.020 (Q(3)=3.65, p=0.30) 0.031 0.206 0.149 0.000 (Q(3)=1.02, p=0.80) 0.075 
Doubly-Corrected 0.096 0.167 0.020 (Q(3)=3.62, p=0.31) 0.033 0.217 0.149 0.000 (Q(3)=1.01, p=0.80) 0.080 
SOURCE: INTERNAL #2 (ALL AVAILABLE COUNSELLING ARMS)  
Naïve - - - 0.009 - - - 0.028 
Blitstein et al  0.054 0.107 0.000 (Q(3)=2.83, p=0.42) 0.014 0.117 0.107 0.000 (Q(3)=0.76, p=0.86) 0.032 
Fisher’s Transformation 0.060 0.121 0.000 (Q(3)=2.19, p=0.53) 0.016 0.121 0.121 0.000 (Q(3)=0.59, p=0.90) 0.033 
Method-Corrected 0.063 0.121 0.000 (Q(3)=2.12, p=0.55) 0.016 0.125 0.121 0.000 (Q(3)=0.55, p=0.91) 0.034 
Skew-Corrected 0.100 0.121 0.000 (Q(3)=1.89, p=0.60) 0.027 0.161 0.121 0.000 (Q(3)=0.47, p=0.92) 0.045 
Doubly-Corrected 0.103 0.121 0.000 (Q(3)=1.85, p=0.60) 0.028 0.165 0.121 0.000 (Q(3)=0.47, p=0.93) 0.046 
SOURCE: EXTERNAL (VARIOUS TREATMENTS)  
Naïve - - - 0.025 - - - 0.069 
Blitstein et al  0.029 0.105 0.040 (Q(9)=15.11, p=0.09) 0.010 0.112 0.075 0.000 (Q(9)=3.70, p=0.93) 0.038 
Fisher’s Transformation 0.055 0.087 0.000 (Q(9)=8.89, p=0.45) 0.018 0.108 0.087 0.000 (Q(9)=2.47, p=0.98) 0.037 
Method-Corrected 0.069 0.087 0.000 (Q(9)=7.19, p=0.62) 0.023 0.124 0.087 0.000 (Q(9)=2.82, p=0.97) 0.043 
Skew-Corrected 0.109 0.087 0.000 (Q(9)=7.70, p=0.56) 0.037 0.167 0.087 0.000 (Q(9)=3.48, p=0.94) 0.059 
Doubly-Corrected 0.122 0.087 0.000 (Q(9)=6.48, p=0.69) 0.042 0.182 0.087 0.000 (Q(9)=4.29, p=0.89) 0.066 
SOURCE: COMBINED (INTERNAL #2 PLUS EXTERNAL)  
Naïve - - - 0.020 - - - 0.057 
Blitstein et al  0.037 0.076 0.021 (Q(13)=17.89, p=0.16) 0.011 0.114 0.061 0.000 (Q(13)=4.35, p=0.99) 0.036 
Fisher’s Transformation 0.057 0.071 0.000 (Q(13)=11.02, p=0.61) 0.017 0.113 0.071 0.000 (Q(13)=2.95, p=1.00) 0.035 
Method-Corrected 0.066 0.071 0.000 (Q(13)=9.38, p=0.74) 0.020 0.124 0.071 0.000 (Q(13)=3.21, p=1.00) 0.039 
Skew-Corrected 0.106 0.071 0.000 (Q(13)=9.49, p=0.74) 0.033 0.165 0.071 0.000 (Q(13)=3.85, p=0.99) 0.054 
Doubly-Corrected 0.115 0.071 0.000 (Q(13)=8.36, p=0.82) 0.036 
 
0.176 0.071 0.000 (Q(13)=4.61, p=0.98) 0.058 
Note: The first iteration pooled estimate was used in place of the population parameter in the Ponzoni and James384 approximation to the bias arising from use of ANOVA as a method of estimation. 
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0.020 is very close to the pooled internal ICC estimates, and its standard error is 
smaller due to the larger number of external studies. The pooled combined ICC is 
identical, and its standard error smaller still. Even so, it is large enough to leave 
substantial uncertainty regarding the size of the mean population ICC. 
 
It is clear from Table 5.8 that the ICC estimates relating to the BDI were larger than 
those for other outcomes. As patient responses to broader outcomes can be expected 
to be more variable than those to more specific ones, the larger ICC seen in relation to 
the BDI is an intuitive consequence of lower within-cluster variation, but it may simply 
be a consequence of sampling variation. It is notable that there is some indication of 
heterogeneity between estimates from the internal studies when they are restricted to 
the BDI, although this vanishes when other counselling arms available are included. As 
effort was made to standardise the counselling given in Friedli et al316 and King et al319 
but not in Chilvers et al315 or Simpson et al320, the ICC might be expected to be larger 
for the latter two315, 320 due to higher between-counsellor variability. The non-censored 
doubly-corrected pooled ICC estimate was -0.058 for the former two316, 319 and 0.171 
for the latter two315, 320 using the main counselling arms, -0.027 and 0.071 respectively 
using available counselling arms, and 0.031 and 0.057 respectively using the combined 
internal and external BDI estimates. 
 
5.5 Discussion 
 
The current shortage of therapist ICC estimates has the potential to leave researchers 
guessing their size or using those from other settings319. While Baldwin et al364 have 
created the first public database of therapist ICC estimates, researchers with a specific 
purpose are still faced with the need to locate missing estimates. It was proposed that 
psychotherapy researchers continue their effort by obtaining the IPD and pooling ICCs 
in the context of systematic reviews. This alleviates some of the precision limitations of 
single estimates while avoiding the validity limitations of external estimates. It reduces 
the time spent searching for studies and arguably increases the incentive for trialists to 
make the IPD available. The collaborative group that is formed are then able to design 
and carry out more definitive trials, while updating the systematic review to assess the 
sensitivity of its conclusions to the presence of within-study clustering. Within the early 
phases, the cost implication of involving large numbers of therapists will inevitably lead 
trialists to search for ways of avoiding the clustering penalties. Standardisation is one 
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option, but it is only partially effective. An alternative would be to explore the use of a 
Bayesian approach and the more ad hoc df* method suggested by Blitstein et al38. 
 
The random-effects meta-analytic approach proposed by Blitstein et al38 was extended 
to allow for imprecision in the within-cluster variances, unequal cluster sizes within the 
study arms, and to correct for bias in the study estimates. It was suggested that if 
ICCs are to be pooled, this is done on Fisher’s z-scale using non-censored doubly-
corrected treatment-specific estimates, with cluster sizes given by him0ˆ  and weights 
given by the inverse of the sum of Fisher’s377 sampling variance and the D-L estimate 
of between-study heterogeneity. It was suggested that Fisher’s z-scale is an 
appropriate scale for the meta-analysis of ICCs because, unlike the raw ICC scale, it is 
unaffected by the cluster sizes within a particular study, ensuring the individual 
estimates are combined on a comparable scale across studies. This requires further 
support from simulation work. Approximations were used for the bias in the ANOVA 
estimate and for average cluster sizes, based on the literature383, 384, 386, 395, 396. While 
simulation studies have been reported383, 401 that suggest these approximations are 
reasonable in the current context, further work is needed to evaluate the extent of any 
residual bias in both the study and pooled estimates under conditions that are typical 
of psychotherapy trials. The adequacy of Fisher’s377 approximate sampling variance 
and of the D-L estimate also require further evaluation. 
 
Baldwin et al364 commented on the range of ICCs observed in the psychotherapy trials 
they reported being wider than that in public health or medicine. The counselling in 
primary care example suggests that this might be simply due to increased sampling 
variability, rather than to larger population values. The pooled estimate of 0.022 based 
on seven randomised trials involved 64 counsellors. In contrast, Wampold and Brown’s 
estimate of 0.078, based on a large naturalistic sample, involved 581 therapists. While 
it may be tempting to interpret this as indicative of a larger therapist effect in a clinical 
setting, the validity of any causal inferences depends on the allocation of therapists to 
patients being both concealed and random. Causal language is therefore inappropriate 
unless an appropriate experimental design has been used. Similarly, one might wish to 
conclude that the therapist ICC is 0.022 in the context of randomised trials. Unless the 
number of therapists involved in a trial is large, researchers should take account of 
sampling variation in the ICC when planning future trials or carrying out meta-analyses 
of existing ones. This could be achieved with a sensitivity analysis, or more formally by 
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adopting a Bayesian approach. 
 
The extension of the CONSORT statement to cluster-randomised trials417, 418 included a 
call to routinely report a coefficient of intraclass correlation for each primary outcome, 
in the form of an ICC or Hayes and Bennett’s419 coefficient of variation. Regrettably, a 
parallel call was not made in the extension for non-pharmacologic treatment trials85. 
Information was sought on the number of care providers, the cluster size distribution 
and the case volume for each treatment arm. However, it was not sufficiently explicit 
that the information supplied in the flow diagram should reflect the analyses reported. 
Case volume may not reflect trial volume where the care providers are part-time. Both 
are potentially of interest, but the latter is used to calculate the ICC and design effect. 
The number of patients allocated to care providers may be different from the number 
receiving treatment, followed-up, or analysed. The number followed-up and analysed 
may also change across outcomes and visits. While the summary statistics suggested 
in the CONSORT extension reflect recognition that the cluster size distribution is likely 
to be skewed, it would be helpful if the average cluster sizes directly applicable for use 
by meta-analysts and those performing sample size calculations115, 420 were reported as 
well. Consequently, it is recommended that non-censored ANOVA estimates of the ICC 
are routinely provided in the principal reports of psychotherapy trials, accompanied by 
the statistical model, number of therapists and average cluster size that relate to these 
estimates. 
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5.6 Appendix: Internal Study Estimates using All Available Data 
 
COUNSELLING IN PRIMARY CARE: INDIVIDUAL INTERNAL ESTIMATES POOLING ARMS WITHIN STUDIES 
Cluster Size 
Variable Visit Study 
Number 
of 
Clusters 
Arithmetic 
Mean  him0ˆ  
Harmonic 
Mean 
ANOVA 
Estimate  
of ICC MSW (Ratio with MSR) 
BDI Baseline Chilvers 2001 23 7.30 7.09 3.43 -0.034 61.39 (0.97) 
  Friedli 1997 4 17.50 15.27 13.28 -0.070 83.23 (0.98) 
  King 2000 14 7.79 6.06 2.07 -0.049 84.68 (1.08) 
  Simpson 2000 8 8.88 8.77 7.94 0.013 33.61 (1.03) 
 Week 8 Chilvers 2001 22 6.50 6.29 3.00 0.068 100.11 (0.99) 
 Month 3 Friedli 1997 4 14.75 12.19 10.28 -0.023 60.93 (0.55) 
 Month 4 King 2000 14 7.21 5.71 2.07 -0.055 72.89 (0.52) 
 Month 6 Simpson 2000 8 8.88 8.77 7.94 0.045 87.74 (1.33) 
 Month 9 Friedli 1997 4 15.50 12.74 10.83 -0.025 73.45 (0.64) 
 Month 12 Chilvers 2001 22 5.45 5.29 2.65 -0.015 132.91 (0.78) 
  King 2000 13 7.00 5.62 2.02 0.015 69.48 (0.97) 
    Simpson 2000 8 8.25 8.15 7.43 0.090 92.43 (1.25) 
HADS: Depression Baseline Harvey 1998 9 11.00 10.39 4.21 0.031 16.87 (0.99) 
 Month 4 Harvey 1998 9 9.11 8.64 3.93 0.090 19.28 (0.76) 
GHQ Baseline Boot 1994 5 21.40 20.11 15.43 0.000 45.58 (1.05) 
  Week 6 Boot 1994 5 13.60 12.63 10.05 -0.029 49.56 (0.62) 
Symptom Index Baseline Hemmings 1997 3 48.33 48.16 47.98 0.017 0.52 (0.70) 
 Month 4 Hemmings 1997 3 40.00 39.67 39.39 -0.017 0.41 (0.60) 
 Month 8 Hemmings 1997 3 28.33 27.48 26.61 0.016 0.62 (1.00) 
BSI: General Severity Index Baseline Friedli 1997 4 17.50 15.27 13.28 -0.046 0.5 (1.00) 
  King 2000 14 7.64 5.91 2.07 -0.038 0.45 (0.91) 
  Simpson 2000 8 8.88 8.77 7.94 0.048 40.97 (0.84) 
 Month 3 Friedli 1997 4 14.75 12.19 10.28 -0.047 0.42 (0.58) 
 Month 4 King 2000 14 6.93 5.45 2.06 -0.055 0.45 (0.67) 
 Month 6 Simpson 2000 8 8.88 8.77 7.94 0.076 91.16 (1.06) 
 Month 9 Friedli 1997 4 15.50 12.74 10.83 -0.038 0.42 (0.82) 
 Month 12 King 2000 13 6.62 5.33 2.01 -0.126 0.49 (1.04) 
    Simpson 2000 8 8.25 8.15 7.43 0.022 126.99 (1.38) 
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COUNSELLING IN PRIMARY CARE: INDIVIDUAL INTERNAL ESTIMATES POOLING ARMS WITHIN STUDIES – Continued 
Cluster Size  
Variable Visit Study 
Number 
of 
Clusters 
Arithmetic 
Mean  him0ˆ  
Harmonic 
Mean 
ANOVA 
Estimate  
of ICC MSW (Ratio with MSR) 
SF-36: General Health Baseline Chilvers 2001 23 7.04 6.85 3.41 0.058 437.26 (0.87) 
  Harvey 1998 4 10.25 8.80 3.16 0.013 492.22 (1.14) 
 Month 4 Harvey 1998 4 8.50 7.24 2.98 0.065 565.94 (0.93) 
  Month 12 Chilvers 2001 22 5.32 5.15 2.63 0.195 464.88 (0.61) 
SF-36: Physical Functioning Baseline Chilvers 2001 23 6.87 6.67 3.38 0.050 479.45 (1.11) 
  Harvey 1998 4 10.25 8.80 3.16 -0.068 1082.50 (1.20) 
 Month 4 Harvey 1998 4 8.50 7.04 2.88 -0.012 919.46 (1.37) 
 Month 12 Chilvers 2001 22 5.23 5.06 2.61 -0.021 646.53 (1.07) 
Baseline Chilvers 2001 23 7.13 6.92 3.41 0.042 1598.10 (1.00) 
SF-36: Physical Role Limitation  Harvey 1998 4 10.00 8.63 3.15 -0.072 1910.99 (1.02) 
 Month 4 Harvey 1998 4 8.25 6.65 2.72 -0.057 1909.22 (1.24) 
  Month 12 Chilvers 2001 22 5.32 5.16 2.64 0.005 1655.99 (0.91) 
SF-36: Bodily Pain Baseline Chilvers 2001 23 7.17 6.97 3.45 -0.011 677.14 (0.83) 
  Harvey 1998 4 10.00 8.63 3.15 -0.041 877.31 (1.13) 
 Month 4 Harvey 1998 4 9.25 7.73 3.01 -0.039 1055.21 (1.51) 
 Month 12 Chilvers 2001 22 5.41 5.24 2.65 -0.064 791.48 (0.95) 
SF-36: Mental Health Baseline Chilvers 2001 23 7.17 6.96 3.45 0.036 219.31 (1.17) 
  Harvey 1998 4 10.25 8.80 3.16 0.006 485.20 (1.70) 
 Month 4 Harvey 1998 4 9.00 7.57 3.00 0.032 491.95 (1.35) 
  Month 12 Chilvers 2001 22 5.36 5.20 2.62 0.064 504.04 (0.70) 
SF-36: Vitality Baseline Chilvers 2001 23 7.17 6.96 3.45 -0.017 330.20 (1.41) 
  Harvey 1998 4 10.25 8.80 3.16 -0.073 301.28 (0.87) 
 Month 4 Harvey 1998 4 9.00 7.57 3.00 0.063 416.92 (1.03) 
 Month 12 Chilvers 2001 22 5.36 5.19 2.48 0.133 539.26 (0.72) 
Baseline Chilvers 2001 23 7.09 6.88 3.44 -0.010 899.63 (1.01) 
SF-36: Emotional Role Limitation  Harvey 1998 4 10.00 8.63 3.15 0.143 994.47 (1.76) 
 Month 4 Harvey 1998 4 8.25 6.87 2.87 -0.061 1726.88 (1.00) 
  Month 12 Chilvers 2001 22 5.27 5.11 2.63 0.050 1613.76 (0.82) 
SF-36: Social Functioning Baseline Chilvers 2001 23 7.22 7.01 3.46 -0.017 566.47 (1.22) 
  Harvey 1998 4 10.25 8.80 3.16 -0.045 704.37 (1.24) 
 Month 4 Harvey 1998 4 9.25 7.73 3.01 0.074 611.77 (1.47) 
 Month 12 Chilvers 2001 22 5.45 5.29 2.65 -0.008 823.38 (0.89) 
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COUNSELLING IN PRIMARY CARE: INDIVIDUAL INTERNAL ESTIMATES POOLING ARMS WITHIN STUDIES – Continued 
Cluster Size 
Variable Visit Study 
Number 
of 
Clusters 
Arithmetic 
Mean  him0ˆ  
Harmonic 
Mean 
ANOVA 
Estimate  
of ICC MSW (Ratio with MSR) 
SAS-M Baseline Friedli 1997 4 17.25 14.95 13.04 -0.024 0.26 (1.17) 
  King 2000 14 7.64 5.91 2.07 0.013 0.18 (0.57) 
  Simpson 2000 8 8.88 8.77 7.94 0.042 0.17 (0.96) 
 Month 3 Friedli 1997 4 14.75 12.19 10.28 -0.029 0.27 (0.90) 
 Month 4 King 2000 14 6.79 5.35 2.06 0.007 0.21 (0.48) 
 Month 6 Simpson 2000 8 8.88 8.77 7.94 0.097 0.34 (1.41) 
 Month 9 Friedli 1997 4 15.50 12.74 10.83 -0.064 0.25 (0.91) 
 Month 12 King 2000 13 6.46 5.16 2.01 -0.082 0.26 (0.85) 
  Simpson 2000 8 8.25 8.15 7.43 0.080 0.33 (1.02) 
IIP-32 Baseline Hemmings 1997 3 48.33 48.16 47.98 -0.001 0.39 (0.75) 
  Simpson 2000 8 8.88 8.77 7.94 0.044 414.43 (1.64) 
 Month 4 Hemmings 1997 3 40.00 39.67 39.39 -0.001 0.38 (0.80) 
 Month 6 Simpson 2000 8 8.88 8.77 7.94 0.177 360.29 (1.23) 
 Month 8 Hemmings 1997 3 28.33 27.48 26.61 0.003 0.38 (1.06) 
  Month 12 Simpson 2000 8 8.25 8.15 7.43 0.103 467.62 (1.39) 
EPQ: Psychoticism Baseline Friedli 1997 4 17.50 15.27 13.28 0.001 12.51 (0.98) 
  Hemmings 1997 3 48.33 48.16 47.98 0.038 6.72 (1.04) 
EPQ: Extroversion Baseline Friedli 1997 4 17.50 15.27 13.28 0.004 29.97 (1.21) 
  Hemmings 1997 3 48.33 48.16 47.98 0.021 24.70 (0.77) 
EPI: Extroversion Baseline Chilvers 2001 23 6.30 6.09 2.85 0.044 22.11 (0.86) 
EPQ: Lie Baseline Friedli 1997 4 17.50 15.27 13.28 0.034 13.35 (0.89) 
  Hemmings 1997 3 48.33 48.16 47.98 0.006 21.12 (1.12) 
EPI: Lie Baseline Chilvers 2001 23 6.78 6.58 3.33 -0.001 2.55 (0.89) 
EPQ: Neuroticism Baseline Friedli 1997 4 17.50 15.27 13.28 0.037 25.34 (1.35) 
  Hemmings 1997 3 48.33 48.16 47.98 -0.012 15.44 (0.81) 
EPI: Neuroticism Baseline Chilvers 2001 23 6.35 6.14 2.70 -0.008 27.38 (1.31) 
HADS: Anxiety Baseline Harvey 1998 9 11.11 10.49 4.22 -0.017 16.58 (1.23) 
 Month 4 Harvey 1998 9 9.33 8.85 3.96 -0.020 18.69 (0.92) 
Satisfaction Month 3 Friedli 1997 4 11.50 9.64 7.89 0.010 67.32 (0.54) 
 Month 4 King 2000 14 6.86 5.43 2.06 -0.004 0.35 (1.12) 
 Month 9 Friedli 1997 4 12.50 10.61 9.22 -0.060 85.20 (0.62) 
 Month 12 King 2000 12 6.58 5.32 2.15 0.113 0.43 (0.88) 
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COGNITIVE BEHAVIOURAL THERAPY IN PRIMARY CARE: INDIVIDUAL INTERNAL ESTIMATES POOLING ARMS WITHIN STUDIES 
Cluster Size 
Variable Visit Study 
Number 
of 
Clusters 
Arithmetic 
Mean  him0ˆ  
Harmonic 
Mean 
ANOVA 
Estimate  
of ICC MSW (Ratio with MSR) 
Baseline King 2000 12 9.83 7.37 1.82 0.019 62.56 (0.80) 
Month 4 King 2000 12 8.67 6.49 1.79 -0.060 90.22 (0.64) 
BDI 
Month 12 King 2000 12 8.00 5.94 1.76 -0.090 116.82 (1.63) 
Baseline King 2000 11 10.45 7.89 1.97 0.030 0.43 (0.87) 
Month 4 King 2000 11 8.82 6.67 1.90 -0.010 0.47 (0.69) 
BSI: General Severity Index 
Month 12 King 2000 12 7.42 5.45 1.73 0.012 0.44 (0.93) 
Baseline King 2000 12 9.75 7.33 1.82 -0.010 0.27 (0.85) 
Month 4 King 2000 12 8.08 6.21 1.79 -0.060 0.30 (0.70) 
SAS-M 
Month 12 King 2000 11 7.91 5.92 1.88 -0.060 0.27 (0.86) 
Month 4 King 2000 12 8.00 6.10 1.77 -0.070 0.55 (1.75) Satisfaction 
Month 12 King 2000 11 7.18 5.41 1.80 0.000 0.66 (1.35) 
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6 META-ANALYSIS OF MEAN DIFFERENCES FROM 
NESTED THERAPIST DESIGNS  
 
6.1 Introduction 
 
At present, there is limited experience of allowing for within-study clustering effects in 
the meta-analyses of psychotherapy trials (see Chapter 3). However, where allowance 
has been made for dependence arising from cluster-randomisation, its impact appears 
to have been minimal196, 206, 210, 224, 227, 244, 247. The proportions of meta-analyses and 
trials that are potentially affected by therapist variation are by comparison higher (see 
Chapter 3). Studies with therapist trial designs also tend to be smaller, and their ICC 
estimates less precise, so one might expect the standard error of the pooled treatment 
effect estimate to be affected to a greater extent by therapist-related clustering effects 
in the psychotherapy setting. The method by which allowances for clustering are made 
depends on the original analysis, if published aggregate data are used, but also on the 
statistical model assumed for studies in the meta-analysis39, 42, 43, 149-160. Extensions are 
needed for fixed- and random-effects meta-analysis models of mean differences that 
allow for between-arm heteroscedasticity at the therapist and patient levels, consistent 
with the assumption of a two-level heteroscedastic model84, 286 for the studies. 
 
Another possible explanation for the limited impact of within-study clustering observed 
in aggregate meta-analyses is the common practice of ignoring sampling errors arising 
in the estimation of the study weights. In a frequentist framework, the between-study 
variance and the sampling variances of study estimates are fixed but unknown. Hardy 
and Thompson421 suggested a profile-likelihood approach that allowed for imprecision 
in the estimation of the between-study variance while still ignoring the sampling errors 
in the within-study variances, given via the sampling variances of the study estimates. 
As the between-study variance appears in all study weights in a random-effects meta-
analysis, it has been argued that its imprecision is likely to have a larger impact on the 
standard error of the pooled estimate40, 421, 422. Its role in the relative weight each 
study is given led Whitehead102 to come to the same conclusion. However, the degrees 
of freedom available for estimating the variances are also a factor. Viechtbauer422 
showed that it is reasonable to assume the within-study variances are known when 
the sample sizes are equal across arms, and the average sample size per arm is at 
least 40. Hardy and Thompson421 concluded that “Except when all the trials are small, 
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the additional uncertainty would not therefore be expected to have a great impact on 
the results and so pursuing a full likelihood approach is unnecessarily sophisticated for 
most practical purposes” (p. 627). On this basis, one would anticipate results from a 
one-step meta-analysis of the individual-patient-data (IPD) to be almost identical to 
those using the profile-likelihood approach with the aggregate data. 
 
The presence of within-study clustering and between-arm heteroscedasticity in trials of 
psychotherapy makes the assumption of known within-study variances less tenable. As 
more than half the studies in Cochrane reviews involving psychotherapy have sample 
sizes of less than 50 per arm (see Chapter 3), reductions in their effective sample sizes 
arising from therapist variation could be important, making the use of a full likelihood 
approach an attractive option. This is more straightforward to implement if the IPD are 
available421. As this will not always be so, aggregate alternatives are also needed. Sidik 
and Jonkman40 have suggested a robust ‘sandwich’ estimator for the variance of the 
pooled treatment effect estimate. Although this class of estimator is typically used to 
handle heteroscedasticity, their purpose was in making allowance for sampling error in 
the estimated marginal weights of a random-effects meta-analysis. Due to the small 
number of studies commonly pooled in meta-analyses, they suggested a correction for 
reducing the associated bias, following Horn et al423 and Royall and Cumberland424. It 
is unclear how effective this would be in the face of within-study clustering, especially 
when the number of clusters per study is also small. 
 
The presence of between-study heterogeneity in therapist ICC estimates raises further 
issues. One option is to assume a fully unstructured variance-covariance structure for 
the random effects, and allow for between-arm heteroscedasticity at the therapist and 
patient levels on a study-by-study basis. However, the likelihood of negative estimates 
makes it tricky to fit a one-step meta-analysis of this sort using the IPD. An aggregate 
approach, in which ICCs are first estimated, analyses of treatment effect ignoring the 
clustering are then corrected, and these estimates pooled, may therefore be appealing 
even if the IPD are available. One alternative might be a semi-exchangeable variance-
covariance structure where the ICC is assumed to be equal across studies within arms, 
and treatment-specific ICC estimates are pooled across studies. If the assumption of 
no between-study heterogeneity in ICCs is acceptable and a one-step meta-analysis of 
the IPD is used, this represents two meta-analyses for the price of one, reducing the 
number of steps required. Where it is not, a further option would be to adopt a middle 
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road, and investigate the use of meta-regression models for the random effects. 
 
Focusing initially on treatment effects given in the form of absolute mean differences 
has several advantages. Firstly, their estimates are unbiased, their sampling variances 
are independent of the population parameter, and their sampling distribution is exactly 
normal422. This avoids some of the additional complications that are encountered when 
pooling standardised mean differences or odds ratios and relative risks. It also allows 
the general implications to be considered before concentrating on those that are more 
specific. Moreover, the prevalence of continuous outcomes in a psychotherapy setting 
(see Chapter 3) makes methods for pooling mean differences important in their own 
right. It also provides a means for analysing multicentre trials of psychotherapy, as the 
studies in a meta-analysis correspond to the centres in a multicentre trial. The aim of 
this chapter was therefore to adapt, illustrate and compare methods for pooling mean 
differences from nested therapist designs. Aggregate methods are described, followed 
by one-step multilevel models for use with the IPD. In both cases, fixed- and random-
effects meta-analysis models will be considered. These are then illustrated using the 
counselling in primary example introduced in Chapter 4, restricted to the four trials315, 
316, 319, 320 that used the Beck Depression Inventory (BDI) as their primary outcome. 
 
6.2 Aggregate-Data Methods 
 
6.2.1 Standard Fixed- and Random-Effects Meta-Analysis Models 
 
In the simplest meta-analysis model, an underlying treatment effect θ  common to all 
h  studies is assumed such that Hθθθ === L1 . The fixed-effects model implies102 
 
Hhehh ,,1,ˆ K=+= θθ     (6.1) 
 
where hθˆ  is the treatment effect observed in study h , θ  is the population value, and 
he  are the sampling errors, with { }( )2,0~ heh Ne σ . Heterogeneity in treatment effects 
observed across studies is therefore ascribed only to sampling error. The more realistic 
random-effects model permits the population treatment effects to vary across studies, 
with hh εθθ +=  and { }( )2,~ hNh ετθθ , where { }2 hετ  is the between-studies variance and 
θ  is now the mean of the population treatment effects. Thus102 
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Hhehhh ,,1,ˆ K=++= εθθ          (6.2) 
 
and { } { }( )22,~ˆ hheh N ετσθθ + . The total variance of hθˆ  is thus { } { } { }222ˆ hhh eT εθ τσ += , which 
reduces to a fixed-effects meta-analysis model when { }
2
hε
τ  is zero. 
 
The uniformly minimum-variance unbiased estimate (UMVUE) of the pooled treatment 
effect θ  is given by146, 147 
∑
∑
=
=
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where 
{ } { }
22
1
hhe
hw
ετσ +
=  is the weight assigned to study h  under a random-effects 
meta-analysis model. Its standard error is given by 
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so the two-sided ( )α−1100 % confidence interval for wθˆ  is given by 
 
{ }wzw θα σθ ˆ2/1ˆ −±         (6.5) 
 
and the corresponding null hypothesis of no treatment effect is rejected at the %100α  
significance level if the test statistic 
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where 2/1 α−z  is the critical value of the standard Normal distribution. It is standard
102 
for { }
2
he
σ  and { }
2
hε
τ  to be simply replaced by their respective estimators { }
2
ˆ
he
σ  and { }
2
ˆ
hε
τ . 
 
6.2.2 Sampling Distribution of the Study Mean Differences 
 
Suppose 1hµ  and 0hµ  are the true mean outcomes in the intervention and control arm 
 Page 150 of 238 
of study h  respectively. The population mean difference is then 
 
01, hhhMD µµθ −=   (6.7) 
 
The outcome of patient l  in the i th arm of the h th study is denoted by hily . If the 
outcomes can be assumed to be statistically independent both within and across arms, 
the population variances homogeneous ( 220
2
1 hhh σσσ == ), and the sample means ( 1hy  
and 0hy ), variances (
2
1hs  and 
2
0hs ) and sizes ( 1hn  and 0hn ) are all available, the study 
estimate and its sampling distribution are given by425 
 
Hh
nn
Nyy
hh
hhhhhhMD ,,1,
11
,~
ˆ
01
2
0101, K=













+−−= σµµθ       (6.8) 
 
where { } 





+=
01
22
ˆ
11
ˆ
,
hh
h
nn
s
hMDθ
σ    and    
2
)1()1(
01
2
00
2
112
−+
−+−
=
hh
hhhh
h
nn
snsn
s  
 
Note that 2hs  is the analysis of variance estimator of 
2
hσ  and that, if the independence 
and equal variance assumptions hold, 
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If the outcome variances are heterogeneous across arms (i.e. 20
2
1 hh σσ ≠ ) and their ratio 
is unknown, the study estimate hMD,
ˆθ  is unaffected but its variance becomes 
 
{ }
0
2
0
1
2
12
ˆ
,
h
h
h
h
nnhMD
σσ
σ θ +=    (6.10) 
 
The variances are replaced by 21hs  and
2
0hs  to give the estimator
425 { }2ˆ
,
ˆ
hMDθ
σ . This scenario 
is referred to as the Behrens-Fisher problem426. The analysis of variance estimator 2hs  
is now a linear combination of two independent mean square terms, 1hMSE  and 
0hMSE , one for each arm. 
 
Suppose now that the outcome of patient l  is nested within the j th cluster of arm i  
 Page 151 of 238 
and is denoted by hijly . Then assume, for each of h  studies, that 
i) Two distinct samples of hik  clusters were assigned to intervention and control 
in a nested therapist trial, implying a two-level heteroscedastic model (2.5); 
ii) One sample of hk2  clusters was randomly allocated to intervention or control 
in a nested therapist trial, implying a random-intercept model (2.2); or 
iii) One sample of 1hk  clusters was assigned to the intervention arm of a partially 
nested therapist trial, implying a two-level heteroscedastic model (2.7). 
 
Scenarios ii) and iii) can be viewed as special cases of i), where clusters are nested 
within treatment arms in all three. The study estimate 01,
ˆ
hhhMD yy −=θ  remains a valid 
estimator of hMD,θ , where the sample means in the clustered arms are given by 
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when the cluster sizes are equal within arms. 
 
Analysis of variance estimators of the within- and between-cluster variances, the total 
and the naïve variance are given in Table 6.1. Simple pooling of the sums of squares 
across arms is justified by homogeneity of the population within- and between-cluster 
variances across arms. This assumption is reasonable in the psychotherapy context if a 
cluster-randomised or multi-tiered design is employed and the source of the clustering 
is unrelated to treatment delivery. As the psychotherapies are likely to require different 
skills and performance biases may play a part, between-arm heteroscedasticity may be 
expected even when psychotherapies are randomly allocated to therapists. However, if 
homoscedasticity could be assumed, the variance of hMD,
ˆθ  would be estimated by107 
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Table 6.1 Analysis of Variance Estimators for Nested Designs 
Between-Arm Heteroscedasticity 
Control  
Intervention 
Nested Design Partially Nested Design 
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so if the cluster sizes are also equal across arms with hhh mmm == 01 , this simplifies to 
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If a two-level heteroscedastic model84 applies, pooling of between- or within-cluster 
sums of squares across arms cannot be justified. In this context, Kwong and Higgins39 
gave the sampling distribution of hMD,
ˆθ  as 
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The sampling variance simplifies to39 
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in the case of partial nesting. In a frequentist framework, the population ICC is simply 
replaced by the relevant internal estimate. 
 
6.2.3 Impact of Sampling Errors in the Estimated Weights 
 
Sidik and Jonkman40 argue that, if the population weights in (6.3) are replaced by their 
estimated counterparts, the structure of the variance of the pooled estimate will be of 
the form 
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When { } 12ˆ ˆ −= hwT hθ , (6.16) simplifies to the familiar form of this variance, so { }
2
ˆ
wˆθ
σ  tends 
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to { }2ˆwθσ  as the sampling errors in the weights decrease. Sidik and Jonkman
40 
suggested estimating 2
ˆ
h
Tθ with the squared residual ( )2ˆˆˆ wh θθ − to give a ‘sandwich’ 
estimator of the variance, adding a correction factor to reduce the bias arising when 
this is based on a small number of studies. They gave the biased-reduced robust 
estimator as 
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This is approximately unbiased, providing that { }2ˆˆ hθσ  and { }
2
ˆ
hθτ  are unbiased
40. 
 
The within-study variance estimates given in the previous section are unbiased for the 
models specified. However, they assume the treatment effect is present in each model 
so they are biased for fixed-effects meta-analyses102. The extent of this bias depends 
on the size of the study-by-treatment interaction102. The most regularly used estimate 
of 2
hθτ  is that of DerSimonian and Laird
380 (D-L), 
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ˆˆ/ˆˆ θθσθθ θ , and hθˆ , wθˆ  and hw  all relate to the 
corresponding fixed-effects meta-analysis. This is unbiased if the within-study variance 
is known and homogeneous across studies422. 
 
Sampling error in the within-study variances means that the test of no between-study 
heterogeneity is an F  test, with 1−H  and HN 2− degrees of freedom, rather than a 
chi-squared test, with 1−H  degrees of freedom, under assumptions of independence 
and common within-study variances102. The F  statistic is given by ( )1−HQ , and N  
is the total number of patients in a meta-analysis. If there is clustering present within 
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the studies, the denominator degrees of freedom become HK 2− , where K  is the 
total number of clusters in the meta-analysis. Moreover, if the within-study variances 
are heterogeneous, the test is no longer an F test, although it can be approximated to 
one where the denominator degrees of freedom are estimated using a Satterthwaite’s 
procedure102, 108. Thus, the D-L estimator is likely to be biased if there is clustering 
within studies, unless the total number of clusters is large. The additional complication 
of variable cluster sizes is expected to be of less importance, although it would have a 
similar effect to heteroscedasticity, in that the test is no longer an F test. 
 
In turn, Sidik and Jonkman’s40 robust `sandwich’ estimator is expected to be biased, if 
it is used in conjunction with the D-L estimator for a random-effects meta-analysis, or 
study-specific within-study variance estimates for a fixed-effects meta-analysis. One 
possibility might be use of a robust `sandwich’ estimator along with the study-specific 
within-study variance estimates, as a proxy for a random-effects meta-analysis. This is 
suggested due to the consistency of the within-study variances with a random-effects 
meta-analysis and of ‘sandwich’ estimators in the presence of model misspecification. 
 
6.2.4 Allowance for Finite Samples 
 
In a fixed-effects meta-analysis, the test of no treatment effect is a t test based on 
1−− HN  degrees of freedom, under the assumptions of independence and common 
within-study variances102. In the presence of within-study clustering, the t test is based 
on 1−− HK  degrees of freedom, and if the within-study variances differ across arms 
or studies, it becomes an approximate t  test, with the degrees of freedom given by a 
Satterthwaite procedure108. A correction is needed for the t  statistic, due to the bias in 
the within-study variance estimates102. In contrast, in a random-effects meta-analysis, 
the test of no treatment effect is a t  test on 1−H  degrees of freedom, regardless of 
the random structure at lower levels. As the number of studies contributing to a meta-
analysis is finite, Rosner427 and others40 have suggested testing hypotheses of the 
pooled treatment effect using a t  as opposed to the usual z  statistic. Approximate 
two-sided %100α  hypothesis tests and ( )α−1100 % confidence intervals for wˆˆθ  are 
thus given in the random-effects meta-analysis by 
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and 
{ }wHw t ˆˆ2/1,1ˆ ˆˆ θα σθ −−±        (6.20) 
 
respectively, where 2/1,1 α−−Ht  is the critical value of the t  distribution. 
 
6.3 One-Step Multilevel Models of the IPD 
 
6.3.1 Fixed-Effects Meta-Analysis Models 
 
Using notation introduced in Chapter 2 for study-level analyses, where ly  denotes the 
outcome for the l -th patient, the standard fixed-effects meta-analysis model is102, 428 
 
ll
H
h
hlhl etxy +++= ∑
=2
θβα    (6.21) 
 
where α  represents the mean outcome in the control arm of study 1, hlx are indicator 
variables for the other studies, lt is an indicator variable for the treatment arm, and hβ  
and θ  are the fixed study and treatment effects respectively. It is commonly assumed 
that the patient-level residuals le are iid ( )2,0 eN σ , though the relaxation of a common 
patient-level variance across studies has been discussed, so that ( )2,0~ ehl Ne σ 102, 428. 
It is equally possible to let the patient-level variance vary across arms, in which case 
the model becomes 
( ) lllll
H
h
hlhl tetetxy 10
2
1 +−+++= ∑
=
θβα  (6.22) 
 
with the le0 iid ( )20,0 eN σ  and the le1 iid ( )21,0 eN σ . As the assumption of independence 
is inappropriate due to the presence of therapist variation in this context, model (6.22) 
can be extended to give the fixed-effects meta-analysis corresponding to model (2.6), 
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The random effects )2( )(0 ltherapistu  and 
)2(
)(1 ltherapistu are assumed iid ( )20,0 uN σ  and ( )21,0 uN σ . 
In the event that all the studies are partially nested, )2( )(0 ltherapistu can be constrained to 
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equal zero, and omitted from the model. If only a subset is partially nested, more 
complex random structures should be considered (see Section 6.3.3). While the study-
level random-intercept and random-coefficient models are not recommended for use in 
the present context, their fixed-effects meta-analysis equivalents can be obtained, for 
nested designs, by adding fixed study effects to models (2.2) and (2.4) respectively. 
 
6.3.2 Random-Effects Meta-Analysis Models 
 
The standard random-effects meta-analysis is one in which the study effects are fixed 
but the treatment effect is permitted to vary randomly across studies102, 428. If studies 
have nested therapist designs, the random-effects meta-analysis model becomes 
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where the )3( )(lstudyτ are iid ( )2,0 τN  and the random effects are mutually independent. As 
before, the therapist-level variance in the control arm )2( )(0 ltherapistu is constrained to equal 
zero, and the term omitted from the model, if all of the studies are partially nested. 
 
6.3.3 Random-Effects Meta-Regression Models 
 
Meta-regression models have been described that allow the pooled treatment effect to 
vary subject to one or more study-level characteristics428-430. These are used to explore 
systematic explanations for between-study variation 2τ , and require a large number of 
studies. Incorporation of a categorical study-level covariate into model (6.24) gives 
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where pls  are indicator variables for the levels of the study characteristic, and pW  are  
fixed treatment-by-covariate interaction effects. Further categorical or even continuous 
covariates could be added. When the number of studies is small any variation between 
studies in the treatment effect is perhaps better left accounted for but unexplained, as 
in model (6.24). If data are available on one or more therapist-level characteristics, it 
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may be of interest to explore whether the treatment effect varies conditional on these. 
Here, the covariate varies within studies but is identical for every patient seen by each 
therapist. Since the number of therapists per study is often small, it may only begin to 
be feasible to address such questions in a meta-regression. Even so any treatment-by-
study-by-covariate interactions may have to be assumed to be zero. As with other IPD 
meta-regressions, patient-level covariates can also be investigated428. In this case, the 
covariate varies between the patients within the therapists and studies. 
 
Up to this point, the meta-regressions considered are of fixed effects, and in particular 
of the treatment effect in the form of treatment-by-covariate interactions in a one-step 
model. Meta-regressions of random effects may also be of interest. The study designs 
may vary making a more complex variance-covariance structure realistic. The inclusion 
of fully and partially nested studies is one example. Another is inclusion of studies with 
and without clustering effects. The standardisation of patient characteristics, or of the 
therapist’s delivery of the treatments, in some studies but not in others is yet another. 
In these circumstances, there is reason to expect between-study variation in therapist- 
or patient-level random effects even if there is insufficient statistical power available to 
detect this. Model (6.24) can be extended for meta-analyses of mixed nested designs 
as follows, 
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where lX is an indicator variable equal to one when the study has a fully nested design 
and zero if it is partially nested. Here the residual error in the control arm is allowed to 
differ across study designs. This ensures that the therapist ICC in the control arm is 
based on the subset of studies with fully nested designs. It is assumed, as before, that 
the therapist ICC in the control arm is homogeneous for all fully nested studies. If the 
assumption of independence is reasonable in some of the studies, model (6.26) can be 
extended to give 
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where lC  is an indicator variable equal to one when a study has clustering effects and 
zero otherwise. Again the residual error is permitted to differ as a function of the study 
design. For non-clustered studies, it is ( )( )lll Cte −− 11)1(0  in the control and ( )lll Cte −1)1(1  
in the treatment arm, both terms replaced by ( )ll Ce −1)1(  if the patient-level variance is 
assumed to be homogeneous across arms. 
 
It is reasonable to suppose the patient- and therapist-level variances to be affected by 
standardising patient or therapist characteristics and behaviour via the use of selection 
criteria and therapist training, certification, monitoring and supervision. Assuming the 
study designs are comparable in all other respects, a categorical study-level covariate 
can be incorporated for the therapist-random effect in model (6.24) as follows, 
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where lT  is an indicator variable equal to one if therapist characteristics or behaviour 
were standardised and zero otherwise. This might be considered if some of the studies 
used treatment manuals, while others did not, or if therapists were selected for their 
expertise, given training, accreditation, monitoring or supervision in some studies but 
not others. It is assumed in model (6.28) that these design characteristics do not have 
a simultaneous effect at the patient level. One could instead incorporate a categorical 
study-level covariate for the patient-level residual error, 
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where lP  is equal to one for studies in which patient characteristics were standardised 
and zero otherwise. This might be considered if the studies adopt a mix of explanatory 
and pragmatic approaches to patient eligibility. The potential complexity of the random 
effects increases with the variability in the study designs. This makes the unstructured 
alternative appealing but it also reduces the random effects to nuisance parameters. If 
the number of studies is small, there may be a trade-off between assuming a realistic 
model for the random effects and computational feasibility too. These models can also 
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be extended to include therapist- and patient-level predictors of the random effects. 
 
6.4 Application to Counselling in Primary Care 
 
Short-term outcomes relating to the BDI were available for 460 patients from four315, 
316, 319, 320 of the counselling in primary care trials. Of these, 224 (49%) were allocated 
counselling with one of 39 counsellors. Overall, the cluster sizes ranged from 1 to 33, 
with a median of 3, and an inter-quartile range of 1 to 8. Data were available for 5 or 
more patients for 18 of the counsellors. Since all four of the trials had a partially 
nested design, some of the potential complexities were avoided. Given the number of 
trials, an exchangeable variance-covariance structure was initially assumed for the 
counselling arm. 
 
6.4.1 Aggregate versus One-Step Meta-Analyses 
 
To reflect common lack of knowledge about the cluster size distribution, equal cluster 
sizes were assumed for all aggregate analyses. The pooled ICC estimate of 0.033 from 
Chapter 5, based on the non-censored doubly-corrected internal estimates, was used 
regardless of the model, and despite the between-study heterogeneity observed. One-
step models were implemented in MLwiN using RIGLS, due to its flexibility in modelling 
the random effects. RIGLS is comparable to REML95, implemented in xtmixed in Stata. 
This command has been updated in Version 11 to permit inclusion of one covariate for 
the patient level error. It can thus be used to implement the simpler models. Details of 
the programming for both packages are given as an appendix (see Section 6.6). 
 
Table 6.2 summarises the estimates and their standard errors for fixed- and random-
effects meta-analyses, progressively relaxing the independence and common variance 
assumptions within the studies. While the meta-analyses using an aggregate approach 
all assume an ICC of 0.033, the one-step analyses gave estimates varying between 
0.083 and 0.146, depending on the model. The reason for larger one-step estimates is 
not clear. It may reflect differences in the assumed variance-covariance structure or 
bias in the RIGLS estimates. Further work is needed to establish the cause. It can be 
seen that the pooled mean difference and its standard error for a standard aggregate 
fixed-effects model are -2.429 and 0.886. The associated two-sided 95% CI is -4.17 to 
-0.69 indicating that counselling reduces short term depression symptoms, measured 
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Table 6.2 Aggregate versus One-Step Meta-Analyses of the Absolute Mean Difference in BDI between Counselling and Control 
AGGREGATE APPROACH 
 Ignoring Within-Study Clustering Allowing for Within-Study Clustering (Internal #1) 
Level 1 Variance Homogeneous Heterogeneous Homogeneous Heterogeneous 
Weights Mean Difference Weights Mean Difference Weights Mean Difference Weights Mean Difference 
Study % F % R (Standard Error) % F % R (Standard Error) % F % R (Standard Error) % F % R (Standard Error) 
Chilvers 2001 13.9 19.4 0.36 (2.377) 13.7 19.3 0.36 (2.397) 15.1 19.8 0.36 (2.413) 14.6 19.5 0.36 (2.439) 
Friedli 1997 25.7 26.0 -3.86 (1.747) 24.8 25.6 -3.86 (1.785) 23.8 25.0 -3.86 (1.920) 23.9 25.1 -3.86 (1.909) 
King 2000 22.9 24.8 -5.75 (1.852) 24.3 25.4 -5.75 (1.803) 24.2 25.2 -5.75 (1.903) 26.0 26.0 -5.75 (1.831) 
Simpson 2000 37.6 29.8 -0.45 (1.445) 37.2 29.7 -0.45 (1.458) 37.0 29.9 -0.45 (1.540) 35.5 29.4 -0.45 (1.567) 
Fixed: Usual 100 100 -2.429 (0.886) 100 100 -2.475 (0.889) 100 100 -2.424 (0.936) 100 100 -2.526 (0.933) 
Fixed: Robust 100 100 -2.429 (1.409) 100 100 -2.475 (1.439) 100 100 -2.424 (1.435) 100 100 -2.526 (1.459) 
Random: Usual 100 100 -2.497 (1.402) 100 100 -2.517 (1.415) 100 100 -2.484 (1.417) 100 100 -2.528 (1.427) 
Random: Robust 100 100 -2.497 (1.395) 100 100 -2.517 (1.408) 100 100 -2.484 (1.411) 100 100 -2.528 (1.422) 
D-L 2ˆ
hθτ
 4.500 4.626 4.335 4.480 
ONE-STEP APPROACH 
 Ignoring Within-Study Clustering Allowing for Within-Study Clustering (Internal #1) 
Level 1 Variance Homogeneous Heterogeneous Homogeneous Heterogeneous 
Meta-Analysis Fixed Random Fixed Random Fixed Random Fixed Random 
Intercept 16.15 (1.139) 15.46 (1.311) 16.31 (1.154) 15.53 (1.365) 15.70 (1.190) 15.36 (1.293) 15.75 (1.245) 15.41 (1.361) 
Friedli 1997 -1.29 (1.402) -0.16 (1.738) -1.53 (1.391) -0.26 (1.802) -0.49 (1.581) 0.00 (1.730) -0.54 (1.659) -0.06 (1.820) 
King 2000 -0.61 (1.382) 1.01 (1.681) -0.96 (1.376) 0.87 (1.744) 0.25 (1.490) 1.11 (1.658) 0.09 (1.544) 0.97 (1.738) 
Simpson 2000 0.77 (1.318) 0.83 (1.613) 0.72 (1.312) 0.79 (1.675) 0.91 (1.424) 0.93 (1.590) 0.93 (1.484) 0.94 (1.669) 
 
Counselling -2.469 (0.900) -2.469 (1.423) -2.465 (0.897) -2.467 (1.423) -2.429 (1.082) -2.485 (1.446) -2.458 (1.116) -2.507 (1.452) 
2τˆ   (Level 3: Int.)  4.802 (4.581)  4.830 (4.462)  3.845 (4.888)  3.560 (4.758) 
2
ˆ
vσ  (Level 2: Int.)     9.659 (6.044) 8.062 (6.094) 12.531 (6.411) 11.203 (6.540) 
2
ˆ
eσ  (Level 1: Cont.) 92.773 (6.117) 91.877 (6.085) 102.913 (9.472) 101.878 (9.379) 89.100 (6.069) 88.979 (6.061) 102.198 (9.408) 101.865 (9.377) 
2
ˆξσ  (Level 1: Int.)   82.111 (7.759) 81.329 (7.754)   73.198 (7.451) 73.241 (7.457) 
Counsellor ICC - - - - 0.098 0.083 0.146 0.133 
-2 Log Likelihood 3384.30 3385.26 3381.43 3382.71 3382.24 3382.86 3376.94 3377.68 
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by the BDI, by an average of approximately 2.4 points, and that this reduction is 
statistically significant at the 5% level. The equivalent one-step estimate and its 
standard error are -2.469 and 0.900 with the two-sided 95% CI based on the t  value, 
-4.24 to -0.70. The similarity of these results implies that bias and sampling error in 
the aggregate within-study variance estimates is not important under this model in 
this example. The pooled mean difference and its standard error in the analogous 
aggregate random-effects model are -2.497 and 1.402. The increase in the standard 
error arises from between-study heterogeneity in the mean differences across studies. 
This widens the two-sided 95% CI to -5.24 to 0.25, so the reduction in BDI is no 
longer statistically significant at the 5% level. If a one-step model had been used, the 
estimate and its standard error would be -2.469 and 1.423, and the 95% CI using the 
t  value -7.00 to 2.06. The disparity in the standard errors is partly explained by that 
of the between-study variance estimates (4.500 vs. 4.802), which in turn is due either 
to bias arising from sampling error or heterogeneity in the within-study variance 
estimates. Its impact is less pronounced than that of allowing for the finite sampling of 
studies in the CI in this example. Either way, the evidence in favour of counselling in 
primary care is less clear if between-study heterogeneity is taken into consideration. 
 
The impact of allowing for between-arm heteroscedasticity and within-study clustering 
appears to be minimal if the pooled estimates and their standard errors are compared 
across the usual aggregate analyses. Within-study clustering has a greater impact than 
between-arm heteroscedasticity in this case, although the effect of the latter is more 
perceptible in random-effects analyses. A similar pattern can be seen for the one-step 
analyses. The impact is slightly more pronounced, increasing the disparity between the 
aggregate and one-step results as the model becomes more realistic. It is of note that 
the D-L and one-step estimates of between-study heterogeneity differ with the pattern 
reversing when clustering is taken into account. One-step estimates of the counsellor 
ICC are also larger than the pooled aggregate estimate (see Chapter 5), and vary from 
model to model. These differences arise, in part, because the variances are estimated 
simultaneously in a one-step model, and make appropriate allowance for all the other 
effects in the model. The exchangeability assumption was not made when pooling ICC 
estimates in Chapter 5, as this would have required a fixed-effects model for the ICCs. 
As such, one might expect the disparity between aggregate and one-step results to be 
greater the larger the between-study heterogeneity in the ICC estimates. In this case, 
the results continue to be dominated by between-study heterogeneity in the treatment 
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effects. 
 
The most realistic one-step pooled mean difference and standard error are -2.507 and 
1.452, with the two-sided 95% CI given by -7.13 to 2.11. The aggregate proxy to this 
is the corresponding robust fixed effects analysis, where the estimate and its standard 
error are -2.526 and 1.459, and the two-sided 95% CI is -7.17 to 2.12. Both are very 
similar, and in each case the confidence interval is marginally wider than the standard 
random effects one with the conclusion remaining unchanged. What is more striking is 
a comparison of the robust aggregate results to the usual ones. In the random-effects 
case, the robust standard errors are smaller than the usual ones. At the same time the 
robust standard errors are larger for the fixed- than the random-effects analyses. This 
suggests that bias in the robust estimator is an important consideration, and that care 
should be taken when using Sidik and Jonkman’s40 estimator in this setting. However, 
it does show potential for providing an adequate proxy for the one-step results if used 
in conjunction with a fixed effects analysis. 
 
6.4.2 Sensitivity to the Population ICC 
 
The sensitivity of the mean difference and its standard error to the population ICC are 
plotted in Figure 6.1. The dashed lines represent the study-level results, while the solid 
lines correspond to the pooled results for aggregate models allowing for clustering and 
between-arm heteroscedasticity within the studies. 
 
Figure 6.1 Sensitivity of the Mean Difference and its SE to the Population ICC 
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The study estimates are unaffected as the ICC increases, but the pooled estimates are 
more extreme. This is because King et al319 has more weight as the ICC increases. This 
is slightly more pronounced for the fixed-effects estimate. There is some evidence of 
between-study heterogeneity in the slope of the standard error over the range of the 
ICC. This questions the validity of the exchangeability assumption in this example. The 
slope of the pooled standard error is not especially steep, indicating that the results 
are not sensitive to the ICC in the anticipated range, if between-study heterogeneity in 
the treatment effects is taken into account. 
 
The relationship between the population ICC and between-study heterogeneity in the 
treatment effects is depicted below in Figure 6.2. It can be seen that the D-L estimate 
decreases as the ICC increases, and is censored at zero when the ICC is over 0.8. This 
implies that the heterogeneity in the mean differences across studies is contributed to, 
but is not simply explained by, heterogeneity between the counsellors. 
 
Figure 6.2 Sensitivity of Between-Study Heterogeneity to the Population ICC 
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6.4.3 Meta-Regression Analyses 
 
While the studies all had partially nested designs, Friedli et al316 and King et al319 used 
a treatment manual and additional training or monitoring to standardise the delivery of 
counselling. Chilvers et al315 and Simpson et al320, instead, took a pragmatic approach. 
Patient eligibility was restricted to depression, or comorbid depression and anxiety, in 
Chilvers et al315, King et al319 and Simpson et al320. Friedli et al316, in contrast, accepted 
a broad set of referrals. None of the four studies adopted a doubly pragmatic design. 
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Table 6.3 summarises the results of two meta-regression models, one for the therapist 
random effect (model 6.28) and the other for the patient residual (model 6.29). Both 
explore sources of heterogeneity in the counsellor ICC between studies. Computational 
problems were avoided by illustrating the extension of the most realistic fixed-effects 
meta-analysis. If further studies had been available, a random-effects meta-regression 
would have been preferable. 
 
Table 6.3 Meta-Regression Analyses of the Mean Difference in BDI 
 Source of Heterogeneity in ICCs 
 
Model 
Patient 
Eligibility 
Treatment 
Standardisation 
Intercept 15.73 (1.164) 15.84 (1.268) 
Friedli 1997 -0.56 (1.540) -0.58 (1.375) 
King 2000 -0.50 (1.513) -0.15 (1.452) 
Simpson 2000 0.90 (1.387) 0.86 (1.591) 
 
Counselling -2.373 (1.050) -3.576 (0.905) 
2
ˆ
vσ  (Level 2: Int.) 8.624 (5.217)  
2
0ˆξσ (Level 1: Int./Mix.) 80.712 (9.307)  
2
1ˆξσ (Level 1: Int./Dep.) 53.318 (10.924)  
2
0ˆ eσ (Level 1: Cont./Mix.) 86.914 (9.318)  
2
1ˆ eσ (Level 1: Cont./Dep.) 142.062 (25.518)  
2
0ˆ vσ  (Level 2: Int./Not Stand.)  28.188 (14.074) 
2
01ˆ vσ (Level 2 Covariance)  -15.138 (7.026) 
2
ˆξσ   (Level 1: Int.)  71.708 (7.120) 
2
ˆ
eσ   (Level 1: Cont.)  102.133 (9.403) 
Counsellor ICC (Mixed) 0.097  
Counsellor ICC (Depression) 0.139  
Counsellor ICC (Not Standardised)  0.282 
Counsellor ICC (Standardised)  -0.030 
-2 Log Likelihood 3368.22 3364.33 
 
A reduction of 8.72 was seen in the log likelihood by including separate residual terms 
for studies with broad and narrow referrals. The pooled treatment effect reduced very 
slightly, as did its standard error. As one would expect, the counsellor ICC was higher 
when the patients were more homogeneous. When distinct therapist-level terms were 
included for studies standardising counselling and those that did not, the log likelihood 
reduced by 12.61. Here, the pooled treatment effect also increased appreciably, which 
reflects the association between the study estimate and counsellor ICC. The standard 
error also reduced perceptibly, being similar to the standard fixed effects equivalent. 
As the pooled counsellor ICC is negative for the studies that standardised counselling, 
a different parameterisation of the model was used which included a covariance term 
rather than an explicitly negative estimate. Again, as one would expect, the counsellor 
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ICC was higher when counselling was not standardised. The standard errors for these 
variance estimates are very large due to the number of studies and counsellors. It was 
also not possible computationally to simultaneously allow for heterogeneity from both 
these sources, and to fit the model of choice. The potential to do so when the number 
of studies available is larger is clear, however. The facility to disentangle the predictors 
of the components of an ICC is also extremely attractive, as it allows for the possibility 
that the predictors differ between the components. 
 
6.5 Discussion 
 
Extensions have been described that allow for between-arm heteroscedasticity at the 
therapist- and patient-levels in meta-analyses of studies with nested therapist designs. 
Aggregate and one-step models were contrasted, and the potential for exploring meta-
regression models for fixed and random effects outlined. The example of counselling in 
primary care was used to illustrate a selection of the issues that arise in this context. It 
was shown that the robust `sandwich’ estimator of the variance of a pooled treatment 
effect put forward by Sidik and Jonkman40 is a promising proxy for a one-step random-
effects meta-analysis using the full-likelihood, when used in an aggregate fixed-effects 
meta-analysis with study-specific within-study variance estimates. A simulation study is 
needed to investigate this further, and to evaluate the scenarios under which sampling 
errors in the estimated weights can be safely ignored, or a profile-likelihood approach 
adopted. A Bayesian approach would be of interest in this respect, to fully account for 
sampling error in the ICC, and to formally incorporate external estimates of the ICC. 
Sensitivity analyses were instead applied here, to evaluate the impact of uncertainty in 
the population ICC, consistent with the frequentist approach adopted. 
 
Where the IPD are available, meta-regression analyses that incorporate treatment-by-
covariate, therapist-by-covariate or indeed patient-by-covariate interactions may be of 
interest. Covariates may be available at the study-, therapist- or patient-levels. These 
explicitly account for unexplained variation at each level, and give appropriate weight 
to the studies, therapists and patients. They are therefore to be preferred over other 
analyses proposed in this context363, 365, 367. The ability to assess different predictors at 
each level also offers more flexibility, increasing the range of models that can be 
explored. While the increased sample sizes open up opportunities not usually present 
at a study-level, if the number of studies, or clusters per study, is small, computational 
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problems may arise due to the presence of negative estimates, making additional 
assumptions necessary. The complexity of the model also needs balancing against the 
precision of its estimates. Analogous models for use when the IPD are unavailable 
would be useful only if cluster averages were reported alongside averages at the 
study-level. As this is unlikely to be typical in practice, interest in estimating 
interactions of this sort justifies collection of the IPD. 
 
The focus here has been exclusively on meta-analyses of absolute mean differences in 
the context of a three-level model. It is important that issues arising specifically in the 
context of odds ratios, relative risks, hazard ratios, and standardised mean differences 
are considered too. Allowance for between-arm heteroscedasticity at multiple levels is 
less straightforward for these summary statistics. If an aggregate approach is adopted 
population averaged or marginal estimates are required, rather than cluster-specific or 
conditional ones431. Properties of the sampling distribution are also more complex422. 
Extensions that allow for further levels, such as centres or repeated observations over 
time, may also be important. These could be fit if the IPD were available. 
 
6.6 Appendix: Programming Code for One-Step Models 
 
STATA VERSION 11 
 
The standard fixed-effects meta-analysis (model 6.21), for a dataset IPD_wide.dta with 
the variables study, treat and outcome can be fitted using the Stata code  
 
use IPD_wide.dta, clear 
xi: regress outcome i.study i.treat 
 
The patient-level error can be allowed to differ by treatment, as in model (6.22), using 
 
xi: xtmixed outcome i.study i.treat, resid(ind, by(treat)) 
 
The fixed-effects meta-analysis corresponding to the two-level heteroscedastic model, 
given in model (6.23), where t_id is the therapist identifier, can be fitted with 
 
xi: xtmixed outcome i.study i.treat || t_id: treat, resid(ind, by(treat)) 
 
For partially-nested designs, this becomes 
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xi: xtmixed outcome i.study i.treat || t_id: treat, nocons resid(ind, by(treat)) 
 
The random-effects meta-analysis, given in model (6.24), can be fitted using 
xi: xtmixed outcome i.study i.treat || study: treat, nocons || t_id: treat, resid(ind, by(treat)) 
 
The meta-regression models in (6.25) to (6.29) cannot currently be fitted in Stata. 
 
MLwiN VERSION 2.02 
 
A dataset was imported starting with variables study_id, t_id, p_id identifying the study, 
cluster (i.e. counsellor or control patient), and patient, followed by indicator variables 
study_id2, study_id3, study_id6, study_id7 for Chilvers 2001, Friedli 1997, King 2000 and 
Simpson 2000, treatment for counselling, control for no counselling, poutcome for the 
BDI, and constant for a column of ones. The data were already sorted on study_id, t_id, 
and p_id and the data had been reduced to complete cases. Once in MLwiN, the RIGLS 
option under Equations was used, and the worksheet then saved. The Equations under 
Model was used to open an interactive window. The outcome was specified, and three 
levels. The standard fixed-effects meta-analysis (model 6.21), was fitted as follows: 
 
 
 
The patient-level error was allowed to differ by treatment, as in model (6.22), using 
 
 
 
where the constant is a fixed parameter only, while the control indicator variable is a 
level 1 term without a fixed parameter. 
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The fixed-effects meta-analysis corresponding to the two-level heteroscedastic model, 
given in model (6.23), was fitted with 
 
 
while the random-effects meta-analysis, given in model (6.24), was fitted using 
 
 
 
In order to fit the meta-regression models in Table 6.3, indicator variables broad_treat, 
broad_cont, narrow_treat, narrow_cont for the treatment-by-patient eligibility interaction 
and man_treat, noman_treat for the treatment-by-standardisation interaction were first 
added to the dataset. The fixed-effect meta-regression for the patient-level variance is 
given as: 
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While the fixed-effect meta-regression for the counsellor-level variance is given as: 
 
 
The parameterisation was altered to include a covariance term to avoid computational 
problems arising from a negative counsellor-level variance observed if counselling was 
standardised. 
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7 META-ANALYSIS OF STANDARDISED MEAN 
DIFFERENCES FROM NESTED THERAPIST DESIGNS 
 
7.1 Introduction 
 
If continuous outcomes are measured with different scales or standards across studies 
the relevant treatment effect may be the mean difference standardised to a common 
metric. Outcomes are then assumed to be linearly equitable across studies, regardless 
of the measurement tool used, and the treatment effect is interpreted as an absolute 
mean difference given in standard deviation units432. In the typical case, where study 
outcomes are independent within and across arms and their variance is homogeneous, 
the population standardised mean difference (SMD) is defined simply as the difference 
in means divided by the common standard deviation of the outcome. Where outcomes 
are clustered within arms, or outcome variances are heterogeneous across arms, there 
is no longer a single standard deviation, and the options available for scaling the mean 
difference can be numerous. In general, each alternative is associated with a different 
population SMD and therefore requires a different interpretation. Figure 7.1 gives an 
overview of the steps in a meta-analysis of SMDs based on the aggregate data. 
 
Figure 7.1 Summary of Steps in Aggregate-Data Meta-Analyses of SMDs 
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In the context of the Behrens-Fisher problem426, Glass433, 434 argued that heterogeneity 
in treatments provided between studies complicates interpretation, and recommended 
the control arm standard deviation be used as the metric of choice if the comparator is 
no treatment. If the control content also varies from study to study, this advantage is 
lost. As an alternative, Huynh41 suggested pooling the standard deviations, using the 
effect size proposed by Cohen435 (p.44) where the sample size in each arm is assumed 
to be equal. While the resulting distribution is somewhat contrived and requires careful 
interpretation436, this SMD has the advantage of reducing to the standard SMD when 
outcome variances are homogeneous. It also utilises all the available data, minimising 
the small-sample bias in the study estimates identified by Hedges432, 437. When sample 
sizes differ across arms, a more general pooled outcome variance could be used (see 
6.8). Again the sample variances estimate different population variances in this case. A 
further option, if available, might be to use the associated baseline standard deviation. 
As a metric this is more usually recommended for standardised mean change scores149-
151, 438, 439, and assumes homoscedasticity across arms, but not necessarily across time, 
due to random allocation of treatments to patients150, 151. This may appeal particularly 
when the eligibility criteria are similar across the studies. 
 
Where outcomes are clustered within arms but the outcome variances are assumed to 
be homogeneous across arms, a situation that is plausible in cluster-randomised trials, 
the total outcome variance is split into within- and between-cluster components. White 
and Thomas42 and Hedges43 have suggested three further population SMDs based on 
these standard deviations, respectively. When the ICC is known and between zero and 
one, they can be easily converted. This facilitates comparability in the definition of the 
SMD across studies. If there is only one cluster per arm, the between-cluster variance 
will not be defined. Likewise the within-cluster variance may be unavailable if analyses 
are reported at the cluster-level. As a result, assumptions could be made regarding the 
ICC in such studies, so that the SMD might be reported and interpreted in units of the 
total standard deviation. While the choice of metric depends on the inference that is of 
interest to the meta-analyst43, SMDs based on the total and within standard deviations 
reduce to the usual SMD when outcomes are independent. If clustering was ignored in 
published analyses, estimates of the total, within and between standard deviations are 
unlikely to be readily available. White and Thomas42 and Hedges43 therefore suggested 
the usual or naïve standard deviation as a proxy for the total standard deviation when 
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estimating the SMD based on the latter, allowing for an additional bias that arises in 
doing so. 
 
Use of the individual-patient-data in meta-analyses of SMDs appears to be limited, but 
see440-442 for examples. Goldstein et al44 described a one-step approach, suggesting the 
level-1 or within-cluster standard deviation as the common metric. This was illustrated 
using studies of class sizes, in which students were nested within classes, schools and 
studies and small versus large class sizes represented the treatment arms. Inclusion of 
a further level in the meta-analysis between the classes and studies makes Goldstein 
et al’s44 approach very relevant. However the schools were crossed with the treatment 
arms in their example, and while they alluded to more complex models which allow for 
between-arm or study heteroscedasticity, they did not consider nested study designs; 
the rationale for, or implications of, the choice of metric; allowance for imprecision in a 
standardising standard deviation; or the relationship between the means by which the 
data are standardised and the choice of model for the meta-analysis. 
 
Nested therapist designs are characterised by between-arm heteroscedasticity at both 
the therapist and patient levels84, 286. Methods are therefore needed that relax both the 
independence and common variance assumptions for the studies, allowing the sample 
sizes to differ across arms. The aim of this chapter was accordingly to adapt, illustrate 
and compare aggregate and one-step methods for pooling SMDs from nested therapist 
designs. The mixture of designs employed in a psychotherapy context (see Chapter 3), 
implies a general metric, with an equivalent interpretation across study designs, would 
be attractive. The use of the pooled total, naïve or within-cluster standard deviation in 
an aggregate setting acts as a natural extension of Huynh41, White and Thomas42 and 
Hedges43. As the within-cluster standard deviation is not defined for the control arm of 
studies with partially nested designs, methods relating to the pooled total SMD have a 
greater potential in this regard. However, since the total and naïve standard deviations 
are affected by within-study clustering, their SMD estimate is too. This complicates the 
meta-analysis, and makes its interpretation more difficult, particularly if the underlying 
ICCs are believed to vary from study to study. Given that Glass’ SMD avoids the impact 
of clustering on the study estimate in the context of partially nested designs, it has the 
potential to avoid some of the additional complexities found for the pooled total SMD. 
Its use is however restricted to the special case where studies have partially nested or 
independent designs. 
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The chapter is structured as follows. Section 7.2 sets out the aggregate-data methods, 
initially outlining standard fixed- and random-effects meta-analyses and the distinction 
between Cohen’s d  and Hedges’ g , and then proposing a more general approach that 
simultaneously allows for within-study clustering and between-arm heteroscedasticity. 
Section 7.3 sets out the one-step methods, initially describing the means by which the 
outcomes are transformed, and then outlining the multilevel meta-analysis models that 
correspond to different choices of standardising metric. These are illustrated in Section 
7.4 using the counselling in primary care example introduced in Chapter 4. 
 
7.2 Aggregate-Data Methods 
 
7.2.1 Standard Fixed- and Random-Effects Meta-Analysis Models 
 
Where the independence and common variance assumptions hold for all the studies to 
be combined, the population SMD is defined as145 
 
Hh
h
hh
hSMD ,,1,01, K=
−
=
σ
µµθ  (7.1) 
 
with the difference in the population means of the intervention and control arms of the  
thh  study given by 01 hh µµ − , and the common metric by the standard deviation of the 
outcome, hσ . The population metric could be estimated by 1hs , 0hs  or by hs , where s  
denotes the sample estimate. However, the pooled standard deviation, hs , maximises 
the degrees of freedom available. As hh MSEs =
2  (see 6.9), it follows that the sampling 
distribution of 2hs  is exactly proportional to a chi-square with 201 −+ hh nn  degrees of 
freedom. Where the study sample sizes are large, so that all of the 2
hs
df  are also large, 
the study estimate of hSMD,θ  is given simply by Cohen’s d , 
 
h
hh
hdsCohen
s
yy 01
,'
ˆ
−
=θ      (7.2) 
 
where 01 hh yy −  is the difference in the sample means, and the sampling distribution is 
given asymptotically by148, 432, 437 
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If the study sample sizes are small, and particularly if { }2hsdf 10≤ , Hedges
432, 437 showed 
that Cohen’s d  is biased for hSMD ,θ , and derived an alternative estimator to correct for 
this. He gave Hedges’ g as 
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An approximation for the small-sample correction )(dfc  was given by Hedges432, 437 as 
 
14
31)(
−
−≈
dfdfc      (7.6) 
 
Hedges’ g  is unbiased, regardless of the degrees of freedom available to estimate 2hs , 
so is preferred over Cohen’s d . Since ( ) 1=∞c , Hedges’ g  converges to Cohen’s d  as 
study sample sizes increase, but it is uniformly smaller than Cohen’s d  otherwise432, 
437. Thus, the difference between these estimators is only important when the degrees 
of freedom available for estimating the standardising metric are very small, in one or 
more of the studies. 
 
It is evident from (7.3) and (7.4) that the sampling variance of Cohen’s d and Hedges’ 
g is a function of the squared parameter, 2
,hSMDθ . Hedges432, 437 suggested substituting 
the squared sample estimate when estimating the standard error, White and Thomas42 
(p.150) show that this introduces bias. This is because the expectation of the squared 
estimate is equal to the squared parameter plus the variance of the estimate. That is, 
( ) { }2ˆ22ˆ θσθθ +=E . They proposed a refined estimator for the exact variance, given by 
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where the first term relates to the variance of the numerator of the study estimate and 
the second to the variance of its denominator. This estimator was originally derived by 
Hedges443 (p.391). 
 
It is clear that the standard error of an SMD increases as a function of its expectation, 
mainly if the degrees of freedom available for estimating its denominator are low. This 
is problematic if a common metric is assumed across studies, as in standard fixed- and 
random-effects meta-analysis models (Models 6.1 and 6.2). It has a similar effect here 
as it did for ICCs (Section 5.3.1), i.e. the pooled estimate may be unduly affected by a 
single study with a small SMD. Hedges437 argued that when the denominator degrees 
of freedom are large this can be ignored. If they are not Hedges432 advised modifying 
the estimate of the sampling variance used for study weights, replacing the population 
value by the pooled estimate and iterating, particularly when the SMDs vary across the 
studies. As with other aggregate meta-analyses, it is common to assume the sampling 
variance is known when estimating the study weights437. A robust sandwich estimator 
proposed by Sidik and Jonkman40 to protect against imprecision in the study weights is 
also applicable in this context (see Section 6.2.3). 
 
7.2.2 General Fixed- and Random-Effects Meta-Analysis Models 
 
7.2.2.1 Choice of Metric for the Population Standardised Mean Difference 
 
The general population SMD is defined as 
 
hden
hh
hSMD
,
01
, σ
µµθ −=  (7.8) 
 
where the form of hden,σ  depends on the choice of metric. So, for example, 0, hhden σσ =  
for Glass’s433, 434 SMD. It is equal to ( ) 22021 hh σσ +  for Huynh’s41 SMD, and to thσ , whσ  
or bhσ  for SMDs using the total, within- or between-cluster standard deviations
42, 43. 
 
The most general standardising metric for studies with nested therapist designs is the 
pooled total standard deviation. The SMD based on this is given by 
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where the cluster sizes are assumed to be equal within the arms, and n  denotes the 
number of patients. This simplifies to 
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for partially nested designs, and to 
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for the Behrens-Fisher problem. When the sample sizes are equal across arms, (7.11) 
simplifies further to Huynh’s41 SMD. If the sample sizes and the outcome variances are 
equal across the arms, (7.9) reduces to the SMD based on thσ , described by White and 
Thomas42 and Hedges43. As such, the standard case, the Behrens-Fisher problem, and 
other two-level nested designs can all be viewed as special cases. While meta-analyses 
of mixed designs are likely to lead to systematic variation in the estimates across study 
designs, the use of a general metric does ensure their interpretation is comparable. 
 
7.2.2.2 Sampling Distributions for the Standardising Standard Deviations 
 
The sample estimate of the pooled total variance is given by 
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Using a Satterthwaite approximation108, the distribution of 2pths  can be approximated to 
a chi-square with degrees of freedom given by 
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This simplifies to give 
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This, in turn, simplifies to give 
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where 00 =hρ , 00 hh nk =  and 10 =hm  for a partially nested design. 
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Tables 7.1 and 7.2 summarise the sample estimates for the pooled total variance and 
their sampling distributions, respectively, under the other more restrictive scenarios. In 
each case the general formula for the degrees of freedom (7.13) simplifies to the more 
specific one. Under the most restrictive assumptions, (7.13) reduces to 201 −+ hh nn . If 
the common variance assumption is relaxed, (7.13) reduces to the degrees of freedom 
Huynh41 (p.21) gave for the Behrens-Fisher problem. If the independence assumption 
is instead relaxed, (7.13) reduces to the degrees of freedom under a random-intercept 
model. This corrects typographical errors in White and Thomas42 (p.151) and Hedges43 
(p.364). The other degrees of freedom relate to (7.9), (7.10) and (7.11), respectively. 
 
The general form of the pooled naïve variance is 
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assuming the cluster sizes are equal within arms. Its expectation under a two-level 
heteroscedastic model is 
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The pooled naïve standard deviation and its expectation are summarised in Table 7.3 
for other more restrictive situations, including that of partial nesting. The expectations 
of the total and naïve standard deviations are identical if the independence assumption 
holds. If clustering is present, the naïve variance underestimates the total variance by 
a factor linked to the design effect, denoted b  by Hedges43. 
 
As ( )1−= hihi
hi
hi
mk
SSWMSW  and 
1−
=
hi
hi
hi k
SSBMSB , it follows that 
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Table 7.1 Family of Total Standard Deviations under Various Model Assumptions 
Assumptions Standardising Metric 
Outcome 
Variances 
Clustering Sample Sizes hdens ,  as Sums of Squares 
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Note σ = the population outcome variance, s = its sample estimate, ρ = the population intraclass correlation, k = the number of clusters, m = the cluster size, n = the sample size, h = study, i = arm, b = between,   
t = total, w = within, e = error, SS = sums of squares
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Table 7.2 Sampling Distributions for the Family of Total Variances 
Assumptions  Degrees of Freedom 
Outcome 
Variances 
Clustering Sample Sizes 
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Note σ = the population outcome variance, s = its sample estimate, ρ = the population intraclass correlation, k = the number of clusters, m = the cluster size, n = the sample size, h = study, i = arm, b = between,   
t = total, w = within
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The pooled naïve variance is thus distributed proportionately to a chi-square according 
to Satterthwaite108, with approximate degrees of freedom given by 
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Rearranging (5.26) gives 
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and substituting (7.19) into (7.18) gives 
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which, in turn, reduces to 
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where 00 =hρ , 00 hh nk =  and 10 =hm  for a partially nested design. 
 
Table 7.4 summarises the sampling distributions for the more restrictive scenarios. As 
expected, under independence, the degrees of freedom are the same for the total and 
naïve sample variances. Where homogeneous clustering is assumed, (7.20) reduces to 
the degrees of freedom given under the random-intercept model by Hedges416 
(p.156), correcting a further typographical error in White and Thomas42 (p.151). 
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Table 7.3 Family of Naïve Standard Deviations under Various Model Assumptions 
Assumptions Standardising Metric 
Outcome 
Variances 
Clustering Sample Sizes hdens ,  in Sums of Squares Expectation of hdens ,  
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Note σ = the population outcome variance, s = its sample estimate, ρ = the population intraclass correlation, k = the number of clusters, m = the cluster size, n = the sample size, h = study, i = arm, b = between,   
t = total, w = within, e = error, SS = sums of squares 
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Table 7.4 Sampling Distributions of the Family of Naïve Variances 
Assumptions  Degrees of Freedom 
Outcome 
Variances 
Clustering Sample Sizes 
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Note σ = the population outcome variance, s = its sample estimate, ρ = the population intraclass correlation, k = the number of clusters, m = the cluster size, n = the sample size, h = study, i = arm, b = between,  
t = total, w = within 
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7.2.2.3 Sampling Distribution of the Study Estimates 
 
Sampling distributions for SMD estimates all have a similar form. Huynh41 (pp.4-6) and 
Hedges43 (pp.360-362) gave general distributions for biased and unbiased estimators 
under independence and homoscedasticity, respectively. White and Thomas42 (p.150) 
gave a general sampling variance for cluster-randomised trials. These can be extended 
to give a yet more general sampling distribution, as follows. 
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( ) hihthi ma ρ11 1 −+= ,  ( )
hi
hih
whi
m
a
ρ
ρ
−
−+
=
1
11 1  or ( )
hi
hih
bhi
m
a
ρ
ρ11 1 −+
=      (7.23) 
 
could be used if the SMD denominator is a function of total, within- or between-cluster 
standard deviations, respectively. Suppose then that [ ] hhdenhden bsE /2 ,2 , =σ , where hb  is 
a known bias in the standardising metric, given by 
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for the pooled total standard deviation. The biased estimator of hSMD,θ  is given by 
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where 2
,hdens  is a quadratic form in normal variates derivable from the study report and 
the sample means hiy  and variances 
2
his  are mutually independent. Extending Huynh
41 
and Hedges43, hung ,  can be re-written as 
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where 
hhdft ϕ, is a non-central t-distribution with degrees of freedom { }2
,hdensh
dfdf = .  
 
The noncentrality parameter is equal to 
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This simplifies to Cohen’s d  where 101 == hh aa , 1=hb  and 
2
0
2
1 hh σσ = . In which case, 
[ ] 01 11 hhh nnGVar += . It simplifies to Huynh’s41 (p.4) g  where 101 == hh aa , 1=hb  
and [ ]hGVar  is equal to Huynh’s 2k ; to White and Thomas’42 (p.150) ung where 
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It follows from the definition of a non-central t-distribution444 that where 2>hdf  
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and that 
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as given by Huynh41 (p.4) and White and Thomas42 (p.150). 
 
The asymptotic standard error of hung ,  is given by 
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This corrects typographical errors in Huynh41 (p.5) and Hedges43 (p.361), where =hdf  
hh cb
2 in Hedges43, due to use of Box’s445 generalisation of Satterthwaite’s procedure108 
for the degrees of freedom. 
 
The result in (7.29) implies that the unbiased estimator of hSMD,θ  is 
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This simplifies to Hedges’ g  where 101 == hh aa , 1=hb  and 
2
0
2
1 hh σσ = . In which case, 
[ ] 01 11 hhh nnGVar += . It simplifies to Huynh’s41 (p.6)h  where 101 == hh aa , 1=hb  
and [ ]hGVar is equal to Huynh’s 2k ; to White and Thomas’42 (p.150) adjg where 
hihi deffa =  ( )( )hhim ρ11 −+= , 1=hb  and 2021 hh σσ =  with ( ) ( )01 11 hhhh nndeffGVar +=  
or 11 hh ndeff  00 hh ndeff+ ; and to Hedges’43 (p.362) ( )cbDJ /2  where 101 ≠= hh aa , 
2
0
2
1 hh σσ =  and [ ]hGVar  hh Na ~=  where ( ) 101 11~ −+= hhh nnN .  
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It follows that 
 [ ] ( ) [ ] hSMDhunhhadj gEdfcgE ,,, θ==     and that 
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where 2>hdf , as given by Huynh41 (p.6) and White and Thomas42 (p.143). 
 
If 1=hb , the variance of hadjg ,  can be re-written42 as 
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As noted by White and Thomas42, these properties follow from hU  having a Gamma 
distribution with shape parameter 2/hdf  and mean 1. They are equally properties of a 
noncentral t-distribution, in that the raw and central moments of the noncentral t-
distribution are functions of the noncentrality parameter hϕ  whose coefficients are, in 
turn, functions of the degrees of freedom446. Hogben et al446 give coefficients for the 
first and second central moments and the second raw moment as [ ]hUE , [ ]hUVar  
and [ ]2hUE , respectively. 
 
White and Thomas42 (p.150) show that a further adjustment is required to estimate 
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As the degrees of freedom are approximate, so is the estimated standard error. The 
accuracy of the Satterthwaite108 approximations are dependent on the imprecision with 
which the component parameters are estimated by their sample counterparts. 
 
Table 7.5 summarises the sampling distributions for the estimators that are considered 
here for nested therapist designs. It can be seen that clustering and heteroscedasticity 
affect the study estimate and its standard error via the degrees of freedom, the study 
estimate via the denominator and its associated bias, where applicable, and finally, the 
standard error via [ ]GVar . 
 
7.3 One-Step Multilevel Models of the IPD 
 
7.3.1 Data Preparation 
 
When the IPD are available, Goldstein et al44 suggested the following transformation, 
 
s
yy
y hhijlhijl
0−
=′       (7.35) 
 
where hijly is the outcome for patient l  in cluster j  of treatment arm i  of study h . 
 
They argued that subtracting the control mean 0hy  gives the outcomes within studies 
a common origin, transforming outcomes in a one-step approach into differences from 
this origin. It was claimed that this is important when the studies use different 
measurement scales because standardised means, like absolute means, are expected 
to vary as a function of the study44 and that it is the differences between standardised 
means that are assumed to be comparable. In practice, however, subtracting the 
control mean only affects the estimates of the fixed study effects and is unnecessary44. 
Standardised outcomes could then be used in place of absolute outcomes in the 
models described in Chapter 6. 
 
As before, the divisor s  provides the metric. Goldstein et al44 assumed the population 
value is known, and equal to the sample estimate, ignoring Hedges’432, 437 small-sample 
bias. While this is reasonable for studies that have large effective sample sizes such as 
those in their example, it will lead to bias otherwise, even if the total sample size is
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Table 7.5 Sampling Distributions for Estimators of the Standardised Mean Difference 
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large. This can be avoided by first dividing the metric by its correction factor ( )hdfc , 
using (7.5) or (7.6) and the degrees of freedom given in Table 7.2 or 7.4. As a result, 
the one-step models described by Goldstein et al44 give estimates of Cohen’s d , but 
they could be easily adapted to provide estimates of Hedges’ g . 
 
In the standard case, s  denotes the pooled within-treatment standard deviation hs . It 
is either the pooled naïve phs  or control arm standard deviation 0hs under the Behrens-
Fisher problem, depending on the inference that is of interest to the meta-analyst. If 
crossed therapist designs are to be combined, the pooled within-treatment standard 
deviation may be a within, between or total standard deviation. As therapists provide 
both treatments, the standardisation could operate at either the study or the therapist 
level. Goldstein et al44 chose to standardise at the cluster-level within studies, adopting 
a cluster-specific, or conditional, approach. Aggregate meta-analyses implicitly adopt a 
population-average, or marginal, approach, standardising at the study-level, even in 
the presence of within-study clustering effects. 
 
Regardless of the availability of IPD, standardising at the cluster-level is not advisable 
for nested study designs because the clusters relate to only one treatment arm, and a 
within-cluster metric cannot be pooled across arms within studies. It would be possible 
to use the within-cluster variance averaged across clusters within studies, but this is a 
marginal quantity and implies a random-intercept or random-coefficient model for the 
studies. If the interpretation of an SMD is to be meaningful, its metric should not be 
confounded with the mean difference within the studies (see Greenland447 for a similar 
argument regarding standardised regression coefficients). Suppose, for instance, that 
the true outcomes were unity in all arms and studies. Rather than equalling zero, the 
study SMDs would be positive or negative, depending on the respective values of the 
treatment-specific standard deviations. For this reason, the standardising metric must 
be common to all arms of a study, especially if there is heteroscedasticity between the 
arms. 
 
7.3.2 Random-Effects Meta-Analysis Models 
 
Once the data are prepared, the one-step models described in Chapter 6 for absolute 
mean differences can be applied (see Section 6.3). The choice of model, however, will 
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depend on the characteristics of the studies included and the choice of metric. Starting 
with the standard case, a random-effects meta-analysis model is appropriate because 
within-study variance estimates are used to define the study metric. This is given by 
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2
lllstudyl
H
h
hlhl ettxy ++++=′ ∑
=
τθβα      (7.36) 
 
where α  is the mean standardised outcome in the control arm of study 1, hlx  and lt  
are indicator variables for the other studies and for the treatment arm respectively, hβ  
and θ  are fixed standardised study and treatment effects respectively, and )2( )(lstudyτ and 
)1(
le  are the random treatment effect for study h  and the random error for patient l  in 
study h  respectively, with ( )2)2( )( ,0~ ττ Nlstudy  and ( )1,0~)1( Nel .  
 
Where Glass’ SMD is used in the context of the Behrens-Fisher problem, between-arm 
heteroscedaticity at the patient-level should be taken into account in the meta-analysis 
as well. The appropriate random-effects model is 
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where the )1(0le  are now random errors for patient l  in the control arm of study h , and 
the )1(1le  are their treatment arm counterparts. Here, ( )1,0~)1(0 Ne l  and ( )21)1(1 ,0~ el Ne σ , 
where 121 ≠eσ .  
 
If Glass’ SMD is instead used for studies with partially nested designs, clustering in the 
treatment arm should also be taken into account. The meta-analysis model becomes 
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where the lltherapist tu
)2(
)(1  are random effects for therapist j  in the treatment arm of 
study h  and ( )21)2( )(0 ,0~ ultherapist Nu σ . The therapist random effects are assumed equal 
across studies, resulting in an exchangeable random structure at the study-level within 
arms. 
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When the pooled within-treatment standard deviation phs  is used in the context of the 
Behrens-Fisher problem, Model (7.37) is the appropriate model. Here, ( )20)1(0 ,0~ el Ne σ  
and ( )21)1(1 ,0~ el Ne σ  with ( ) ( ) /11 211200 ee nn σσ −+− 1210 =−+ nn . If the pooled within-
treatment naïve standard deviation phs  is used for nested study designs, Model (7.37) 
should be extended to allow for within-study clustering, giving 
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where )2( )(1 ltherapistu  and 
)2(
)(0 ltherapistu  are random effects for therapist j in the treatment and 
control arms of study h  respectively, and ( )21)2( )(1 ,0~ ultherapist Nu σ , ( )20)2( )(0 ,0~ ultherapist Nu σ  
and 001 =uσ . The average of the total variances ( )( ) ( )( )2021120200 11 eueu nn σσσσ +−++−  
( )2/ 10 −+ nn  is equal to one, assuming bias in the naïve standard deviations has been 
taken into account when preparing the data. Model (7.39) remains appropriate where 
the pooled total standard deviation pths is used directly, although this implicitly assumes 
an unstructured random structure at the study-level. Where the within- and between-
cluster variances are homogeneous across arms, Model (7.39) simplifies to 
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7.4 Application to Counselling in Primary Care 
 
Short-term outcomes relating to the GHQ314, the Symptom Index318, the BDI315, 316, 319, 
320 and the HADS depression-subscale317 were available for 850 patients from seven 
counselling in primary care trials. Of these, 494 (58%) had been allocated counselling 
with one of 56 counsellors. Overall, the cluster sizes ranged from 1 to 47, and had a 
median of 4.5, and an inter-quartile range of 2 to 10.5. Data were available relating to 
5 or more patients for 33 of the counsellors. Since all seven of the trials had a partially 
nested design, some of the complexities were avoided. For simplicity, an exchangeable 
variance-covariance structure was assumed for the counselling arm in this chapter, 
consistent with Chapter 5. 
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7.4.1 Aggregate versus One-Step Meta-Analyses 
 
To reflect common lack of knowledge about cluster size distributions, as in Chapter 6, 
equal cluster sizes were assumed for all aggregate analyses. The pooled ICC estimate 
of 0.022 (Chapter 5), based on the non-censored doubly-corrected internal estimates, 
was used regardless of the model. Second iteration estimates of the standard errors 
were used throughout for the weights. One-step models were implemented in MLwiN 
using RIGLS for its flexibility, with the data prepared ignoring small-sample bias from 
( )dfc  and bias in the pooled naïve standard deviation pertaining to hb . Programming 
details for MLwiN and Stata are given as an appendix (see Section 7.6). 
 
7.4.1.1 Glass’ SMD 
 
Table 7.6 summarises the estimates and their standard errors for fixed- and random-
effects meta-analyses, progressively relaxing the independence and common variance 
assumptions within the studies. Glass’ pooled SMD and its standard error for the usual 
aggregate fixed-effects meta-analysis are -0.224 and 0.072. The associated two-sided 
95% CI is -0.37 to 0.08 indicating that counselling reduces mental health symptoms in 
the short-term by an average of about 0.2 standard deviations, although this reduction 
is not statistically different from zero at the 5% significance level. The equivalent one-
step estimate and its standard error are -0.228 and 0.067, with the two-sided 95% CI 
using the t  value, -0.36 to 0.10. As in Chapter 6, the similarity of these results implies 
that imprecision in aggregate within-study variance estimates is not important in the 
example under this model. The patient-level variance estimate is not 1.000, however, 
but 0.870 because this model is inconsistent with the way in which the study metrics 
were defined. The interpretation of the SMD is therefore problematic under this model. 
 
If within-study clustering is ignored, it can be seen that the one-step random-effects 
model with heterogeneous patient-level variances is appropriate, as it has an estimate 
of 1.000 for the patient-level variance in the control arm. Between-study heterogeneity 
in the SMD estimates has less impact than between-arm heterogeneity in the patient-
level variances on the interpretation of the model estimates here. The pooled SMD and 
its standard error are -0.230 and 0.079. The small observed increase in the standard 
error is largely due to between-study heterogeneity in the SMD, which is estimated to 
be 0.011 indicating that about 1% of the total variance is among the studies. The 95% 
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CI using the t value, given by -0.42 to 0.04, is wider because the degrees of freedom 
is a function of the number of studies rather than the number of patients in a random-
effects meta-analysis. If the aggregate model had been used, the pooled SMD would 
have been -0.249. Allowing for between-arm heteroscedasticity altered the aggregate 
estimates but not their one-step counterparts in this example. The explanation for this 
may be bias in the estimate of 2τ , or it might reflect the need for additional iterations 
of the weights. In contrast to Chapter 6, the usual and robust standard errors are very 
similar, but the pattern of results across fixed- and random-effects analyses in Chapter 
6 does appear to be replicated. 
 
When within-study clustering is taken into account, the appropriate model remains the 
random-effects model with heterogeneous patient-level variances. The between-study 
heterogeneity estimate, 2τˆ , is however zero so its fixed-effects counterpart is equally 
appropriate in this case. The patient-level variance estimate in the control arm is 0.999 
rather than precisely one. The explanation for this is unclear, as the small-sample bias 
( )dfc  for Glass’ SMD is not affected by clustering in the treatment arm. One probable 
reason is that the therapist-level variance estimate is biased, since it is 0.066, which is 
larger than expected. It is given with reference to the variance in the control arm due 
to the choice of metric, which is inappropriate under a two-level heteroscedastic model 
at the study-level. Although this needs further investigation, it implies that Glass’ SMD 
is not appropriate for partially nested designs. The impact of model misspecification on 
the pooled SMD, its standard error or interpretation appears to be unimportant in this 
example. In fact, Glass’ SMD is insensitive to the choice of model, presumably because 
the between-study heterogeneity is minimal. 
 
7.4.1.2 Pooled Total SMD 
 
Table 7.7 summarises the estimates and their standard errors for the equivalent fixed- 
and random-effects meta-analyses for the population pooled total SMD. The published 
meta-analysis (Table 4.2) used a slightly different subset of patients. The equivalent 
aggregate fixed-effects model with homogeneous patient-level variances in Table 7.7 
gives a pooled SMD of -0.259, standard error of 0.072 and 95% CI of -0.40 to -0.12. 
This is comparable to what was published (SMD=-0.24, 95% CI -0.38 to -0.10), which 
suggests that excluding 18 patients with missing counsellor identifiers had little impact 
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Table 7.6 Aggregate versus One-Step Meta-Analyses of Glass’ SMD in Outcome between Counselling and Control 
AGGREGATE Ignoring Within-Study Clustering Allowing for Within-Study Clustering (Internal #1) 
Level 1 Variance Homogeneous Heterogeneous Homogeneous Heterogeneous 
Weights  Glass’ SMD Weights Glass’ SMD Weights Glass’ SMD Weights Glass’ SMD 
Study % F % R (Standard Error) % F % R (Standard Error) % F % R (Standard Error) % F % R (Standard Error) 
Boot 1994 13.0 13.2 -0.46 (0.205) 13.8 14.0 -0.46 (0.190) 12.9 13.0 -0.46 (0.214) 13.8 14.0 -0.46 (0.196) 
Chilvers 2001 10.6 11.0 0.04 (0.220) 8.1 9.1 0.04 (0.238) 11.3 11.5 0.04 (0.222) 8.5 9.3 0.04 (0.241) 
Friedli 1997 14.0 14.1 -0.36 (0.195) 15.9 15.7 -0.36 (0.174) 13.4 13.5 -0.36 (0.207) 15.6 15.5 -0.36 (0.182) 
Harvey 1998 13.4 13.6 -0.18 (0.196) 12.9 13.3 -0.18 (0.190) 13.9 14.0 -0.18 (0.201) 13.1 13.4 -0.18 (0.195) 
Hemmings 1997 15.0 14.9 -0.07 (0.184) 15.0 14.9 -0.07 (0.175) 13.6 13.6 -0.07 (0.203) 14.1 14.2 -0.07 (0.187) 
King 2000 14.9 14.9 -0.48 (0.190) 19.9 18.4 -0.48 (0.158) 15.7 15.6 -0.48 (0.194) 20.9 19.4 -0.48 (0.160) 
Simpson 2000 19.1 18.3 -0.06 (0.164) 14.4 14.5 -0.06 (0.179) 19.2 18.7 -0.06 (0.171) 14.0 14.2 -0.06 (0.188) 
Fixed: Usual 100.0 100.0 -0.224 (0.072) 100.0 100.0 -0.255 (0.068) 100.0 100.0 -0.225 (0.075) 100.0 100.0 -0.258 (0.071) 
Fixed: Robust 100.0 100.0 -0.224 (0.078) 100.0 100.0 -0.255 (0.080) 100.0 100.0 -0.225 (0.079) 100.0 100.0 -0.258 (0.081) 
Random: Usual 100.0 100.0 -0.224 (0.078) 100.0 100.0 -0.249 (0.078) 100.0 100.0 -0.225 (0.079) 100.0 100.0 -0.252 (0.079) 
Random: Robust 100.0 100.0 -0.224 (0.078) 100.0 100.0 -0.249 (0.079) 100.0 100.0 -0.225 (0.079) 100.0 100.0 -0.252 (0.080) 
D-L 2ˆ
hθτ
 0.006 0.009 0.003 0.007 
ONE-STEP Ignoring Within-Study Clustering Allowing for Within-Study Clustering (Internal #1) 
Level 1 Variance Homogeneous Heterogeneous Homogeneous Heterogeneous 
Meta-Analysis Fixed Random Fixed Random Fixed Random Fixed Random 
Intercept -0.15 (0.099) -0.11 (0.113) -0.17 (0.100) -0.13 (0.116) -0.10 (0.110) -0.10 (0.113) -0.10 (0.118) -0.10 (0.118) 
Chilvers 2001 0.28 (0.136) 0.21 (0.155) 0.31 (0.136) 0.24 (0.158) 0.20 (0.149) 0.19 (0.153) 0.21 (0.156) 0.21 (0.156) 
Friedli 1997 0.08 (0.126) 0.06 (0.148) 0.08 (0.125) 0.07 (0.150) 0.05 (0.147) 0.05 (0.150) 0.05 (0.157) 0.05 (0.157) 
Harvey 1998 0.18 (0.123) 0.14 (0.150) 0.20 (0.121) 0.15 (0.152) 0.11 (0.143) 0.10 (0.149) 0.10 (0.153) 0.10 (0.153) 
Hemmings 1997 0.27 (0.116) 0.20 (0.147) 0.29 (0.114) 0.22 (0.148) 0.18 (0.148) 0.17 (0.152) 0.17 (0.161) 0.17 (0.161) 
King 2000 0.03 (0.125) 0.03 (0.144) 0.03 (0.124) 0.03 (0.147) 0.00 (0.140) 0.01 (0.144) -0.01 (0.149) -0.01 (0.149) 
Simpson 2000 0.24 (0.118) 0.17 (0.138) 0.26 (0.117) 0.19 (0.141) 0.17 (0.133) 0.16 (0.137) 0.18 (0.142) 0.18 (0.142) 
 
Counselling -0.228 (0.067) -0.230 (0.078) -0.229 (0.068) -0.230 (0.079) -0.230 (0.075) -0.230 (0.078) -0.232 (0.079) -0.232 (0.079) 
2τˆ   0.012 (0.013)  0.011 (0.012)  0.003 (0.014)  0.000 (0.000) 
2
ˆ
vσ      0.045 (0.027) 0.043 (0.030) 0.066 (0.031) 0.066 (0.031) 
2
ˆ
eσ  0.870 (0.042) 0.868 (0.042) 1.003 (0.075) 1.000 (0.075) 0.852 (0.042) 0.852 (0.042) 0.999 (0.075) 0.999 (0.075) 
2
ˆξσ    0.775 (0.050) 0.774 (0.050)   0.732 (0.049) 0.732 (0.049) 
Counsellor ICC - - - - 0.050 0.048 0.083 0.083 
-2 Log Likelihood 2286.17 2288.48 2279.31 2282.01 2286.30 2286.75 2277.87 2277.87 
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on these results. At a 5% significance level, the standard SMD is statistically different 
from zero. The one step counterparts are extremely similar with the pooled SMD being 
-0.262 and its standard error 0.071. The 95% CI using the t  value is also -0.40 to 
0.12, so that nothing is gained by using a full-likelihood approach under this model in 
this example. The patient-level variance estimate is 1.005. As the metric for the one 
step models was the pooled naïve standard deviation, the appropriate model making 
standard assumptions is the random-effects model, where the patient-level variance 
estimate is exactly 1.000. 
 
Under the Behrens-Fisher problem, the appropriate model allows for heteroscedasticity 
between arms at the patient-level as well. Since its impact on the degrees of freedom 
and the standard error is a function of the ratio of the sample sizes between arms, the 
relevant SMD is an extension of Huynh’s41 SMD which allows for a ratio other than 
one. Unequal patient sample sizes were observed between arms for Boot et al314, 
Harvey et al317 and Hemmings et al318 all favouring counselling, making this issue 
pertinent for this example. The pooled SMD and standard error for the aggregate 
random-effects model with heterogeneous patient-level variances are -0.264 and 
0.094, while their one-step counterparts are -0.265 and 0.093. Here it is the average 
of the patient-level variances i.e. ((494-1)*0.878+(356-1)*1.170)/(850-2) that is equal 
to 1.000. 
 
The methods described by White and Thomas42 and Hedges43 do not apply where the 
within-cluster variance is not defined for at least one study arm, unequal sample sizes 
are observed across study arms, or the assumption of between-arm homoscedasticity 
does not hold for the within- or between-cluster variance components. In the context 
of a one-step approach, a random-intercept model could be assumed for the studies, 
but a choice must be made between including patients in the control arms as clusters 
of size one or as clusters of size 0hn . If clusters of size one are used, the within-cluster 
variance is not defined for the control arm and is estimated solely within the treatment 
arm. Although the between-cluster variance is available for both arms, it is unlikely to 
be equal. If clusters of size 0hn  were used instead, the between-cluster variance is not 
defined for the control arms. This time, while the within-cluster variance is available in 
both arms, the number of clusters is unequal, giving disproportionately greater weight 
to the treatment arm. In neither case is a random-intercept model appropriate. 
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Table 7.7 Aggregate versus One-Step Meta-Analyses of the Pooled Total SMD in Outcome between Counselling and Control 
AGGREGATE Ignoring Within-Study Clustering Allowing for Within-Study Clustering (Internal #1) 
 Homogeneous SD Heterogeneous SD Pooled Total SD Pooled Naive SD 
Weights SMD Weights SMD Weights SMD Weights SMD 
Study % F % R (Standard Error) % F % R (Standard Error) % F % R (Standard Error) % F % R (Standard Error) 
Boot 1994 13.0 13.6 -0.54 (0.040) 12.2 13.0 -0.54 (0.046) 12.2 13.0 -0.54 (0.049) 12.2 13.0 -0.54 (0.049) 
Chilvers 2001 10.5 11.9 0.03 (0.048) 11.0 12.1 0.03 (0.049) 11.5 12.4 0.03 (0.050) 11.5 12.4 0.03 (0.050) 
Friedli 1997 13.9 14.2 -0.42 (0.037) 14.2 14.3 -0.42 (0.039) 13.9 14.1 -0.42 (0.043) 13.9 14.1 -0.42 (0.043) 
Harvey 1998 13.5 13.9 -0.20 (0.038) 13.3 13.8 -0.20 (0.041) 13.6 14.0 -0.20 (0.043) 13.6 14.0 -0.20 (0.043) 
Hemmings 1997 15.1 14.8 -0.08 (0.034) 12.7 13.4 -0.08 (0.043) 12.0 12.8 -0.08 (0.049) 12.0 12.8 -0.08 (0.049) 
King 2000 14.9 14.7 -0.57 (0.036) 16.6 15.8 -0.57 (0.034) 17.4 16.4 -0.57 (0.035) 17.4 16.4 -0.57 (0.035) 
Simpson 2000 19.1 16.9 -0.05 (0.027) 19.9 17.5 -0.05 (0.027) 19.3 17.4 -0.05 (0.030) 19.3 17.4 -0.05 (0.030) 
Fixed: Usual 100.0 100.0 -0.259 (0.072) 100.0 100.0 -0.264 (0.074) 100.0 100.0 -0.266 (0.076) 100.0 100.0 -0.266 (0.077) 
Fixed: Robust 100.0 100.0 -0.259 (0.093) 100.0 100.0 -0.264 (0.096) 100.0 100.0 -0.266 (0.097) 100.0 100.0 -0.266 (0.097) 
Random: Usual 100.0 100.0 -0.261 (0.093) 100.0 100.0 -0.264 (0.094) 100.0 100.0 -0.265 (0.094) 100.0 100.0 -0.265 (0.094) 
Random: Robust 100.0 100.0 -0.261 (0.093) 100.0 100.0 -0.264 (0.094) 100.0 100.0 -0.265 (0.095) 100.0 100.0 -0.265 (0.095) 
D-L 2τˆ  0.057 0.060 0.062 0.062 
ONE-STEP (sph) Ignoring Within-Study Clustering Allowing for Within-Study Clustering (Internal #1) 
Level 1 Variance Homogeneous Heterogeneous Homogeneous Heterogeneous 
Meta-Analysis Fixed Random Fixed Random Fixed Random Fixed Random 
Intercept -0.18 (0.106) -0.11 (0.127) -0.20 (0.107) -0.13 (0.133) -0.15 (0.113) -0.11 (0.127) -0.14 (0.121) -0.11 (0.133) 
Chilvers 2001 0.32 (0.146) 0.20 (0.175) 0.36 (0.146) 0.24 (0.181) 0.27 (0.153) 0.20 (0.174) 0.28 (0.161) 0.22 (0.179) 
Friedli 1997 0.09 (0.136) 0.06 (0.168) 0.10 (0.134) 0.07 (0.174) 0.08 (0.148) 0.06 (0.168) 0.07 (0.159) 0.06 (0.176) 
Harvey 1998 0.22 (0.132) 0.14 (0.173) 0.24 (0.130) 0.16 (0.178) 0.18 (0.144) 0.13 (0.172) 0.16 (0.153) 0.13 (0.177) 
Hemmings 1997 0.31 (0.125) 0.19 (0.170) 0.33 (0.122) 0.21 (0.175) 0.25 (0.144) 0.18 (0.171) 0.24 (0.158) 0.19 (0.178) 
King 2000 0.03 (0.134) 0.02 (0.163) 0.03 (0.133) 0.02 (0.169) 0.01 (0.143) 0.02 (0.163) -0.01 (0.152) 0.00 (0.169) 
Simpson 2000 0.28 (0.127) 0.16 (0.157) 0.31 (0.126) 0.19 (0.163) 0.24 (0.135) 0.16 (0.156) 0.24 (0.144) 0.18 (0.162) 
 
Counselling -0.262 (0.071) -0.265 (0.092) -0.263 (0.073) -0.265 (0.093) -0.262 (0.076) -0.265 (0.092) -0.264 (0.081) -0.266 (0.092) 
2τˆ   0.024 (0.021)  0.023 (0.019)  0.021 (0.021)  0.015 (0.020) 
2
ˆ
vσ      0.022 (0.023) 0.012 (0.023) 0.043 (0.027) 0.037 (0.029) 
2
ˆ
eσ  1.005 (0.049) 1.000 (0.049) 1.177 (0.088) 1.170 (0.088) 0.995 (0.049) 0.995 (0.049) 1.172 (0.088) 1.170 (0.088) 
2
ˆξσ    0.881 (0.056) 0.878 (0.056)   0.853 (0.056) 0.854 (0.057) 
Counsellor ICC - - - - 0.022 0.012 0.048 0.042 
-2 Log Likelihood 2408.30 2411.02 2399.67 2403.08 2409.02 2410.82 2400.12 2401.69 
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For illustrative purposes, one-step meta-analysis models were fitted which assumed a 
random-coefficient model for the studies, including the patients in the control arms as 
clusters of size one. The pooled SMD and its standard error for the fixed-effects model 
are extremely similar to the usual estimates. The patient-level variance is 0.995 rather 
than 1.000 due to bias in the study estimates arising from ( )dfc  and hb  being ignored 
in the data preparation. Although their combined impact is observable to three decimal 
places, it is not particularly important in this example. The ICC estimate for this model 
is, interestingly, 0.022. It may be a coincidence that this is equal to the non-censored 
doubly-corrected estimate from Chapter 5, but as the variance components included in 
both models are comparable, it provides support for the methods proposed in Chapter 
5. The pooled SMD and its standard error for the random-effects model are identical to 
the usual estimates. The between-study heterogeneity estimate 2τˆ  is also very similar, 
which largely accounts for this. The pooled counsellor ICC estimate reduces to 0.012, 
however, which indicates that some of the between-counsellor variation in outcomes is 
accounted for by variation between the studies. This is realistic because the treatment 
protocols varied from study to study. 
 
The recommended model for this metric is the random-effects meta-analysis model for 
which a two-level heteroscedastic model has been assumed for the studies. Table 7.7 
gives the aggregate estimates using the pooled total and naïve standard deviations. It 
can be seen that the estimates and their standard errors are essentially identical under 
this model. This implies that using a pooled ICC estimate in the pooled total standard 
deviation but study-specific ICC estimates in the pooled naïve standard deviation is not 
important in this example. This is reasonable because no between-study heterogeneity 
was observed in the ICC estimates in Chapter 5. The pooled SMDs relating to the one-
step models are similar for this model, and across all the models using the pooled total 
and naïve standard deviations. The standard errors relating to the fixed-effects models 
increase as the complexity of the model increases, while those relating to the random-
effects models remain stable regardless of the assumptions made. As in Chapter 6, the 
D-L estimate of between-study heterogeneity is biased, although the impact of this on 
the robust standard errors is less pronounced. Under this model, it is the pooled total 
variance i.e. ((494-1)*(0.854+0.037)+(356-1)*1.170)/(850-2), that should be equal to 
1.000. It is equal to 1.008 in this case, due to bias in the study estimates arising from 
ignoring ( )dfc  and hb  when the data was prepared.  
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7.4.2 Sensitivity to the Population ICC 
 
The sensitivity of the SMDs using the control, pooled total and pooled naïve standard 
deviations, and their standard errors, to the population ICC is plotted in Figure 7.2. As 
in Figure 6.1 for the mean difference (see Section 6.4.2), the dashed lines denote the 
study-level results, while the solid lines represent the pooled results for the aggregate 
models allowing for clustering and between-arm heteroscedasticity within the studies. 
As for mean differences, the study estimates of Glass’ SMD are unaffected as the ICC 
increases. In contrast, the study estimates of the pooled total SMD are pulled towards 
the pooled estimate, though this is less perceptible in the range of the population ICC 
expected. This effect is more marked for the pooled total SMD estimate as the degrees 
of freedom for the pooled total standard deviation reduce at a faster rate than those 
for the pooled naïve standard deviation, so the impact of the small-sample bias, ( )dfc , 
is greater in this case. The pooled fixed- and random-effects estimates of Glass’ SMD 
become more extreme at a similar rate as the ICC increases. Pooled random-effects 
estimates of the pooled total SMD, in contrast, are more stable than their fixed-effects 
counterparts, providing further support for the conclusion that within-study clustering 
has less impact on random-effects than on fixed-effects meta-analyses. 
 
The study standard errors are larger for Glass’ SMD than for the pooled total or naïve 
SMDs. This is because the part of the standard error relating to the standardising 
metric is more important because the effective degrees of freedom are lower here. 
There is some evidence of between-study heterogeneity in the slope of the standard 
errors for Glass’ SMD but not for the pooled total or naïve SMDs. This arises from use 
of the control arm standard deviation as the standardising metric. Robust standard 
errors for the pooled SMDs are fairly stable across the full range of the population ICC. 
They are also comparable for all three SMD estimates. 
 
The relationship between the population ICC and the between-study heterogeneity in 
the SMD is shown below in Figure 7.3. It can be seen that the D-L estimate decreases 
as the ICC increases for Glass’ SMD and is censored at zero when the ICC reaches 0.1. 
In contrast, the D-L estimate increases for the pooled total and naïve SMDs, until the 
ICC is in the mid-range, and then decreases again up to its maximum. This difference 
arises because the total and naïve SMDs are a function of the ICC, while Glass’ SMD is 
not. Even when the ICC is zero the D-L estimate is higher for the total and naïve SMDs 
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Figure 7.2 Sensitivity Analyses of SMDs and their SEs to the Population ICC 
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than it is for Glass’ SMD. This is because there is more between-study heterogeneity in 
the outcomes for the counselling arm, when compared to the control arm, as Glass434 
expected. 
 
Figure 7.3 Sensitivity of Between-Study Heterogeneity to the Population ICC 
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7.5 Discussion 
 
Standardising the mean difference by a standard deviation creates further complexities 
for the meta-analysis of continuous outcome data from nested therapist designs. The 
small-sample bias in SMD estimates, and the dependency of the sampling variance on 
the population parameter, are issues for all meta-analyses of SMDs432, 437. Where there 
is between-arm heteroscedasticity at both the therapist- and patient-levels, the size of 
the SMD, its small-sample bias, its sampling variance and interpretation depend on the 
choice of standardising metric. A general approach was described, for an SMD in units 
of the pooled total standard deviation, which allows the assumptions of independence 
and common variance to be relaxed within studies and the sample size to differ across 
arms. If the pooled total standard deviation is not available, the pooled naïve standard 
deviation can be used in its place. Hedges’437 g, Huynh’s41 h, White and Thomas’42 gadj, 
and Hedges’43 ( )cbDJ 2  can all be viewed as special cases. This facilitates the pooling 
of continuous outcomes across studies with diverse designs, because the SMDs have a 
comparable interpretation. Between-study heterogeneity in the size of the SMD would 
however be anticipated across study designs, especially if the clustering effect is large.  
 
The example of counselling in primary care was used to illustrate the methods outlined 
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in this chapter. All seven trials had partially nested designs, and there was no evidence 
of between-study heterogeneity in the counsellor ICC, based on the methods proposed 
in Chapter 5. The clustering effect was small, as the pooled counsellor ICC was 0.022, 
the cluster size distribution in the counselling arm was positively skewed, with median 
4.5, and a higher number of patients had been allocated counselling compared to no 
counselling. Consequently, the impact of within-study clustering on the standard error 
of the pooled SMD estimate was not important. Use of a random-effects meta-analysis 
model meant the degrees of freedom for testing the hypothesis of no treatment effect 
were based simply on the number of studies. No allowance was made for imprecision 
in the counsellor ICC due to the frequentist approach adopted. There was evidence of 
bias in the D-L estimate of between-study heterogeneity. The usual standard error for 
the pooled SMD estimate from the random-effects meta-analysis model and the robust 
standard errors were almost identical however. A similar pattern of results was found 
if Glass’ SMD was used. Further work is needed to evaluate the importance of allowing 
for treatment-related clustering effects in meta-analyses involving psychotherapy trials 
more generally. 
 
Glass’ SMD, like the absolute mean difference, is not a function of the counsellor ICC 
under the meta-analysis model assumed for this example. The term within its standard 
error which relates to the denominator of the SMD is not either, so the dependency of 
the standard error on the population SMD is unaffected by the size of the within-study 
clustering effect. The estimate of between-study heterogeneity is lower for Glass’ SMD 
than it is for the pooled total SMD in this example as well. All of these features make it 
an appealing alternative. It is not clear whether it is appropriate to use it under a two-
level heteroscedastic model for the studies, however. Although there is no evidence of 
between-study heterogeneity in the counsellor ICC for the pooled total SMD consistent 
with the results in Chapter 5 (see Figure 7.2), there is for Glass’ SMD. Misspecification 
of the variance-covariance structure may, therefore, be responsible for a bias apparent 
in the counsellor ICC estimate. If this was the explanation, it would simply imply that a 
more complex model is appropriate when using Glass’ SMD for this example. 
 
One advantage of fitting one-step meta-analysis models to the IPD, evident from the 
results presented here, is that the appropriate model is more obvious. There is a clear 
relationship between the means by which the data are standardised and the choice of 
model for the meta-analysis. The impact that model misspecification has on the size or 
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precision of the pooled SMD estimate is also easier to judge on a case-by-case basis. A 
range of issues were raised by this which deserve further consideration. Firstly, even if 
no between-study heterogeneity is observed in a SMD, the fixed-effects meta-analysis 
model is inappropriate because within-study variance estimates are used to define the 
metric. This is necessary because outcome data is standardised across different scales, 
standards and study designs, and extends a point Whitehead102 made about aggregate 
meta-analyses of absolute mean differences to meta-analyses of SMDs. Secondly, a 
population-average model is implicitly adopted in aggregate meta-analyses of SMDs. It 
is arguably necessary for all meta-analyses that involve nested therapist designs too. 
Further work is needed to evaluate the implications of this in meta-analysis models 
including within-study clustering effects, extending the work of Bohning et al431 and 
Viechtbauer422 to a more general setting. Thirdly, the assumption of a common origin 
across studies is less justified when data are obtained from different scales, standards 
or study designs. If a random study intercept were included in a one-step model of the 
IPD, correlation between heterogeneity in the SMD and its origin can be estimated. 
While this correlation is a nuisance for aggregate meta-analyses, it might be of interest 
in one-step meta-analyses.  
 
7.6 Appendix: Programming Code for One-Step Models 
 
STATA VERSION 11 
 
The data were prepared for a dataset IPD_wide.dta with variables study, treat, outcome, 
n1, n0, m1, s1_sq, s0_sq and icc using the Stata code 
 
use IPD_wide.dta, clear 
gen pv=((n1-1)*s1_sq+(n0-1)*s0_sq)/(n1+n0-2)  ** POOLED NAÏVE VARIANCE 
gen st1_sq=s1_sq/(1-((m1-1)*icc/(n1-1)))  ** COUNSELLING ARM TOTAL VARIANCE 
gen ptv=((n1-1)*st1_sq+(n0-1)*s0_sq)/(n1+n0-2) ** POOLED TOTAL VARIANCE 
gen ss_s0_sq=outcome/sqrt(s0_sq)   ** STANDARDISED SCORES 
gen ss_pv=outcome/sqrt(pv) 
gen ss_ptv=outcome/sqrt(ptv) 
gen o_s0_sq=.      ** STUDY ORIGINS 
gen o_pv=. 
gen o_ptv=. 
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levelsof study, local(slist)     
foreach study in `slist’ { 
 qui sum ss_s0_sq if treat==0 & study==`study’ 
 replace o_s0_sq=r(mean) if study==`study’ 
 qui sum ss_pv if treat==0 & study==`study’ 
 replace o_pv=r(mean) if study==`study’ 
 qui sum ss_ptv if treat==0 & study==`study’ 
 replace o_ptv=r(mean) if study==`study’ 
} 
gen outcome_glass=ss_s0_sq-o_s0_sq   ** TRANSFORMED OUTCOMES 
gen outcome_pnaive=ss_pv-o_pv 
gen outcome_ptotal=ss_ptv-o_ptv 
 
A random-effects meta-analysis (model 7.37) for Glass’ SMD under the Behrens-Fisher 
problem can be fitted using 
 
xi: xtmixed outcome_glass i.study i.treat || study: treat, nocons resid(ind, by(treat)) 
 
If clustering is taken into account in the treatment arm (model 7.38), this becomes 
 
xi: xtmixed outcome_glass i.study i.treat || study: treat, nocons || t_id: treat, nocons 
resid(ind, by(treat)) 
 
where t_id is the therapist identifier. The outcome outcome_glass can be replaced by 
outcome_pnaive or outcome_ptotal for the pooled naïve or pooled total SMDs. Model 
7.40 is given by 
 
xi: xtmixed outcome_pnaive i.study i.treat || study: treat, nocons || t_id:  
 
MLwiN VERSION 2.02 
 
A dataset was imported starting with variables study_id, t_id, p_id identifying the study, 
cluster (i.e. counsellor or control patient), and patient, followed by indicator variables 
study_id2, study_id3, study_id4, study_id5, study_id6, study_id7 for Chilvers 2001, Friedli 
1997, Harvey 1998, Hemmings 1997, King 2000 and then Simpson 2000, treatment for 
counselling, control for no counselling, outcome_glass, outcome_pnaive, outcome_ptotal 
for the outcomes, and constant for a column of ones. The data were already sorted on 
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study_id, t_id, and p_id and had been reduced to complete cases. Once in MLwiN, the 
RIGLS option under Equations was used, and the Equations under Model was used to 
open an interactive window. The outcome was specified and the levels. The standard 
random-effects meta-analysis model (7.36) was fitted for outcome_pnaive as follows: 
 
 
Under the Behrens-Fisher problem (see model 7.37) this becomes 
 
Allowing for clustering in the treatment arm (see model 7.38) it is 
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8 DISCUSSION  
 
The objective of this thesis was to develop a conceptual framework for understanding 
the role of therapists in psychotherapy trial designs and to review, adapt, illustrate and 
compare methods for meta-analysing trials involving psychotherapy. Chapter 1 set out 
the rationale and scope of the thesis. Chapter 2 described a framework for considering 
therapist variation, using the broad concepts of precision, internal and external validity 
to outline the implications of nesting of patients within therapists for randomised trials 
of psychotherapy. Chapter 3 systematically reviewed Cochrane reviews of comparative 
studies involving psychotherapy, exploring the range, complexity and recognition of 
issues arising from the multilevel aspects of their designs. It was clear that reviewers 
were aware that therapist variation had implications but were unfamiliar with those for 
precision due to the clustering effects. Chapter 4 introduced the counselling in primary 
care meta-analysis that was used to illustrate the methods described in Chapters 5, 6 
and 7. Chapter 5 adapted methods described by Blitstein et al38 for the meta-analysis 
of ICC estimates, comparing several methods for reducing bias. Chapter 6 extended 
the methods outlined by Kwong and Higgins39 for meta-analysing absolute mean 
differences. And finally Chapter 7 integrated the methods described by Huynh41, White 
and Thomas42 and Hedges43 for aggregate data, and extended those described by 
Goldstein et al44, for the meta-analysis of standardised mean differences, using a one-
step multilevel model for nested therapist designs. The novel aspects of this work are 
outlined in this chapter. 
 
8.1 A Conceptual Framework 
 
Psychotherapy research has developed its own methodological literature, published in 
books, book chapters, and subject-specific journals, separated from the statistical and 
trial methodology literature. This dates back at least as far as the 1952 special issue of 
Journal of Clinical Psychology448-451. It is clear from this that the therapist is central to 
psychotherapy and to psychotherapy research designs. While the complexities inherent 
in conducting research in this area are widely recognised and debated, a methodology 
that adequately addresses them has been slower to develop. One reason for this is the 
lack of a clear, and sufficiently broad, conceptual framework. In 1966, Kiesler45 argued 
that 
“One of the unfortunate effects of the prolific and disorganized psychotherapy research 
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literature is that a clear-cut, methodologically sophisticated, and sufficiently general 
paradigm which could guide investigations in the area has not emerged. Perhaps this is 
an unavoidable state of affairs in a new area of research. Yet a perusal of this literature 
indicates that most of the basic considerations necessary for a general paradigm have 
appeared, albeit in many cases parenthetically, at some place or another. But to date 
no one has attempted to integrate empirical findings and methodological concerns in a 
way that might lead to a useful research paradigm. This lack of integration of the 
paradigm ingredients has minimized their impact on investigators in the area.” (p. 110) 
 
Regrettably, this remains largely the case 40 years later. One explanation is that, over 
the intervening period, generic methodologists, among them statisticians, have tended 
to be more familiar with the statistical and mainstream literature than with the subject 
specific one. It is only recently that issues concerning therapist variation were raised in 
the statistical literature81 with no reference made here to the psychotherapy literature. 
Since 1999, attention has focused on the implications for precision of treatment effect 
estimates. Reading this one might be forgiven for linking the role of the therapist in 
randomised trials, from a statistical perspective, simply to the size and precision of the 
associated clustering effect. The therapist, however, is more fundamentally part of a 
complex or multi-component intervention. They are on the causal pathway from the 
psychotherapy to the patient. It is their joint status as a potential treatment factor and 
experimental unit which makes them central to the design and analysis of randomised 
trials of psychotherapy. Characteristics of the therapist delivering the intervention are 
important regardless of the size of the clustering effect because of the implications for 
internal and external validity. They are of specific interest as the predictors of therapist 
variation could be used to inform the selection and training of therapists. 
 
The conceptual framework developed provides one basis for understanding the nature 
and impact of performance bias, and by extension, selection, detection and attrition 
biases in all clinical trials. By tackling the complexities around the role of therapists in 
psychotherapy trials, a general research paradigm has begun to emerge, with the 
potential to guide the design and analysis of complex intervention trials in the future, 
when more fully developed. This should contribute to a clearer understanding of the 
methodology used in drug trials and epidemiological studies. The broad concept of 
multiple levels of experimental units joins longitudinal, multicentre, cluster-randomised 
and crossover trials together, since each has a multilevel trial design. The inability to 
randomise centres, time or clusters to patients leads to cluster sampling of outcomes, 
necessitating an observational component, which perhaps deserves greater attention. 
The combination of experimental and observational design aspects in randomised trials 
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has implications for their analysis and interpretation. Clarity is needed to ensure they 
follow directly from, and are thus appropriate to, the trial design. 
 
The concept of multiple treatment variables characterising complex interventions, with 
some fixed and others random, some categorical, others continuous, has the potential 
for facilitating greater understanding of the components of complex interventions, how 
they interact, which are important, to what extent, and for whom. This brings what is 
currently referred to as process research within the remit of randomised trials enabling 
a more complete evaluation of the causal effects of multi-component interventions. In 
this thesis, two components have been considered – the therapeutic approach and the 
therapist. Both are categorical, the former is fixed and the latter random. This provides 
a relatively simple illustration of a more general paradigm. Going back to the example 
comparisons given in Figure 2.1, it is clear that what is being proposed is an extension 
to factorial trial designs. Currently, the majority of psychotherapy trials are incomplete 
factorial trials of packages of therapeutic approaches and therapist characteristics. The 
PACE trial3 discussed in Chapter 1 is typical of this. It is consistent with the evaluation 
of the effectiveness of complex interventions, implying a pragmatic research question. 
This could be viewed as a little premature if a detailed understanding does not exist of 
the causal effects of the components of the therapeutic approach, and their interaction 
with therapist characteristics. At present, earlier-phase psychotherapy trials tend to be 
smaller versions and do not provide a sufficient basis for determining the optimal form 
of a complex intervention for taking forward to a large-scale definitive trial. This is why 
psychotherapy researchers have found the drug metaphor and associated trial designs 
uncomfortable for complex interventions. 
 
Integrating the relevant psychotherapy and statistical literatures on therapist variation 
has proved fruitful. Initial discussions with psychiatrists, psychologists and statisticians 
working in the field helped to locate different sections of this literature. The references 
and more focused searches identified the remainder. Although extensive, the approach 
taken was not fully systematic, based on the standards of Cochrane reviews. It served 
to provide the ingredients necessary to develop a conceptual framework however. The 
systematic methodological review of Cochrane reviews described in Chapter 3 provided 
a means of assessing how adequate and complete this framework was. This generated 
in its turn an overview of further areas of methodological research currently needed. It 
is clear in hindsight that this component of the thesis is a form of qualitative research. 
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Its potential as a means for improving the speed with which important methodological 
issues are addressed is also clear. Over time, as the relevant methodological literature 
becomes increasingly vast and disparate, its implementation by researchers in the field 
requires them to be aware of more, to synthesise more, and to have a greater level of 
expertise. For the same reasons as it became necessary to summarise clinical research 
in Cochrane reviews, now is perhaps time to do so on a larger scale for methodological 
research. Systematic methodological reviews could then feed into the guidance given 
to researchers on reporting of primary research studies, and more generally in courses 
and textbooks. Regular updates of this guidance might then help them keep abreast of 
developments, and ultimately improve the standard of research and patient care. This 
has the potential to avoid unnecessary duplication of effort and to help to set priorities 
for future methodological research. 
 
8.2 Therapist Variation in Meta-Analyses of Psychotherapy 
 
Traditionally, meta-analyses of treatment effects provided by randomised trials involve 
two levels: one represents the trials and the other the patients in the trials. As in other 
multilevel situations, implications of both levels should be considered for the precision, 
internal and external validity of treatment effect estimates. Precision is affected by the 
number of trials and patients-per-trial, and the relationships among treatments, trials, 
and patients. Internal validity is affected by the nature of the allocations of treatments 
to trials, trials to patients, and treatments to patients. External validity is then affected 
by the selection of trials, and of patients within trials. As in many psychotherapy trials, 
only the allocation of treatments to patients is random in meta-analyses, and then only 
within the trials. The importance of investigating treatment-by-covariate interactions is 
hence raised above that of an exploratory analysis. Heterogeneity in the patient-level 
variance may also be expected between trials, unless the patient eligibility criteria and 
sample characteristics are identical across the trials. Accordingly, greater attention is 
needed to the observational aspects of meta-analyses as well. 
 
Additional levels in meta-analyses of psychotherapy trials have further implications for 
the precision, internal and external validity of treatment effect estimates. Nevertheless 
it was clear from the systematic methodological review described in Chapter 3 that the 
precision implications of therapist variation had not been considered within any of the 
relevant reviews published in Issue 1, 2007, of the Cochrane Database of Systematic 
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Reviews. There is also no published methodological guidance, although a paper was in 
preparation and a draft of this was kindly shared39. The methods proposed in Chapters 
5, 6 and 7 can be viewed as extensions of this. It has been argued here that between-
arm heteroscedasticity at the therapist- and patient-levels in trials affects the choice of 
an appropriate model for meta-analyses. The size of the therapist and patient samples 
and a current lack of published therapist ICC estimates add other complexities. Use of 
individual-patient-data to conduct meta-analyses is also rare, necessitating adoption of 
an aggregate approach, based on the summary statistics and standard errors available 
in published reports. In part in response, Kwong and Higgins39 restricted their work to 
aggregate methods. They derived the sampling distribution of a mean difference under 
a two-level heteroscedastic model, and suggested a method for obtaining internal ICC 
estimates from outcome variances often reported. They proposed a general approach 
for meta-analyses of odds ratios, absolute and standardised mean differences. Finally, 
they assessed the sensitivity of conclusions to assumptions about the underlying ICC. 
 
Meta-analyses of the individual-patient-data tend to have been justified on the basis of 
problems with meta-analyses of aggregate data obtained from published reports152, 428, 
452-456. Yet, the distinction between IPD and aggregate approaches confounds whether 
data for the meta-analysis is obtained from the published reports or original datasets 
with whether an aggregate or one-step approach is taken to the analysis of this data. 
The limitations of using published reports are predominantly practical, while those that 
relate to use of an aggregate approach are predominantly statistical. In this context, it 
is expected that therapist ICC estimates will not be available in published reports, and 
that the analyses presented will ignore treatment-related clustering effects associated 
with therapists. So, summary statistics and appropriate standard errors taking account 
of clustering, which are necessary for an aggregate meta-analysis, are expected to be 
missing from published reports. This data could be imputed from other sources, but if 
this is done the same principles apply here as to all forms of missing data. Uncertainty 
in the value of these estimates should be formally taken into account. Little is currently 
known about the size or predictors of therapist ICC estimates. Thus, one advantage of 
collecting the IPD for meta-analyses of psychotherapy trials is that doing so minimises 
the impact of uncertainty on the precision of the treatment effect estimate. Given the 
imprecision of ICC estimates, the additional resource required might be an acceptable 
price to pay. 
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The distinction between aggregate and one-step meta-analyses mirrors that of cluster-
level and individual-level analyses of cluster-randomised trials. However, in the context 
of an aggregate meta-analysis, it is common practice to assume the estimated weights 
are known and the number of trials and patients sampled is infinite102, 457. It is not 
entirely clear why this is the case. It does reduce the apparent complexity of the 
analyses, but at a cost. It makes it more difficult for researchers to generalise their 
understanding of multilevel analyses gained from other areas, and less easy for them 
to appropriately assess the validity of model assumptions in their circumstances. As it 
is the principal approach in use, textbooks, such as Whitehead102, include equivalent 
one-step models rather than aggregate counterparts to them. Comparison of the two 
approaches was helpful here for clarifying their strengths and limitations. 
 
One potential limitation of the usual aggregate approach, discussed in Chapter 6, is its 
failure to fully allow for the uncertainty present when testing hypotheses regarding the 
treatment effect. The impact is more apparent if the number of studies, therapists or 
patients is small and the corresponding design effects are large. Cornfield337 described 
clustering penalties for the standard error and effective degrees of freedom. Kwong 
and Higgins39 considered the implications for the standard error but not the degrees of 
freedom. These were considered here in the context of meta-analyses of standardised 
mean differences because they are important in determining the extent of Hedges’432, 
437 small-sample bias and the standard error of a standardised mean difference. They 
are also important for the meta-analysis of absolute mean differences where a fixed-
effects meta-analysis model is fitted in the presence of within-study clustering. If a 
random-effects meta-analysis model is adopted, the number of studies determines the 
degrees of freedom, because the studies represent the highest level in the model. The 
number of therapists is thus less important for meta-analyses than it is for randomised 
trials. Its importance instead lies in the precision of the estimated weight given to each 
study. This presumably depends on the sampling distribution of the standard error of 
the treatment effect. Since this is unknown and likely to be a function of the therapist 
ICC,use of a robust sandwich estimator offered a compromise. The methods described 
by Sidik and Jonkman40 were therefore adapted. 
 
An issue that became apparent, when comparing the estimates and standard errors of 
one-step models with those based on the robust sandwich estimator, was bias in a D-L 
estimate of between-study heterogeneity of the treatment effect (see Chapter 6). This 
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appeared to bias the robust sandwich estimator, when it was used in conjunction with 
a random-effects meta-analysis. Component-wise estimation of the variance terms and 
failure to account for their imprecision provides a likely reason422. However the impact 
of bias on a robust sandwich estimator deserves further consideration, since it implies 
model misspecification is less important than the use of unbiased estimates. A second 
issue, highlighted by one-step meta-analysis models of standardised mean differences, 
is a relationship between the data, or the method of data handling, and the choice of 
model for the meta-analysis. It was apparent that fixed-effects meta-analysis models 
were not generally appropriate when obtaining data from published study reports. This 
is because they ignore the cluster sampling of patients within studies. Similarly, bias is 
known to result from between-study heterogeneity in the patient-level variance422. As 
this is expected, due to non-random allocation of studies to patients, it can be argued 
that a random-effects meta-analysis model is appropriate even if there is no between-
study heterogeneity in the treatment effect. 
 
Kwong and Higgins39 generalised an approach proposed for absolute mean differences 
to odds ratios and to standardised mean differences. It has been shown that methods 
for ICCs, absolute and standardised mean differences share common features, but are 
also quite specific. Use of a population-average or cluster-specific meta-analysis model 
becomes an issue deserving of greater attention where the summary measure is not a 
mean difference. This was discussed in Chapter 7 in relation to the use of therapist- or 
study-level standardising metrics and the need for a common metric for all arms in the 
studies. It is not clear at this stage what should be done for odds ratios, relative risks, 
risk differences, or indeed hazard ratios. 
 
The most influential papers on therapist variation in the psychotherapy field are those 
of Crits-Christoph and colleagues80, 363 but the statistical methods used in these papers 
are unsophisticated. In contrast, the idea of pooling therapist ICC estimates to explore 
predictors and to inform methods for minimising the clustering penalties in early-phase 
trials is reasonably advanced, even by today’s standards. Baldwin et al were preparing 
an extension to these papers and kindly shared a draft364. The statistical methods used 
reflect recent developments. These therefore served as the starting point in Chapter 5. 
Psychotherapy trials, unlike cluster-randomised trials, often constitute the majority, if 
not all, the trials in relevant meta-analyses, as was seen in Chapter 3. As such, pooling 
of therapist ICC estimates and exploration of their predictors is an additional analysis 
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of interest in this setting. As with any meta-regression, a large number of studies are 
required for adequate precision. The number of predictors which can be considered is 
further limited by the precision of the ICC estimates within the trials. As the chance of 
obtaining negative ICC estimates is higher in smaller trials, this has implications for the 
complexity of the assumed variance-covariance matrix in meta-analyses of early-phase 
psychotherapy trials, as observed in Chapter 6. An unstructured variance-covariance 
matrix led to computational problems, while an exchangeable one might be unrealistic. 
Nevertheless the presence of between-study heterogeneity in the ICCs is an important 
consideration. It was evident from the illustrative example that, where ICCs are closely 
matched, much of the heterogeneity in estimates can be attributed simply to sampling 
variation. This reflects the level of imprecision of these estimates in the counselling in 
primary care trials seen in Chapter 5. Since the sample size is limited in meta-analyses 
of randomised trials, large naturalistic databases may initially provide a better setting 
for exploring predictors. The relative ease of fitting complex models highlights one of 
the main practical reasons for using the IPD. 
 
One dilemma faced by the meta-analyst in this setting is the interpretation and choice 
of metric for standardised mean differences in the presence of clustering. The options, 
being numerous, fall into two broad categories, relating to specific or pooled standard 
deviations. It is arguable which is easier to interpret and it will probably depend on the 
circumstances. For the example of counselling in primary care, the small size of the 
clustering effect makes the pooled total standard deviation a preferred metric over the 
control arm standard deviation, as its interpretation is similar to Hedges’ g. The need 
for a common metric across treatment arms defined on a study-by-study basis implies 
a treatment-specific unstructured variance-covariance matrix, if the metric is based on 
a specific standard deviation. In the case of pooled metrics, the averaging of two or 
more population standard deviations makes the random structure somewhat contrived. 
In a one step meta-analysis, the numerator and denominator of an ICC are separately 
estimated. Since the denominator depends on the choice of metric, the ICC varies as a 
function of the metric even when the model is correctly specified. 
 
8.3 Limitations and Future Work 
 
It is clear that this is a fairly untouched area in need of further exploration. Limitations 
of the thesis are linked to the possibilities for future work. For example, the conceptual 
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framework could be elaborated to include situations in which there are more than two 
levels, such as repeated measurements in therapist designs and trials of group-based 
interventions. Further consideration could be given to use of multi-tiered experimental 
designs138 in early-phase psychotherapy trials, reflecting possible interest in 
therapeutic approaches per se rather than their combination with specific therapist 
characteristics. Similarly, the advantages of crossed designs for early-phase trials could 
be considered further in relation to learning curves, as might the possibility of 
evaluating the optimal levels of multiple interacting treatment components using 
response surface designs458. The aim of this work would be respond more fully to 
Kazdin’s26 challenge of using experimental manipulations to explore both common and 
specific factors contributing to psychotherapy, providing a greater understanding of 
the individual causal effects of a complex intervention. A broader investigation of 
issues arising in the context of other complex interventions, such as surgery and 
physiotherapy, might also be carried out. 
 
Further work is needed to evaluate the meta-analysis methods proposed here. As was 
discussed in Chapter 5, simulation work is needed to assess the extent of residual bias 
in the study and pooled ICC estimates from approximations for ANOVA estimates and 
average cluster sizes. This work could also include an assessment of the adequacy of 
Fisher’s377 approximate standard error and the D-L estimate of between-study 
heterogeneity in this context. As was discussed in Chapter 6, simulation work is also 
needed to evaluate the use of Sidik and Jonkman’s40 robust ‘sandwich’ estimator in an 
aggregate meta-analysis of clustered data, with the aim of elucidating the impact of 
bias in the between-study variance estimate. This might also include an assessment of 
the scenarios with which allowance should be made for imprecision of the estimated 
weights. The role of imprecision in the clustering effect might also be explored within 
a Bayesian framework, adapting existing methods459. Further work is also needed in 
relation to Chapter 7 to assess the impact of unequal cluster sizes on the proposed 
methods. It might be possible to do this within a sensitivity analysis, where relevant 
information is unavailable. Finally extensions are needed for meta-analyses involving 
crossed designs and for binary and survival outcomes. Methods proposed for repeated 
measures149, 151, 152, 460 could be extended to allow for other sources of clustering, such 
as therapist variation. 
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